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ABSTRACT 
The pathogenesis of the enteric protozoan parasite Entamoeba histolytica remains poorly 
understood. Moreover, the host responses during the early periods of interaction in the 
gut remain to be clarified. In this study 1 investigated the cell specific responses to the 
parasite and the importance of cross talk between epithelial-immune cells that could 
potentially influence the outcome of infection, with a central focus on Nuclear factor 
(NF)-KB. NF-KB is a ubiquitous transcription factor that plays a critical role in mucosal 
inflammation and its regulation by E. histolytica has not been studied so far. Gal-Iectin is 
a weIl characterized parasite virulence factor and vaccine candidate. 1 first characterized 
the interactions between Gal-Iectin and macrophages and found that several 
proinflammatory genes are upregulated as early as 2h. The Gal-Iectin activated NF-KB 
and up-regulated Toll like receptor-2 expression in an NF-KB- and p38 Mitogen 
Activated Protein (MAP) kinase-dependent manner. As intestinal epithelial cells (IEC) 
form the first line of active ho st defense against mucosal pathogens, 1 determined the 
interaction between ameba soluble proteins and naive IEC. 1 observed that the parasite 
could elicit a chemokine response via activation of PB kinase and phosphorylation of 
p65 subunit to induce monocyte chemoattractant protein-l. The consequent recruitment 
of immune cells could be responsible for colonic inflammation. FinalIy, 1 made the novel 
observation that in macrophage-primed IEC, ameba proteins elicited a cytoprotective 
stress response. Using a combination of siRNA and over expression studies, 1 
demonstrated that amebic proteins increased the expression and phosphorylation of Heat 
shock protein (Hsp) 27 thereby enhancing its association with and subsequent inhibition 
of Inhibitory KB kinase (IKK). The resulting inhibition of NF-KB could be a potential 
mechanism that explains the absence of inflammation in the majority of infected 
individuals. Taken together, the findings of this study open up a new facet in the 
pathogenesis of amebiasis and unravel a novel paradigm to study host-parasite 
interactions in the gut. 
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.~---- ABREGE 
La pathogénèse du parasite protozoaire Entamoeba histolytica demeure inconnue. De 
plus, la response immunitaire de l'hôte durant les premières intéractions dans l'intestin 
doit être clarifié. Dans cette etude, j'ai investigé la response cellulaire spécifique au 
parasite et l'importance de la diaphonie entre les cellules épithéliales et immunitaires qui 
pourrait influencer l'infection,spécifiquement au niveau de NF-KR. NF-KR est un facteur 
de transcription omniprésent qui joue un rôle critique dans l'inflammation mucosale. 
Jusqu'à date la régulation de NF-K'B par E. histolytica n'a pas été étudié. La Gal-Iectin est 
un facteur de virulence du parasite bien charactérisé et une protéine candidate pour un 
vaccin contre l'amibiase. J'ai premièrement charactérisé les intéractions entre la Gal-
lectin et les macrophages et j'ai trouvé que l'expression de plusieurs gènes 
proinflammatoires augmente après deux heures. La Gal-Iectin a activé NF-KR et 
augmenté l'expression du récepteur Toll-2 de façon dépendente de NF-KR et des MAP 
kinases. Puisque les cellules intestinales épithéliales (CIE) forment une première ligne de 
défense contre les pathogènes intestinaux, j'ai déterminé l'intéraction entre les protéines 
solubles de l'amibe et des CIE naïves. J'ai observé que le parasite pouvait induire 
l'expression de chimokines (MCP-l) par l'activation de PI3 kinase et par la 
phosphorylation la sub-unité p65. Le recrutement des cellules immunitaires pourraient 
donc être responsable pour l'inflammation colonique. Finalement j'ai fait la nouvelle 
observation, que dans les CIE premièrement exposées aux macrophages, les protéines 
solubles amibiennes peuvent provoquer une response stress cytoprotectrice. En utilisant 
la siARN et étudiant l'expression des gènes, j'ai démontré que les protéines amibiennes 
augmentent l'expression et la phosphorylation de la protéine de choc thermique, Hsp27. 
Cette activation augmente l'association d' Hsp27 avec IKK résultant dans l'inhibition de 
IKK. L'inhibition de NF-KR pourrait être un mécanisme qui expliquerait l'absence d'une 
response inflammatoire dans la majorité des cas d'infections. Les résultats de cette étude 
permettent d'explorer d'autres aspects dans la pathogenèse de l'amibiase et permettent 
d'introduire un nouveau paradigme pour étudier les intéractions entre les parasites 
intestinaux et l'hôte. 
iii 
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SECTION 1: LITERA TURE REVIEW 
Introduction 
Amebiasis is an acute or chronic intestinal disease caused by the protozoan parasite 
Entamoeba histolytica. The disease affects 1% of the world population and is widely 
prevalent in tropical developing countries su ch as India, Bangladesh, Mexico and South 
Africa (1). The intestinal form of the disease is characterized by colonie inflammation, 
dysentery with severe abdominal pain and discomfort. 
Pathogenesis of amebic colitis is poorly understood. In vivo and in vitro studies suggest 
two different modes of initiation of inflammation. One theory proposes that parasite 
contact with intestinal epithelial cells is required to initiate tissue destruction while the 
other school of thought suggests that soluble amebie factors can initiate an abnormal host 
response in the absence of contact. These processes may not necessarily be mutually 
exclusive but might operate simultaneously during infection. Both the concepts suggest 
that host inflammatory response plays a major role in tissue destruction and the ensuing 
symptoms such as colonic ulceration and bloody diarrhea. A major hindrance in our 
understanding of how the disease occurs stems from the lack of a suitable animal model 
that mirrors the human disease. The SCID-HU- Xenograft model attempted to address 
this and the in vivo observations made from this model has contributed significantly to 
our understanding of the host responses during amebic infection (2, 3). However, these 
studies are not mechanistie and have drawbacks such as species specificity. 
Consequently, despite few novel observations during the last decade, unfortunately the 
pathogenesis of intestinal amebiasis still remains a puzzle. For example, the host and 
parasite factors that mediate inflammation have not been elucidated fully; also it is not 
clear if host cells, in particular, intestinal epithelial cells play an active role in the 
initiation of inflammation and finally, it is not known if the cross talk between different 
cells of the mucosa can potentially modulate the outcome of infection. 
1 
The parasite has three well-defined virulence factors: GalactoselN-acetyl Galactosamine 
inhibitable lectin (Gal-Iectin), Cysteine proteases and amebapores (4). Gal-Iectin is a 
surface adhering protein (adhesin) essential for binding to the host cells and subsequent 
cell death. It is also highly immunogenic and is a candidate vaccine molecule. It has 
previously been shown to induce TNF-a (5) and IL-12 (6) from mou se and human 
macrophages. Apart from this, its potential to activate innate defenses and role in the 
pathogenesis have not been studied well. Toll like receptors (TLR) are a recently 
discovered group of pattern recognition receptors of the innate immune system that are 
increasingly being shown to play a major role during infection and inflammation (7). AIl 
TLRs discovered to date, activate the transcription factor NF-KB whieh is a key regulator 
of the pro-inflammatory response. It has been previously shown that inhibiting this 
transcription factor significantly reduced inflammation in the mouse xenograft model (2). 
However, the parasite molecules that induce NF-KB and the significance of its induction 
or suppression in amebic infection are not known. 
Intestinal epithelial cells form a single layer of mucosal barrier that respond to pathogens 
by secreting various mediators such as chemokines and cytokines and by increased 
surface expression of receptors (8). Thus, they are increasingly being demonstrated to 
play an active role in signaling the immune system and modulate the disease process. 
Given the extensive cellular infiltration observed during amebic colitis, it is of great 
interest to understand the mechanism of immune cell homing that could potentially 
aggravate tissue damage. While previous studies implicate IL-8 as a potent mediator for 
neutrophil infiltration during amebic infection (9), the chemokines responsible for 
homing of other cell types have not been explored. 
Recently the intestinal epithelial cell responses to pathogens or commensals have been 
shown to be altered by immune cells (10). The stress response is a universal response to 
various stressors su ch as thermal, chemical, oxidative or toxie stimuli. It is characterized 
by expression of heat shock proteins which act as chaperones and prevent the cellular 
proteins from denaturation, ultimately conferring protection to cells. This stress response 
has been shown to suppress the cellular inflammatory responses (11) and its role in 
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intestinal amebiasis has been hitherto unexplored. Moreover a frank amebiasis is seen 
only in 10% of infected people suggesting that sorne sort of anti-inflammatory 
mechanisms operate in majority of individuals. 
With this background, the current study was taken up with the following specific 
objectives. 
1. To study the regulation of Tolllike receptors by Gal-Iectin in macrophages 
2. To understand the mechanism of induction of monocyte chemotactic protein-l by 
amebic components from naive intestinal epithelial cells 
3. To check the stress response induced by amebic components and its modulation 
of NF-KB activation in macrophage conditioned intestinal epithelial cells. 
Our studies showed that Gal-Iectin induces a global pro-inflammatory response in 
macrophages and also up regulates TLR-2 expression via NF-KB and p38 MAP kinase. 
This could have significant effect both in the pathogenesis of amebiasis and also during 
vaccination with Gal-Iectin molecule. For the first time we also observed that soluble 
amebic factors could differentially activate NF-KB in naive and macrophage conditioned 
intestinal epithelial cells. The significance of this observation is 2-fold; in naive epithelial 
cells the activation of NF-KB via PB kinaseIP65 pathway results in the secretion of 
chemokine MCP-l, which could play a role in the initiation of inflammation. On the 
other hand, our observation of suppressed NF-KB activation via the stress response in 
macrophage conditioned epithelial cells could explain the absence of inflammation in 
majority of individuals infected with the parasite. 
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CHAPTER 1: ENTAMOEBA HISTOLYTICA AND AMEBIASIS 
1.1 E. histolytica - Epidemiology and life cycle 
Entamoeba histolytica is a unicellular parasite belonging to the Phylum Protozoa, Class 
Lobosea, Order Amoebida and Family Entamoebidae. It is the causative agent of human 
amebiasis which is found to affect 50 million people around the world causing 40,000-
100,000 thousand deaths per year (1). The disease is the fourth leading parasitic cause of 
mortality behind malaria, Chagas' disease and Schistosomiasis. Amebiasis is widely 
prevalent in developing countries in Asia, Africa, Middle East and South America. 
Susceptible factors include poor personal hygiene, unsanitary conditions, and 
overcrowding. Incidence in non-endemic countries such as the United States and Canada 
is around 1-2%. Increased cases in developed countries are observed in institutionalized 
populations (2, 3), male homosexuals (4) and international travelers (5). While in the 
majority of infected people the parasite resides in the large intestine as a non-harmful 
commensal, in 10 % of people, it invades the mucosa and cause amebic dysentery with 
severe abdominal discomfort (6). Rarely, the parasite penetrates deep into the submucosa 
and reaches different organs such as the liver, lung or even the brain via the blood 
circulation. Amebic Liver Abscess (ALA) is a severe complication with high mortality in 
1 % of amebiasis patients and is found more often in men (10 male to 1 female) (7). 
However, severe cases are found in young children, pregnant women and elderly people 
(8). Invasive amebiasis has also been reported as an emerging parasitic disease in AIDS 
patients (9). 
Earlier studies of the parasite and pathogenesis of disease were confusing because of the 
presence of morphologically indistinguishable but non-pathogenic E.dispar. Recent 
genetic and biochemical advancements have been successful in differentiating these 
organisms as two distinct species and lead to a shift in research to identify how these 
differences define the pathogenic or otherwise nature of the se two amebae. 
Immunological tests su ch as ELISA, genetic tests as PCR and restriction length 
polymorphism are now available that can reliably identify these two species (l0-12). 
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The life cycle of E. histolytica is simple and straightforward with humans as the only 
natural hosts and no secondary or intermediate hosts. Infection occurs through ingestion 
of quadrinucleated cyst (8-20 /-lM) through food and water contaminated by feces of 
infected hosts. Excystation takes place in the terminal ileum releasing eight motile 
vegetative forms, trophozoites (10-60 /-lM) that colonize the large intestine, primarily the 
colon. During this phase, the parasite can invade the mucosa and cause disease in 10% of 
individuals. Trophozoites feed on the gut flora, multiply by binary fission and under 
unknown environmental cues, form cysts which are passed out through feces to continue 
the life cycle. To summarize, amebiasis, caused by the enteric protozoan parasite E. 
histolytica, is a signiflcant health problem around the world and poor sanitation and 
personal hygiene are risk factors for the disease. 
1.2 Pathogenesis of intestinal amebiasis 
Both host and parasite factors play a role in the pathogenesis of amebiasis which involves 
three distinct stages; colonization, mucus depletion and destruction of host epithelial and 
immune cells. The first stage is the colonization of trophozoites to the mucosal surface of 
large intestine. Trophozoites adhere to the mucins via surface Gal-Iectin molecule and 
various inhibitors su ch as Galactose, N-acetyl Galactosamine, monoclonal antibodies to 
Gal-Iectin and secretory IgA can effectively prevent colonization and also binding to 
target cells. In the next stage, the parasite disrupts the mucous barrier by a host of 
enzymes, particularly, the cysteine proteases. Finally, amebae cornes in contact with 
epithelial cells and kills them through a yet unknown mechanism, most probably 
involving amebapores. Following destruction of epithelial layer, trophozoites penetrate 
further and kill immune cells whose products contribute to tissue destruction and 
aggravate inflammation. At this stage, parasite might get into blood vessels and be 
carried to different organs such as li ver, lung or even brain. Amebic li ver abscess is the 
most frequent extra-intestinal manifestation. While 90% of intestinal amebiasis cases are 
manifested in the form of bloody diarrhea/dysentery, other forms su ch as fulminating 
colitis, appendicitis and ameboma of colon are not uncommon. 
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Colonization is the first and essential step for both establishing the infection and for 
pathogenesis of invasive disease. As mentioned, this is mediated by the parasite surface 
molecule, Gal-Iectin which binds to the Galactose and N-acetyl D-Galactosamine 
moieties of the colonic mucin (13, 14). E. histolytica Gal-Iectin is a hetero-dimeric 
protein consisting of a 170 kDa heavy subunit linked to a 31/35 kDa light subunit via 
disulphide bond. Recently, the light chain was found to associate non-covalently with a 
150 kDa intermediate subunit (15). Gal-Iectin binds to the exposed terminal sugars of 
mucins and the target cens like bacteria and host epithelial/immune cells. Owing to their 
high oligosaccharide content, mucins bind to amebae and prevent them from making 
contact with host epithelial cens (16-18). Intestinal microbiota also competes with 
amebae for binding to the mucins and thus reducing the trophozoite colonization (19). 
Amebae have been shown to bind purified rat and human colonic mucins with high 
affinity (Kd=8.2X 10-11 M-1) (14). In addition, mucins, by their gel forming properties, 
trap the pathogens and protect the underlying epithelial layer. Thus mucins serve two 
different purposes; on one hand they help in establishing the amebic infection while at the 
same time trap the parasite and prevent its invasion. However, paradoxically it has been 
observed that while purified rat colonic mucins can effectively bind amebae trophozoites, 
the parasite fails to colonize the rat gut, suggesting involvement of additional host and / 
or parasitic factors that determine the success or otherwise of parasite colonization (13). 
In the second phase, trophozoites overcome the mucous barrier by two purported 
mechanisms; depletion and destruction. The precise mechanism of mucous depletion is 
not known. Studies in the gerbil model of invasive disease suggest that E. histolytica 
trophozoites release a mucous secretagogue that induces hypersecretion and eventual 
depletion of mucous from goblet cens (20, 21). The exact nature of this secretagogue has 
not been identified. Recent studies suggest this could be the prostaglandin E2 (PGE2). 
PGE2 has a potent mucous secretogogue effect on rat and human colonic epithelial cells 
(22) and E. histolytica has been shown to contain a cyc100xygenase (COX)-like enzyme 
(23). The enzyme has been isolated from the parasite, purified and shown to catalyze the 
conversion of arachidonic acid to PGE2. Amebic trophozoites also evoke massive 
mucous secretion in human colonic cens in a PKC-dependent manner (24). In contrast to 
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the mucous depletion, mechanisms of mucous destruction have been recently elucidated 
weIl. Cysteine proteases (CP) are key players in the destruction of the mucous layer while 
glycosidases might also be important. Amebae secreted products have been shown to 
degrade purified mucins from human colonic epithelial cells and the degraded mucins 
were less efficient in binding to amebae trophozoites (25). Specifically, suppressing E. 
histolytica cysteine protease 5 (EhCP5) expression makes the parasite less virulent (26). 
Interestingly, this particular CP is absent in the non-virulent species E. dispar. In addition 
to CPs, ameba also produce glycosidases such as ~-N-acetylhexosaminidase, a-D-
glucosidase, ~-L-fucosidase, ~-D-galactosidase and ~-D-glucosidase (27, 28). Indeed, 
amebae secreted products can degrade colonic mucin oligosaccharides independent of 
proteolytic activity (29). These observations confirm that virulent ameba have evolved 
mechanisms to overcome host defense mechanisms. However, as invasion is a dead-end 
for the parasite life cycle, it is not clear why trophozoites would actively degrade mucins 
and invade. It could be that CPs in principle serve a different function and under an 
aberrant host response, facilitate inadvertent parasite invasion. 
After breaching the mucous protection, trophozoites get in contact with intestinal 
epithelial cells. As for intestinal mucins, adherence of ameba to host cells including 
epithelial cells is mediated by Gal-Iectin molecule. This is followed by cytolysis, the 
mechanism of which is poody understood. Gal-Iectin mediated cell contact is essential 
for cell cytolysis. This was evident in studies using Chinese Hamster ûvary (CHû) cells 
deficient in terminal galactoselN-acetyl galactosamine residues and these mutant cells are 
resistant to amebic adherence and cytolytic activity (30). Rapid death of ho st target cells 
was observed within 5-15 minutes after contact with the parasite (31) and the cells were 
found to undergo both apoptotic and necrotic death (32, 33). Amebapores are thought to 
play an important role in this (34-36). These are pore-forming proteins which are inserted 
by the parasite into the target ceIl membranes upon contact (37). They have been shown 
to cause depolarization of epithelial cells and are directly involved in celllysis (38). CPs 
also play key role in target cell killing (39). ûverexpression of EhCP2 enhanced the 
parasites ability to destroy CHû monolayer in vitro and this is blocked by cysteine 
protease inhibitor, E-64 (40). However, overexpression of EhCP2 did not augment the 
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parasites ability to cause ALA in animal models (40) while general inhibition of CP 
activity by E-64 abrogated or reduced the virulence to cause ALA (41). This suggests that 
CPs are important for pathogenicity but it is unclear which CPs are specifically involved. 
A recent study (26) has shown that CP5 plays a major role in amebic virulence. In 
addition to the killing of epithelial cells, ameba induced de gradation of the extracellular 
matrix (ECM) (42) and epithelial tight junctions (43) also might contribute to mucosal 
damage. This stems from the observation that proteinases play a major role in cytopathic 
effects su ch as detachment and rounding of cells seen in vitro (44). CPs also have been 
demonstrated to degrade laminin (45). Trophozoites have electron dense granules 
containing collagenase, which could degrade ECM (46). Ameba modulation of epithelial 
permeability changes is being studied. The epithelial barrier has several components of 
which tight junctions (TJ) play critical role. TJ link the adjacent cells and also maintains 
the polarity of cells by separating apical and basolateral portions of cell membrane. They 
selectively permit the passage of solutes through them and thus help in the homoestasis of 
gut physiology. E. histolytica has been shown to disturb the epithelial barrier function in 
vitro by causing a steep decrease in the Trans Epithelial Resistance (TER) of intestinal 
epithelial cell (IEC) monolayer grown in transwells (43). The parasite has also been 
specifically shown to increase paracellular permeability as measured by the abnormal 
passage of small molecules such as mannitol. Understanding the mechanism and the 
parasite factors involved in TJ alterations need further studies. 
The role of the host immune response in the pathogenesis of amebic colitis is increasingly 
being appreciated. The extensive damage to colonic tissue is also a result of infiltration 
and lysis of host immune and inflammatory cells. Once the epitheliallayer is destroyed, a 
massive infiltration of immune cells is seen at the area of invasion (47). Neutrophils are 
the first cells to be seen in the lesion. Based on in vitro studies, two potential mechanisms 
have been proposed. One study demonstrated that contact dependent killing of epithelial 
cells leads to the release of preformed IL-1 a which acts in a paracrine fashion and induce 
the secretion of IL-8 (48), a potent chemoattractant for neutrophils. Co-culturing of 
amebic trophozoites with IEC resulted in the production of several proinflammatory 
cytokines and chemokines such as GRO- a, GM-CSF, IL-la and 1L-6. Another study 
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(49) showed that ameba killing of IEC releases pro IL-l ~ which is cleaved and activated 
to mature IL-I ~ by the ameba cysteine proteases. These cytokines can act on 
neighboring live ceIls and induce chemokine secretion. While aIl these reports suggest 
contact dependent killing of IEC is required for chemokine release, in our laboratory it 
has been elegantly demonstrated that soluble ameba components can induce, in the 
absence of cell contact, IL-8 secretion from IEC (50). Another mechanism of IL-8 
induction is via prostaglandin E2. COX-2 expression and PGE2 production are increased 
in both IEC and macrophages following amebic infection (51-54). PGE2 is a potent 
inducer of IL-8 (55) and as mentioned previously, ameba itself expresses COX-2 like 
enzyme and release PGE2 that can act on host ceIls to induce IL-8. It should be noted that 
apart from the ho st cells, amebic trophozoites themselves have been found to produce a 
chemoattractant to neutrophils (56). AIl the se mechanisms could be operating in vivo 
leading to the enhanced release of chemoattractants and consequent homing of immune 
cells to the ulcerated lesion. In the late invasive stages, plasma cells, macrophages and 
lymphocytes are seen in the lesion (57). The source of chemoattractants specific for each 
of these cells is not known. Cellular infiltration not only fails to kill trophozoites but even 
contributes to tissue destruction. Amebae have been shown to be very efficient in killing 
naive neutrophils and macrophages (58). The lysed immune cells release their toxic 
contents such as proteases, cathepsins, lysozymes, and reactive oxygen and nitrogen 
intermediates, which are lethal to host tissue and worsen the intestinal damage (59, 60). 
Indeed, studies in SCID-HU-INT mice in which human intestinal tissue is grafted on their 
back, have observed decreased tissue damage and colonic ulceration following depletion 
of neutrophils (61). The mechanisms by which ameba are resistant to neutrophil attack 
are not known. Ameba possess superoxide dismutase (62), NADPH:flavin 
oxidoreductase (63) and a cysteine-rich 29 kDa (64) protein that could detoxify reactive 
oxygen. lndeed, in vitro, highly virulent strains of ameba could resist neutrophils at a 
high ratio of 3000 neutrophils per ameba (65). 
Aided by the infiltration and lysis of ho st inflammatory cells as described above, the 
trophozoites extend deep into the submucosa giving rise to the typical flask-shaped ulcer. 
At this stage, few macrophages are present and this paucity might result from parasite 
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secretion of monocyte locomotion-inhibitory factor (66). Invasion is also facilitated by 
locomotory activity of the trophozoite and signaling events in the parasite that regulate 
this process are intensively being studied (67). If the parasites reach blood vessels of 
intestine, they can get into the circulation and spread to soft tissues such as liver, lung or 
even brain. Clearly cysteine proteases play a key role in tissue degradation and invasion 
and the Gal-Iectin is essential for target cell adherence and killing. CP-deficient or E-64 
pretreated trophozoites have reduced virulence to cause ALA in animal models. Similar 
observations were made with parasites in which the expression of Gal-Iectin and 
amebapores has been inhibited by the antisense technique (68, 69). 
Another area of investigation is the mechanism of target cell death by E. histolytica. Most 
of the in vitro studies have been done in CHO and Jurkat T -cells. Following contact with 
the parasite, there is a rapid 20-fold increase of intracellular calcium (Ca2+) level in the 
target cell (31). This is followed by membrane blebbing and cell death in 5-15 minutes. It 
is suspected that Ca2+ could act as a second messenger activating signaling events that 
eventually lead to cell death. While the mechanism of cell death caused by E. histolytica 
is controversial, recent evidence points to apoptotic death in immune cells. Cell death 
characteristic of both necrosis and apoptosis have been reported following attachment of 
host cells by ameba. Necrosis is characterized by cell swelling, rupture of cell membrane 
and release of cell contents while apoptosis has all the features opposite to the ones 
observed during necrosis. Initial reports suggested either necrotic or a non-classical 
apoptotic mechanism of cell death by E. histolytica. Ragland et al. (1994) observed DNA 
fragmentation (a marker for apoptotic death) in murine myeloid cell line FDC-Pl 
exposed to the parasite and this is not inhibited by overexpression of Bcl-2 (70). ALA 
studies in knock-out mice also indicated that ameba mediated apoptosis in hepatocytes is 
independent of Fas ligand or TNF receptor 1 (71). Recently the mechanisms of cell death 
of Jurkat T lymphocytes by E. histolytica have been elucidated. These studies suggest 
ameba induced cell death is apoptotic and is caspase-3 dependent but caspase 8 and 9 
independent (72). Further, Jurkat cell and erythrocyte contact with ameba resulted in the 
host cell surface exposure of phosphatidyl serine (PS), a marker for apoptosis, and ameba 
preferentially phagocytosed apoptotic cells compared to necrotic cells (32, 73). Evidence 
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for apoptotic killing also came from another group of researchers who observed ROS 
mediated ERKl/2 activation leads to apoptotic killing of neutrophils by live trophozoites 
(74). The interaction between amebic trophozoites and intestinal epithelial cells needs to 
be explored. To summarize, amebic pathogenesis in volves distinct phases of 
colonization, degradation of mucins and killing of host cells. Multiple factors are 
involved and host inflammatory response contributes to the lesions seen in amebic 
colitis. 
1.3 GaVGalNAc-Iectin of E. histolytica 
Gal/GaiNAc lectin is the most well studied ameba virulence factor. This is the surface 
adherence protein that is essential for binding to mucins and varied target cells such as 
bacteria and ho st cells like colonie epithelial cells, red blood cells and immune cells (13, 
58, 75-78). It has high affinity for complex, branched carbohydrate chains with Galactose 
or N-acetyl galactosamine terminal residues (79). Later it has been found that Gal-Iectin 
has very high affinity to glycoproteins containing GalNAc-terminal oligosaccharides 
chains, as found in colonic mucin (80). Indeed, rat and human colonie mucins bind 
amebic trophozoites with lOOOO-fold affinity than galactose and N-acetyl galactosamine 
monomers (13). 
Gal-Iectin is a heterodimeric, 260 kDa glycoprotein consisting of 170 kDa heavy subunit 
and 31/35 kDa light subunit which are linked by disulfide bonds (Fig. 1.1) (81). There is 
no antigenic cross reactivity between heavy and light subunits (82, 83) and the molecule 
as a whole is quite distinct from any of the known types of lectins found in eukaryotes. 
The heavy chain is made up of 1276 amino acid (aa) residues which can be classified into 
three domains; extracellular, transmembrane and carboxy terminal cytoplasmic tail (82-
84). The intracellular cytoplsmic tail has several potential phosphorylation sites and also 
has aa sequence similarity with that of J32 and J37 integrin cytoplasmic tails suggesting 
that it could play a role in intracellular signaling (85). The extracellular portion of heavy 
subunit is richly glycosylated and is divided into three distinct regions: a cysteine-
tryptophan rich region (CT; aa 1-187), a cysteine poor region (CP; aa 188-377) and a 
cysteine-rich region (CR; aa 378-1208) that includes a pseudorepeat portion (PR; aa 378-
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.---''- 653) (Fig.l.l). Monoclonal antibodies (MAbs) against defined reglOns of Gal-Iectin 
molecule are available and were shown to block the adherence of lectin to mucins and 
target cells (86, 87). It should be noted that different MAbs to Gal-Iectin affect adherence 
and cytotoxicity functions differently suggesting the involvement of separate 
conformations of the molecule in its biological activity. For example, sorne monoclonal 
antibodies have been shown to enhance the trophozoite binding to target cells (88). Both 
adherence inhibiting and enhancing MAbs of Gal-Iectin map to the cysteine rich region, 
indicating that carbohydrate recognition domain is present in the CR region of heavy 
chain. 
Cysteine-trypatop han 
rich 
Cysteine poor 
Pseudorepeat 
Cysteine ric h 
T ransnte ntb r 
Cyto plas wc 
NH2 
Heavy subunit 
Light subuni t 
CO OH 
Fig. 1.1: Structure of E. histolytica Gal-Iectin. Amebic Gal-lectin is composed of 2 subunits; 
Heavy subunit which is divided into extracellular, transmembrane and cytoplasmic resions and 
light subunit which is GPI-anchored and lacks cytoplasmic tail. 
The light subunit has 2 isoforms of 31 kDa and 35 kDa and associate with the heavy 
chain to form 2 heterodimers: a 170/31 or 170/35 kDa Gal-Iectin molecule. It is a 
glycoprotein with no transmembrane region, but contains a hydrophobie earboxy terminal 
do main which is a feature of glycosylphosphatidyl inositol (GPI)-anehored proteins. Its 
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,--- function is po orly understood. MAbs against light chain do not inhibit adherence of 
trophozoites to target cells (89) and trophozoites deficient in light chain have reduced 
virulence features without any apparent defect in adherence (90). This suggests that light 
chain too plays a yet unidentified role in pathogenesis. 
In addition to adherence, Gal-Iectin was found to contain several immunological 
properties. It is highly antigenic and serum from amebiasis patients collected from 
different parts of the world consistently reacts with this molecule (91-93). The 
immunogenicity of Gal-Iectin is also attributed to the CR region of heavy chain while 
light chain is poorly immunogenic as demonstrated by lack of reactivity with serum 
raised against native Gal-Iectin. CR which has a sequence similarity to human CD59 that 
binds to purified C8 and C9 components of the complement prevents the formation of 
membrane attack complex and thus is thought to confer complement resistance to the 
parasite (94). High cysteine content of this region might also confer protection against 
both host and ameba-derived proteases (83). In short, the CR region of the heavy subunit 
is the most important region that is critical for aIl biological activities of this molecule. 
Recently a 150 kDa intermediate subunit of Gal-Iectin was also identified. A MAb 
against this protein significantly inhibited adherence to target cells, erythrophagocytosis 
and cytotoxicity in vitro (95, 96). It has similar binding properties as 260 kDa Gal-Iectin 
discussed above and is found to be physically associated with the latter. In addition, 
several other adherence proteins that bind to host surface and extracellular matrix 
substances are also present. Examples for the se minor adhesins are a 220 kDa protein and 
80 kDa membrane proteins that bind to hyaluronic acid (97, 98), 140 kDa protein that has 
affinity to fibronectin (99) and a 96 kDa EhADH2 protein which is an alcohol 
dehydrogenase enzyme that also binds to fibronectin and laminin (100). 
Because of the importance of Gal-Iectin in colonization and cell killing, this molecule has 
been a potential vaccine candidate against amebiasis. Moreover, the lack of antigenic 
variation in this molecule makes it attractive to develop as vaccine. Beck et al. (101) 
demonstrated that the Gal-Iectin heavy su bu nits of ameba isolates from three distinct 
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areas of the world (Bangladesh, Georgia, and Mexico) retain remarkable sequence 
conservation. Several studies reported success with Gal-Iectin vaccination against hepatic 
abscess in gerbil and hamsters. Protection was observed with both native and 
recombinant portions of the Gal-Iectin with varying efficacies (102). Initial vaccination 
studies using whole native lectin given parenteraIly, though showed good protection, 
reported larger liver abscesses in unprotected animaIs (103). Similar protection was 
observed using recombinant portions of the cysteine rich region (CR: 378-1208 aa) of 
heavy subunit of Gal-Iectin. However, vaccination with cysteine poor (CP: 1-373 aa) 
region of Gal-Iectin was associated with exacerbation of abscess size (104). Surprisingly, 
oral vaccination with whole lectin did not result in exacerbation and it is ascribed to the 
poor stimulation of systemic humoral response by this route of vaccine delivery (105). It 
is presumed that antibodies against CP region enhance amebic adherence. Vaccination in 
mice has been used to study the immune response elicited by Gal-Iectin and recently 
Houpt et al. (106) showed that purified native and recombinant portion of Gal-Iectin (that 
contains amino acids 578-1154 of the 170-kDa heavy chain of the lectin) protect against 
intestinal amebiasis in a mouse model. Subunit vaccines made from different portions of 
heavy chain are extensively investigated for their potential to stimulate immune response 
in mou se, hamster and gerbil models. The cysteine rich (CR) region that contains the 
carbohydrate recognition domain (CRD) was found to be the most protective portion of 
the Gal-Iectin (102). This molecule contains both Band T cell epitopes as seen by the 
stimulation of humoral immune response and spleen cell proliferation in immunized 
animaIs (103, 107, 108). Indeed, in vitro, animal and field studies showed that mucosal 
IgA (against CRD of CR region) and activated immune cells confer protection against the 
parasite. Gaucher and Chadee (109) reported that a codon-optimized DNA vaccine 
targeting a portion of the Gal-Iectin heavy subunit (inc1uding the CRD), stimulated a 
Th1-type Gal-Iectin specific cellular immune response as weIl as inducing development 
of serum antibodies that recognized a recombinant portion of the heavy subunit. While 
vaccine studies confirmed that both humoral and cell mediated immune (CMI) responses 
mediate protection, the mechanism of how Gal-Iectin stimulates CMI is not c1ear. Recent 
studies on Gal-Iectin-macrophage interactions in vitro are shedding sorne light in this 
direction. Purified Gal-Iectin by itself was shown to activate mou se bone marrow derived 
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macrophages to stimulate TNF-(X production (110). It also stimulates IL-12 production 
from IFN-y primed human macrophage cellline THP-1 (111). As IL-12 is the principal 
cytokine with the ability to drive a Th1 type immune response, it is thought that Gal-
lectin could also act as an adjuvant by stimulating CM!. Interestingly, MAb inhibition 
studies point to the CRD region as mediating the se effects. Recently Cc. Ivory and K. 
Chadee, submitted for publication) the Gal-Iectin was also found to activate dendritic 
cells (DC) by up-regulating co-stimulatory molecule expression and inflammatory 
cytokine induction. A full elucidation of potential mechanisms that could explain Gal-
lectin's ability to activate immune system is awaited. To summarize, Gal-lectin is a weil 
characterized parasite virulence factor and is an excellent vaccine candidate. 
Studying its interaction with host cells would greatly help in understanding the 
pathogenesis and mechanism of protection against the disease. 
1.4 Modulation of host response by E. histolytica 
AlI successful pathogens developed unique mechanisms to subvert or circumvent host 
defense mechanisms in order to survive and perpetuate their life cycle. Studies have 
shown that E. histolytica also developed several mechanisms to suppress deleterious ho st 
responses; both innate and immune mediated. As mentioned previously, the structural 
resemblance of Gal-Iectin molecules to a host cell CD59 molecule confers protection 
against complement attack (94). Two more potential mechanisms by which the parasite 
overcomes complement mediated lysis is by synthesizing a CD59 like molecule (112) 
that can sequester membrane attack complex, and also by means of a complex of 
lipophosphoglycans (LPG) and proteophoshpglycans (PPG) on its surface that form a 
protective surface coat avoiding lysis by the alternative and membrane lysis pathways of 
complement during the invasion of tissue (113, 114). Moreover, cysteine proteases (CP) 
elaborated by the parasite cleave the complement components C3a and C5a to prevent 
immune cell homing and suppress the inflammatory response (115). CPs also cleave 
immunoglobulins and mucins and overcome these barriers (26, 116, 117). A 29 kDa 
surface protein of amebic trophozoite was found to have an anti-oxidant property by 
removing H20 2 thus making the parasite resistant to reactive oxygen-mediated killing by 
leukocytes (64). 
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E. histolytica has also been shown to have a down regulatory effect on ho st immune cells, 
particularly, macrophages and lymphocytes. Macrophages isolated from amebic li ver 
abscess during the acute phase of infection in gerbils are deficient in their ability to 
respond to IFN-y, develop respiratory burst and to kill trophozoites ex vivo (118). Two 
potential mediators were found in the suppressive phenomenon: macrophage migration 
inhibitory factor (MlF) and prostaglandin E2 (PGE2). MlF is an oligopeptide secreted 
into the medium by ameba and is found to inhibit the locomotion of monocytes and also 
the respiratory burst of macrophages and neutrophils (119-120). This factor also inhibited 
delayed hypersensitivity reaction to the allergen l-chloro-2-4 dinitrobenzene in guinea 
pigs, suggesting suppression of T-Iymphocytes (121). The second suppressive mediator is 
PGE2 which down regulates several macrophage functions. It was found that E. 
histolytica stimulates PGE2 production in the liver during abscess development in 
hamsters (122). Inhibiting PGE2 with indomethacin resulted in the reduction of abscess 
size. The ameba mediated suppression is a local event as evidenced by the fact that 
macrophages obtained from distal organs like spleen and peritoneum have normal 
responses to stimuli. E. histolytica suppresses IFN-y-induced major histocompatibility 
complex (MHC) class lIa molecule, I-A~ rnRNA expression and TNF-a production in 
murine and gerbil macrophages in a PGE2 dependent fashion (123, 124). The decreased 
ability of ALA derived macrophages to kill trophozoites ex vivo could be due to the 
modulation of iNOS expression and consequent nitric oxide production in a PGE2 
independent manner (125). 
In addition to macrophages, T -lymphocyte functions are also down regulated by ameba 
trophozoites. In vivo or in vitro treatment of murine splenocytes with amebic antigens 
resulted in a decreased capacity of splenocytes to respond to mitogen-induced 
blastogenesis following a challenge with concanavalin A (Con A), phytohemagglutinin 
(PHA), and lipopolysaccharide (LPS) (126). Aiso serum from human ALA patients 
suppresses T ceil proliferation in response to soluble amebic antigen. A similar 
observation was made with gerbils in which serum coilected during the convalescent 
phase of ALA (20 days after intrahepatic injection) suppressed the T cell response to Con 
17 
A. This suppression is independent of NO and PGE2 and is associated with decreased IL-
2 production (127). T cells from mice immunized with 220 kDa lectin also fail to 
proliferate ex vivo in response to purified antigen. Interestingly, these cells were able to 
produce Th2 cytokines IL-4 and IL-lO that could potentially inhibit T cell responses 
(128). Ventura-Juarez et al. (129) observed in situ interactions between trophozoites and 
immune cells in human ALA biopsies and observed larger number of CD8+ T cells than 
CD4+ cells. As CD8+ cells could be cytotoxic or suppressive type, it is assumed that 
presence of high CD8+ cells leads to local suppression of the immune response, partly 
mediated by IL-I0. The mechanisms for this T cell recruitment are not clear. To 
summarize, E. histolytica has evolved multiple mechanisms to overcome host defense 
mechanisms and this modulation could be important in the pathogenesis of 
amebiasis. 
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*CHAPTER 2: TOLL LIKE RECEPTORS IN HOST DEFENSE 
2.1 Introduction 
Vertebrates have evolved an elaborate system of immune defense against constant threat 
by pathogens. In mammals there are two distinct arms of immune system; innate and 
acquired or adaptive. Innate immune system is activated rapidly, within minutes of a 
pathogen attack and serves two basic purposes; first, to kill/contain the pathogen and 
secondly to signal the acquired immune system which cornes into the battle field a little 
later on. The major hurdle for innate immune function is pathogen recognition and self-
non self discrimination. While adaptive branch evolved a mechanism of gene 
rearrangement to identify molecules unique to each pathogen, innate immune system 
developed germ line encoded Pattern Recognition Receptors (PRRs) which recognize 
Pathogen Associated Molecular Patterns (PAMPs) (note: recent literature suggests an 
alternate and more apt term, MAMP which stands for Microorganism Associated 
Molecular Pattern, keeping in view the fact that TLRs also recognize molecular patterns 
of non-pathogens) (1). PAMPs are molecules that are common to a group of organisms 
and are essential to the survival and/or virulence of the pathogens. Because of their 
importance to the parasite biology, PAMPs are also least subjected to mutations and 
structural alterations. For these reasons, recognition of P AMPs by PRR does not require 
complex receptor diversity as required for antibodies and T cell receptors (2). 
There are two categories of PRRs, non-signaling and signaling (3). Non-signaling PRRs 
could be soluble factors or transmembrane proteins. The former includes C-reactive 
proteins or lectins which bind the microbes and make them susceptible to phagocytosis or 
complement mediated lysis. Example for non-signaling transmembrane proteins is 
scavenger receptors which recognize pathogens and help in internalizing and directing 
them to lysosomal killing. Signaling PRR could be either transmenbrane or cytosolic; 
ToBlike receptors (TLRs) and NODs faB into these categories respectively. 
* Portions of this chapter have been published: Moncada, D. M., Kammanadiminti, S. J., and Chadee, 
K. (2003) Mucin and Toll-like receptors in host defense against intestinal parasites. Trends Parasitol 19: 
305-311. 
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Our knowledge of TLRs started with the discovery of Toll in drosophila and then the 
human TLR-4, which recognizes LPS, in the context of septic shock (4, 5). The last 
decade witnessed an exploding research into TLRs that revolutionized our understanding 
of innate immune system. TLRs are evolutionarily conserved host defense molecules 
which have structural and functional homologues in plants, insects and mammals. They 
are type 1 transmembrane proteins with three distinct domains; N-terminal extracellular 
Leucine Rich Repeats (LRR) for ligand binding, a transmembrane domain and C-terminal 
intracellular signaling tail (6). The tail has a region that is common to TLR and IL-l 
receptor family, designated as TolllIL-1 Receptor (TIR) domain and is essential for the 
signaling function. A total of 13 mammalian TLRs (TLR 1-10 in human and TLR 1-9, 
11-13 in mice) have been discovered to date (7). Table 2.1 shows the ligands and the 
microbes that are recognized by each TLR (7-9). As shown, TLR-2 is the most 
promiscuous receptor capable of recognizing a number of diverse PAMPs. In addition, it 
is apparent that a group of organisms can be recognized by different TLRs (Gram 
negative bacteria are recognized by both TLR-2 and 4) and the same TLR can sense 
different groups of organisms (TLR-2 recognizes both Gram positive bacteria, Gram 
negative bacteria and fungi). 
Table 2.1: Ligands and microbes recognized by Tolllike receptors 
TLR Ligand Microbe Comment 
TLR-l Triacyllipopeptide Bacteria, Mycobacteria with TLR-2 
TLR-2 Bacterial 
Triacyllipopeptide Bacteria, M ycobacteria with TLR-l 
Lipoteichoic acid Group B Streptococcus with TLR-6 
Peptidogl ycan Gram positive bacteria 
Atypical LPS Legionella, Leptospira, 
Porphyromonas, Bordetella 
Lipoarabinomannan Mycobacteria with TLR-6 
Porins Neisseria 
Diacyllipopeptide Mycoplasma with TLR-6 
34 
Fungal 
Zymosan Saccharomyces cerevisiae with TLR-6 
Phospholipomannan Candida albicans 
Glucuronoxymannan Cryptococcus neoformans 
Protozoan 
Phospholipids (GPI) Trypanosoma 
and GIPL 
Lipophosphoglycan (?) E. histolytica 
Helminth 
Phosphorylcholine- Filarial nematode-
glycoprotein (ES-62) Acanthocheilonema viteae 
Viral 
Haemagglutinin protein Measles virus Aiso by TLR-4 
(?) HCMV, HSV-l 
Host-derived Host 
Hsp60, 70 and 90 
TLR-3 Double stranded RNA Viruses, S. mansoni 
Synthetic Poly(l:C) 
Host cell mRNA 
TLR-4 Bacteria 
Lipopol ysaccharide Gram negative bacteria 
Viral 
Envelop glycoproteins RSV,MMTV 
Plant product 
Taxol T axus brevifolia 
Fungal 
Mannan Candida albicans 
Glucuronoxylomannan Cryptococcus neoformans Aiso by TLR-2 
Hsp60 Chlamydia 
Host-derived 
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Hsp60, Hsp70 Aiso by TLR-2 
Surfactant protein A, 
Fibrinogen, Fibronectin 
TLR-5 Flagellin Flagellated bacteria 
TLR-6 Mycoplasmal diacyl AlI with TLR-2 
lipopeptide 
Fungal Zymosan 
Lipoteichoic acid 
TLR-7 Viral single stranded RNA Viruses TLR-8 is inactive in 
TLR-8 RNA mIce 
Guanine analogues-
R484, Imiquimod Synthetic 
siRNA 
Immune complexes 
containing self RNA Host-derived 
TLR-9 Unmethylated double Bacteria and virus 
stranded CpG DNA 
CpG oligonucleotides Synthetic 
Immune complexes 
containing self DNA Host 
TLR-lO Unknown Absent in mice 
TLR-ll ? Uropathogenic bacteria Inactive in human 
Profilin-like molecule T.gondii 
TLR-12 Unknown Absent in human 
TLR-13 Unknown 
Heterodimerization of TLR-2 with TLR-1 or TLR-6 is required to recogmze sorne 
ligands such as lipopeptides, lipoteichoic acid (LTA) and zymosan. Although much is 
known about TLRs 1-9 and Il, the ligands, modes of signaling and biological roles of 
TLRs 10, 12 and 13 have yet to be defined. It is evident that 9 TLRs can recognize the 
36 
".---. 
--~---
whole range of microbes utilizing relatively conserved leucine rich repeat motifs and 
currently research is focused on studying TLR-ligand interactions to understand this 
diversity of recognition. Apart from few differences, in principle, an TLRs activate Th! 
type proinflammatory immune response. This serves the two main functions of innate 
immune system; containing the pathogen and signaling the adaptive arm. TLRs are 
increasingly being shown to play crucial roles in host defense and inflammatory 
conditions during various infections, cancers and autoimmune states. 
2.2 Distribution and regulation of Tolllike receptor expression 
TLRs are the primary sensors of invading pathogens and induce potent anti microbial 
defenses. Consequently they are expressed in diverse ceIl types, both in immune and non-
immune cens. Antigen presenting cells such as macrophages, dendritic cells and B cells 
are the major immune cells while endothelial cells, fibroblasts and epithelial cells are the 
principal non-immune ceIls that express majority of TLRs (10). In addition, TLRs have 
been found in NK cells, monocytes, neutrophils, basophils, mast cells and regulatory T 
cells. The localization of TLRs varies with sorne (TLR-l, 2, 4, 5, 6) expressed 
extracellularly and others (TLR-3, 7, 8,9) are present in intracellular components such as 
endosomes (9, 11). In the latter case, the corresponding ligands have to be intemalized 
before activating the TLR signaling. However even in the case of TLR-2, the receptor is 
found to recruit to the phagosome following stimulation with its ligand, Zymosan (12). 
TLR-5 is found in the baso-Iateral membrane of intestinal epithelial cells and its 
stimulation by flagellin requires the transepithelial transport of flagellin to the basolateral 
membrane or presence of flagellin in the lamina propria (13). These mechanisms are 
thought to represent a regulatory event in the functioning of TLRs to avoid an unintended 
activation by non-pathogens and ho st TLR ligands. 
TLR expression in cens is not static but has been shown to be modulated in response to 
various stimuli such as vitamins, cytokines and pathogens. It is thought that increased 
disease susceptibility and poor adaptive immune responses in the elderly could be due to 
decreased TLR expression and function (14). Vitamin D3 suppresses TLR-2 and TLR-4 
rnRNA and protein expression in human monocytes leading to hypo-responsiveness of 
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monocytes to LPS and LTA in terms ofreduced NF-KR activation and TNF-a production 
(15). Increased expression of TLRs has been reported during inflammatory conditions 
such as inflammatory bowel disease (ffiD). Consistently, proinflammatory Thl cytokines 
such as IFN-y and IL-l ~ have been shown to up regulate the expression of TLRs in 
intestinal epithelial cells (IEC). Mueller et al. (16) recently demonstrated that Th2 
cytokines, IL-4 and IL-13 suppress TLR-3 and TLR-4 expression in IEC and also 
dampened TLR activation induced by Thl cytokines and LPS. This impaired TLR 
signaling and innate defense mechanisms are thought to make the host susceptible to 
chronic inflammatory conditions. 
Recently several reports came out with regard to alteration of TLR expression during 
infectious conditions and by pathogens. Dolganiuc et al. (17) observed an increased 
expression of TLR- 2, 6. 7, 8, 9 and 10 in monocytes and T cells in Hepatitis C Virus-
infected patients compared to controls. TLR4 was only upregulated in T lymphocytes, 
while TLR5 was selectively increased in monocytes of HCV -infected patients. In 
addition to TLRs, co-receptors such as MD-2 and CD14 were also increased in immune 
cells. Mycobacterial infection has been found to result in differential expression of TLRs 
(18). Whole blood from mycobacteria infected patients showed increased rnRNA for 
TLR-l, TLR 2, TLR-4 and TLR-6. In vitro, mycobacterial components increased TLR-l 
expression in THP-l cells and PBMC from healthy donors when exposed to live 
Mycobacteria for prolonged period also exhibited increased expression of TLR-2 but not 
TLR-4. Cabral et al. (19) showed that treatment of human monocytes with Borrelia 
burgdorferi lysate, lipidated outer surface protein A, and triacylated lipopeptide 
Pam3CysSerLys4 (aIl TLR-2 agonists) results in the up-regulation of both TLR2 and 
TLRI but down-regulation of TLR5. Consequently, TLR2 stimulation rendered cells 
hyporesponsive to a TLR5 agoni st. On the contrary, monocytes stimulated with TLR5 
ligands (inc1uding p37 or flaA, the minor protein from B. burgdorferi flagella) up-
regulated TLR5. LTA, a ligand for TLR-2 was also found to induce the expression of its 
own receptor (TLR-2) in odontoblasts resulting in increased chemokine secretion and 
augmented dendrite cell maturation. (20) 
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Certain nematode and protozoan parasites also modulate TLR expression. Baseline 
expression of TLRI, TLR2, and TLR4, but not TLR9 was significantly lower in T cells 
of the filarial-infected individuals compared with the uninfected individuals in both 
endemic and non-endemic are as (21). Consequently, TLR function was significantly 
diminished in T cells of filarial-infected individuals as seen by decreased T cell 
activation/cytokine production in response to TLR ligands. This is thought to be a novel 
mechanism underlying T cell immune tolerance in lymphatic filariasis. However, no 
specific parasitic molecule has been implicated. Trichomonas vaginalis increased TLR-2, 
4 and 9 expressions in HeLa cells in a p38 MAP kinase dependent manner (22). 
Surprisingly, inhibiting NF-KB did not abrogate this protozoan mediated increased TLR-
2 or 4 expression. In certain inflammatory conditions, it is beneficial to suppress TLR 
expression. Indeed, vasoactive intestinal peptide, a neuron-immuno peptide has been 
found to reduce the severity of TNBS-colitis by decreasing TLR-2 and TLR-4 expression 
(23,24). In addition, several substances such as carbon monoxide (25), nitric oxide (26), 
and macrophage migration inhibition factor (27) have been shown to alter TLR 
expression in different cells. 
Apart from the se observations, the signaling events involved in the differential regulation 
of TLRs, except in the case of TLR-2 and 4, have not been studied well. LPS, a TLR-4 
ligand has been shown to increase TLR-2 expression via NF-KB but independent of MAP 
kinases (28, 29). This is not surprising given the fact that promoter region of TLR-2 
contains several NF-KB binding sequences (30). On the contrary, An et al. (31) observed 
that LPS induced TLR-2, 4 and 9 expression is dependent on ERK MAP kinase and 
inhibiting p38 MAP kinase also suppressed TLR-2 and 4 expressions but enhanced TLR-
9 expression in mou se immature dendritic cells. Expression of all the three TLRs is 
dependent on NF-KB. Also TLR-4 up regulation by CO was found to be p38 MAP 
kinase dependent in macrophages (25). The promoter of TLR-2 also has STAT-5 binding 
regions and this plays a role in IL-15 induced TLR-2 expression in T cells (30). 
Physiologically, a novel protein molecule associated with TLR-4 (PRAT4B) has been 
identified which is involved in the cell surface expression of TLR-4 (32). Down 
regulation of PRAT4B mRNA mediated by small interfering RNA decreased cell surface 
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TLR-4 on human embryonic kidney cell li ne HEK293 cells. The role of this molecule in 
microbial regulation of TLR expression needs to be explored. To summarize, diverse 
stimuli including cytokines, microbes or microbial components can cause 
differential TLR expression, and these changes may be useful for either the 
pathogen and/or the hosto 
2.3 TLR signaling and role in host defense 
TLRs utilize the same molecules that are involved in IL-IR signaling. Following binding 
to the ligand, TLRs either homo or heterodimerize with other TLRs. The consequent 
conformational changes lead to the recruitment of TIR containing adaptor proteins. TLR 
signaling pathways can be primarily categorized to two classes; MyD88-dependent and 
MyD88-independentffRIF-dependent (33). Two other adaptor molecules involved are 
TIRAP and TRAM. TIRAPIMAL bridges MyD88 with TLR-2 and 4 (34) while 
TRAMffIRPfTICAM-2 is the adaptor between TRIF and TLR-4 (35). MyD88 is an 
essential signaling component for aIl TLRs except TLR-3. Its association with the TIR 
domain of cytoplasmic tai! of TLRs results in sequential recruitment of IRAK-4, IRAK-I 
and TRAF-6. Then TGF-~ activated kinase 1 (TAKl) and TAKI binding proteins TABI 
and TAB2 are recruited to TRAF-6 and TAKI phosphorylates IKK-~ and MAP kinase 
kinase 6 (MKK6) thus activating the transcription factor NF-KE and MAP kinases (36-
38). This finally results in the induction of severa! genes involved in inflammatory 
response such as TNF-a, IL-l, IL-6, IL-8, and anti microbial peptides like defensins. 
This pathway is the classical TLR signaling and is typical for aIl TLRs (Fig. 2). TLR-4 
requires accessory molecules su ch as CDl4 and MD-2 for activation. In majority of 
cases, CDl4 is essential for activation by LPS (39). It is also found to help in transferring 
the ligands to TLR-2 and TLR-3 (40, 41) and MD-2 is found to be required for the 
membrane localization of TLR-4 (42). Several co-receptors such as dectin-l, c-type lectin 
and CD36 also enhance TLR-2 signaling (43, 44). 
In addition to this proinflammatory signaling pathway, activation of few TLRs such as 
TLR-3, TLR4, TLR-7/8 and TLR-9 also results in the type 1 IFN production. TLR-3 and 
4 have been shown to induce IFN-a/~ secretion, dendritic cell maturation and expression 
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of costimulatory molecules in MyD88-1- ceIls, utilizing other adaptor protein TRIF (45-
51). TRIF mediated signaling has three branches. It can activate NF-KB in TRAF-6 
dependent or independent pathways. The former overlaps with that of MyD88 dependent 
classical NF-KB pathway described above (52). The TRAF-6 independent mechanism 
involves receptor interacting protein (RIP)-l. RIP-l can directly interact with TAKI to 
activate NF-KB (53-55). In the third unique pathway, TRIF interacts with TBK-l and 
IKK-E (or IKK-i) that phosphorylates IRF-3 leading to type 1 interferon (IFN-~) 
production (35, 56-58). Activation of TLR-7/8 and 9 also leads to type 1 interferon (IFN-
a) production in MyD88-dependent manner (51). As shown in Fig. 2.1, activation of 
interferon factors involves the adaptor protein TRAF-3 (50, 51) as opposed to TRAF-6 
that is essential for NF-KB. In summary, TLR activation involves multiple signaling 
components, sorne of which are unique to a particular TLR. As seen from Fig. 2.1, NF-
KB, the principal transcription factor that regulates a number of key genes involved in 
immune and inflammatory response is always activated by TLR signaling. Other 
important transcription factors activated by TLRs are IRF-3 and 7 that induce type 1 
interferons. IRF-5 is activated by aIl TLRs except TLR-3 and acts synergistically with 
NF-KB by binding to the interferon responsive elements in the cytokine genes promoters 
to induce inflammatory cytokines (59, 60). 
The consequences of TLR activation are many fold. TLRs recognize various components 
of bacteria, viruses, fungi and protozoa. In addition they also respond to host derived 
molecules like heat shock proteins and fibrinogen. Molecules induced by TLR activation 
include cytokines such as TNF-a, IL-l~, IL-6, IL-12, IFN-al~; chemokines like IL-8; 
surface molecules such as MHC II, CD 80, CD86; antimicrobial peptides su ch as 
defensins. Chemokines and cytokines released as a sequel to TLR activation recruît and 
activate the immune cells such as macrophages and neutrophils which ingest the invading 
pathogens and limit the spread of infection. These cells also produce nitric oxide and 
reactive oxygen species. and the ensuing inflammation plays a crucial role both in 
resolving the infection and also in contributing to ho st tissue damage. TLRs have also 
been linked wîth phagosome maturation, defensin production, actin remodelling and 
angiogenesis (61-64). Increased co-stimulatory molecule expression by TLR activation 
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,--, aids in efficient antigen presentation by APCs and also influences the type of ensuing 
adaptive response. CD4 T cells that differentiate to Thl cells produce proinflammatory 
cytokines IL-6, IL-12, IL-l8 and TNF-u. while Th2 cells secrete IL-4 and IL-13 (65). 
The Thl response is protective against viral, bacterial and protozoan infections and Th2 
responses are protective against helminthes. Antigen processing cells activated by TLR 
ligands secrete the Th 1 instructive cytokines IL-12 and IL-l8 thus skew the immune 
response towards Thl type (46). Aiso it has been observed that Thl and Th2 responses 
are mutually suppressive. For this reason, TLR activation can be beneficial to counter 
Th2 mediated allergic responses. For example, CpG DNA, a ligand for TLR-9 has been 
shown to inhibit eosinophilia and airway hypersensitivity by shifting the balance to Thl 
type (66). Nonetheless, TLR-4 activation by low doses of LPS or when LPS was 
administered through inhalation, results in Th2 response (67). TLR-2 activation has also 
been shown to induce Th2 response under sorne circumstances (68). Recently, TLRs have 
been found to play a role in the regulation of immune response via direct or indirect 
influence on the function of CD4+ CD25+ T regulatory cells, which results in their 
induction and subsequent suppression of the immune response or a reversaI of 
suppression (69, 70). 
Several inflammatory conditions such as bacterial sepsis, autoimmune disorders and 
chronic inflammatory diseases such as ffiD are the result of dysregulated activation of the 
innate or adaptive immune system. Apart from their beneficial effects as described above, 
TLRs have also been implicated in the immunopathology of many of these diseases (71). 
In order to avoid an uncontrolled TLR activation, cells have several molecules that 
function as negative regulators of TLR signaling. IRAK-M is expressed in monocytes 
and macrophages and its expression is increased following TLR agoni st stimulation. This 
molecule lacks the kinase activity and inhibits the dissociation of IRAK-l and IRAK-4 
from TLRs by either blocking their phosphorylation or stabilizing the 
TLRlMyD88/IRAK-4 complex (72). This excludes TRAF6 from the signaling cascade 
and as such prevents NF-KB and MAP kinase activation by MyD88 dependent TLR 
signaling. Other ex amples for suppressors of TLR activation are Tollip, SOCS-l and 
IRF-4 which are cytoplasmic, and SIGIRR and ST2L which are membrane bound (73-
42 
76). In summary, TLR activation involves a complex network of adaptor molecules 
and signaling intermediates, results in an inflammatory response and also signais 
the adaptive immune system. 
~ 
_---..J V 
+ 
Proinflammatory cytokines 
Fig. 2.1: TLR signaling: TLR-I, 2, 4, 5 and 6 are present extracellularly. TLR-7/8 and 9 are 
exclusively endosomal and TLR-3 is both extracellular and endosomal. TLRs 1,2,5,6, 7/8 and 9 
are exclusively MyD88 dependent; TLR-3 is exclusively TRIP dependent and TLR-4 utilizes 
both MyD88 and TRIP. Signaling via MyD88 involves IRAK-4/ IRAK-l/TRAF-6 complex that 
activate TAKI which in tum activates JNK, p38 and IKK complex ultimately leading to early 
AP-land NF-KB transcription factors. In addition. the MyD88/IRAKlTRAF-6 complex activates 
IRF-5 and IRF-7, which induces cytokine and IPN-a production respectively. TRIP signaling by 
TLR-3 and 4 involves 3 cascades. RIP-I associates with TRIP and also with TRAF-6 and 
activates the classical pathway. RIP-l also directly activates TAKI and NF-KB in a TRAF-6 
independent mechanism. Finally, recruitment ofTRAF-3 to TRIP forms the complex TBKIIIKK-
E that activates IRF-3 and induces IFN-~. pDC-plasmacytoid dendritic cells. 
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CHAPTER 3: INTESTINAL EPITHELIAL CELLS IN MUCOSAL INFECTIONS 
3.1 Intestinal epithelial cells as sensors of microbes 
A single layer of intestinal epithelial cells (IEC) that separate the host from environment 
is a complex dynamic tissue spanning a surface area of about 200 square meters with a 
villous architecture. It serves vital functions such as digestion and absorption of nutrients, 
electrolytes and water from lumen (1). Simultaneously, it forms a highly regulated, 
selective barrier for toxins and microbes present in the lumen. Recently, much knowledge 
has been gained on the role of IEC as first line of host defense against enteric pathogens. 
Defensins (2), nitric oxide (3), trefoil factor (4) and IgA (5) are sorne of the important 
host molecules secreted by IEC that ward off microbes away from gaining systemic 
access. In addition IEC also sense the microbes and signal the ho st immune system. The 
colonization of gut by pathogens results in altered epithelial gene expression leading to a 
coordinated immune and infIammatory response mediated by a spectrum of cytokines, 
chemokines and increased expression of surface receptors su ch as MHC II, intracellular 
adhesion molecule (ICAM-l) and vascular cell adhesion molecule (VCAM) (Fig. 3.1) (6-
14). Activation of the proinfIammatory transcription factor NF-KR is the key event in this 
altered IEC gene expression and the majority of the se observations (14-17) are based on 
interactions between human and mouse intestinal epithelial cell lines with bacterial 
pathogens and on studies in mouse colitis models. Jung et al. (6) reported that human 
colon epithelial cell lines (T84, HT29, Caco-2) produced a specific array of four 
proinfIammatory cytokines, IL-8, monocyte chemotactic protein (MCP)-I, GM-CSF, and 
TNF-a in response to invasive strains of bacteria (Salmonella dublin, Shigella 
dysenteriae, Yersinia enterocolitica, Listeria monocytogenes, enteroinvasive Escherichia 
coli). In contrast, cytokine gene expression was not altered after infection of colon 
epithelial cells with noninvasive bacteria. Subsequently, Eckmann et al. (7) undertook 
global gene expression profiling in S. dublin-infected HT-29 and T84 cells and observed 
up-regulation of GM-CSF, IL-8, macrophage infIammatory protein (MIP)-2a, 
transcription factors (interferon regulatory factor (IRF)-I) and human leucocyte antigen 
(HLA) class 1 genes. Inhibition of NF-KR resulted in the repression of many of the 
bacterial-induced genes underscoring the pivotaI role of this transcription factor. 
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Bacterial induced chemokine IL-8 by IEC was also found to be the key player 
orchestrating mucosal inflammation in shigellosis (18). Stokes et al. (19) studied T84 cell 
response to 8 different strains of Vibrio cholerae and observed 2-5 fold increase in the 
mRNA of several genes involved in innate mucosal immunity, intracellular signaling, and 
cellular proliferation. These include cytokines like IL-8, GRO-a, Gro-~, Gro-y, MIP-3a, 
TNF-a, IL-5, transcription factors Jun-B, Early growth response (EGR)-l and Activating 
transcription factor (ATF)-3. In addition to the pathogens, probiotics also alter IEC gene 
expression. Caco-2 cells treated with probiotic strain, E. coli Nissle 1917 (EcN) 
expressed lü-fold induction of MCP-l, MIP-2a and MIP-2~ (20). MCP-l production by 
EcN was also confirrned in mouse intestinal epithelial cells. Recently, IEC response to 
the gut protozoan parasite Giardia lamblia was studied (21). Differentiated Caco-2 cells 
infected with G. lamblia isolate WB-AlI expressed a novel chemokine profile of CCL2 
(MCP-I), CCL20 (MIP3a), CXCLI (MIP-2), CXCL2 (GRO-~), and CXCL3 (GRO-y). 
E. histolytica trophozoites (22, 23) and soluble factors (24) can also induce IL-8 from 
IEC both in vitro and in vivo. Using high density gene expression arrays, Zhang and 
Stanley (25) studied the epithelial cell responses to E. histolytica and Shigella flexneri in 
human colonic xenografts in severe combined immunodeficient mice (SCID-HU-INT 
mice) and found up-regulation of a number of chemokines including IL-8, GRO, MCP-l, 
MCP-2, MCP-3, ENA-78 from IEC in both the infections. In addition to the pathogens, 
recently the purified toxin A of Clostridium difficile was also found to induce IL-8, GRO-
a and MCP-l from HT-29 and primary human colonic cells in NF-KB dependent fashion 
(26). 
Chemokines are broadly divided into three families, C-X-C (a), C-C (~), and C (y), based 
on the presence and position of the conserved cysteine residues (27) and have 
chemoattractant properties to immune cells. While sorne have effect on specific immune 
cells, many have seemingly overlapping functions. This is owing to the presence of 
restricted or shared chemokine receptor expression on different immune cells (28). For 
example, the receptor CXCR2 that recognizes the CXC chemokine IL-8 is exclusively 
present on neutrophils, making the IL-8 specifically chemotactic to these cells. However 
CCR2, the receptor for CC chemokine MCP-l is present on monocytes, basophils and T 
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.--'- cells. In addition to their chemotactic pro pert y, chemokines can also activate the immune 
ceIl functions. Kim et al. (29) tested various chemokines for their ability to activate 
cytotoxic CD8+ cells and found MCP-l to be the most potent. While the exact role of 
each chemokine in host defense and in pathological responses is not weIl known, Yung et 
al. (30) studied expression of 12 chemokines in response to S. dublin and 
proinflammatory cytokines and reported that their regulated secretion by IEC results in 
temporal and spatial mucosal chemokine gradients that are important for both early and 
late phases of inflammatory response. 
As seen from above examples, chemokine secretion appears to be a signature response of 
IEC to signal both innate and adaptive immune systems. This results in the homing of 
immune cells and has dual effects on pathogenesis. The release of toxie substances such 
as nitric oxide (NO), hydrogen peroxide (H202) and lysozyme by immune cells could kill 
the invading pathogen and eliminate the infection. On the other hand, this could also 
damage the epithelial tissue leading to acute inflammation of the intestine. Thus, it seems 
the immune cell infiltration contains the infection at an early stage, even though it is at 
the cost of extensive mucosal destruction. This was illustrated in a rabbit model of 
Shigella infection (31). Neutralization of IL-8 resulted in reduced neutrophil infiltration 
and epithelial inflammation, however this is accompanied by bacterial overgrowth in 
lamina propria and increased passage into mesenteric blood. 
It should be mentioned that despite the se observations, IEC have been found to respond 
poorly to sorne purified bacterial products and this is attributed to TLR signaling defects. 
In vitro studies using colonic epithelial cell lines demonstrate that IEC are hypo-
responsive to peptidoglycan and LPS owing to the low expression of TLR-2, TLR-6 (32), 
TLR-4 (33) together with high expression of Toll inhibitory protein (Tollip) (32). These 
mechanisms are thought to help in maintaining homeostasis in the face of constant and 
harmless presence of luminal bacteria. On the contrary, Rakoff-Nahoum et al. (34) 
propose that microbial recognition by TLR is essential for intestinal homeostasis. This 
study reported that activation of TLRs by commensal microflora is critical for the 
protection against gut injury and associated mortality. Nonetheless, increased expression 
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and defective functioning of the se receptors was observed during inflammatory 
conditions such as ffiD (35- 37) and indeed cytokines have been shown to modulate TLR 
expression in IEC (38, 39). It seems that intestinal epithelium has evolved dual abilities; 
not to elicit an aberrant response to commensals under physiological state and the 
potential to respond under pathological conditions. To summarize, intestinal epithelial 
cells sense the microbes and respond primarily by secreting chemokines and 
cytokines that mediate mucosal inflammation. 
3.2 Modulation of me responses by immune cells 
Classical studies on mucosal immunity focused primarily on immune cells. However, 
recent observations that epithelial cells express receptors and respond to cytokines has 
dramatically changed our understanding of gut immunology. In fact, this observation is 
not surprising given the microenvironment that surrounds the IEC which is replete with 
cytokine producing immune cells. IEC live in close proximity of intraepithelial 
lymphocytes, dendritic cells, macrophages and granulocytes. Consistent with the basal 
location of the se cytokine sources, IEC possess various cytokine receptors on their baso-
lateral surface (Fig. 3.1) and are activated by cytokines in an autocrine and paracrine 
fashion. In addition, cytokines can also modulate the basic physiological functions in 
IEC. Later studies revealed the epithelial presence of receptors for various cytokines such 
as IL-l, IL-4, IL-6, IL-7, IL-9, IL-lO, IL-Il, IL-13, IL-15, IL-17, IFN-y, TNF-a and GM-
CSF that take part in innate and adaptive immunity (40, 41). IEC also express MHC class 
l, class II receptors, non-classical MHC molecules (12) and chemokine receptors such as 
CXCRl, CXCR4, CCR5 and CCR6 (Fig. 3.1). While interactions between epithelial IEC-
MHC molecules and T cells have been extensively studied (43), the role of IEC 
chemokine receptors is not weIl studied. The surface expression of these receptors is also 
dynamic and is modulated by various stimuli. LPS and IFN-y modulates IL-l, IL-6 
receptors (43) and IFN-y also enhances TNF-a receptor II (44) and MHC class II 
antigens and thus endows them with the ability to present antigen (45, 46). These studies 
suggest that in general, the immune mediated signaIs induce a global phenotypic switch 
in IEC from cells expressing classical epithelial functions su ch as barrier and ion 
transport to those with significant immune functions such as chemokine/cytokine 
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induction, antigen presentation and leucocyte trafficking. Despite the observations that 
IEC do express several receptors for immune mediators and are activated by different 
cytokines, surprisingly, not many reports are available that looked at this phenomenon in 
the context of infectious agents. 
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Fig. 3.1: Intestinal epithelial cell (IEC) - immune cell interactions. Epithelial cells secrete 
innate defense molecules (NO, defensins, IgA), chemokines and cytokines. Chemokines recruit 
immune cells. Cytokines from IEC activate immune cells and influence the immune response. 
Cytokines produced by immune celIs in tum modulate IEC responses. MHC molecules on IEC 
present antigens to recruited T cells. Microbes aiso translocate through IEC and encounter 
immune cells directIy. NF-KB regulates IEC responses. IEC aiso express chemokine receptors. 
Tight junctions (TJ) form a physicai barrier to the passage of microbes. 
To simulate the in vivo situation, researchers have adopted different modifications of in 
vitro co-culture systems to critically analyze how immune cells alter epithelial response 
to a given microbe. Majority of co-culture studies were do ne with no contact using semi-
permeable transwell plates (Fig. 3.2) and aIl these studies show that epithelial response to 
pathogens can be modified by immune ceIl secretions without ceIl-ceIl contact. Haller et 
al. (47) reported that nonpathogenic bacteria elicit a differential cytokine response by 
intestinal epithelial cell/leucocyte co-cultures. Non-pathogenic E. coli and L. sakei 
induced IL-8, MCP-I, IL-l~ and TNF-a from Caco-2 cells in the presence ofunderlying 
peripheral blood mononuclear cells (PBMC) while naive Caco-2 cells remained 
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hyporesponsive, suggesting that sensitization of IEC by neighboring immunocompetent 
cells constitutes a crucial step for recognition of non-pathogenic microbes. Interestingly, 
Epithelial cells 
Immune cells 
Fig. 3.2: ln vitro model for IEC-immune cell co-culture. Intestinal epithelial cells are grown on 
se mi-permeable transwell membrane with immune cells in the bottom weIl without direct contact. 
This facilitates bi-directional cross talk via soluble factors. 
another intestinal commensal Lactibacillus johnsonii induced less inflammatory response 
but more TGF-~ in immune cell sensitized IEC. IL-! ~ and TNF-a, were found to mediate 
the priming of IEC by leucocytes. Another gram-negative commensal bacteria 
Bacteroides vulgatus also induced 1ld3 degradation, NF-1d3 transcriptional activity in rat 
IEC (IEC-6 cellline and primary) and these effects are inhibited when IEC were grown 
in transwell cultures in the presence of lymphocytes (48). This inhibition was observed 
only in the presence of PBMC or peripheral blood lymphocytes (PBL) but not 
monocytes. The same authors in a later study (49) investigated more critically, the 
molecular mechanism of immune-epithelial cell cross-talk on Gram-negative, non-
pathogenic, enteric bacteria-induced NF-1d3 signalling and pro-inflammatory gene 
expression in IEC using HT -29/MTX as well as Caco-2 transwell cultures. Naive HT -29 
cells remained hyporesponsive to both E. coli and B. vulgatus but in the presence of 
PBMC or lamina propria mononuclear cells (LPMC), produced IL-8 in response to E. 
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coli (and its LPS) but not B. vulgatus. Interestingly, both the bacteria induced IKB 
phosphorylation in PBMC sensitized IEC but only B. vulgatus failed to trigger IK:B-Cl 
degradation and NF-KB transcriptional activity. This suggests that immune cell mediated 
tolerance of IEC is stimulus-specific. Another potential mechanism for this differential 
regulation is that immune ceIl signaIs increase the expression of TLR-4 and its co-
receptor MD-2 in IEC which makes the ceIls more responsive to LPS; and B. vulgatus is 
shown to down regulate TLR-4 expression and aiso block PBMC-induced up regulation 
of MD-2 making IEC hyporesponsive to this particular microbe. Moreover, differential 
LPS induced-IL-8 expression was observed when PBMC from Crohn's disease (CD) and 
ulcerative colitis (UC) patients were used. While no significant affect was observed with 
the former, UC derived PB MC dramaticaIly decreased he LPS-induced IL-8 rnRNA. 
Finally, when co-culturing was do ne with purified cell populations from healthy 
volunteers, hyporesponsiveness to B. vulgatus was found to be mediated by lymphocytes 
but not monocytes suggesting that different immune cells confer differential IEC 
responsiveness to microbes. However, the same authors (50) previously reported that co-
culture of HT-29 or Caco-2 with CD1410w monocytes led to reduced inflammatory 
response by IEC against commensal bacteria. Secretions from IEC have been shown to 
induce a phenotypic switch in peripheral blood monocytes from a CD 14 high to a CD 14 low 
/CDI6 low with immunosuppressive functions. These cells secreted immunoregulatory 
cytokine IL-lO and IL-l receptor antagonist, and antagonized lymphocyte-mediated 
activation of the intestinal epithelium in response to intestinal and food derived bacteria. 
Two recent studies (51, 52) reported induction of chaperone stress proteins, Hsp25 and 
Hsp72 in mouse intestinal epithelial ceIls co-cultured with lymphocytes and IL-2 was 
found to be the mediator. It should be noted that in all these studies, bacteria were added 
apical to the IEC with immune ceIls below and it was possible that bacterial products 
could have translocated through IEC to gain access to immune cells who se response 
might have aitered IEC cytokine production. AIso, bi-directional cross talk is invoived in 
this differential IEC response wherein epithelial secretions could also have modified 
immune ceIls. Indeed it has long been known that epithelial ceIls contribute to mucosal 
immune homeostasis in many ways. However, reports of specific modification of 
immune ceIl functions by IEC secretions in the absence of co-culture have been rare. 
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Kanzato et al. (53) showed that paracrine factors from Caco-2 cells increased the 
phagocytic capacity of differentiated THP-1 macrophages. While the mediators from IEC 
are thought to be TGF-~ or MCP-1, the exact identity of these effective substances is not 
known. Stockmann et al. (54) reported that supernatants of HIV-infected immune celIs 
decreased transepithelial resistance (TER) in HT-291B6 cells and this effect cou Id be 
mimicked by recombinant TNF-u. It was also demonstrated that colonie epithelial celI 
lines (HT-29, Caco-2, HCT-116 and Colo-320) down-regulate IL-8 expression in human 
intestinal microvascular endothelial celIs in a TGF-~l dependent manner (55). To 
summarize, immune cells modify intestinal epithelial cell responses and in many 
instances, these responses are anti-inflammatory and cyto-protective. 
3.3 Stress response and IEC 
Heat shock proteins (Hsp) are a family of endogenous proteins that are highly conserved 
across aIl species and are induced by a variety of stress stimuli su ch as thermal (56, 57), 
chemical (58), oxidative stress (59, 60), depletion of ATP (61), free radicals (62), and 
during different patho-physiological conditions such as ischemia (62) and hypoxia (63). 
Recently, several microbial agents have also been shown to induce stress response in 
intestinal epithelial cells (51, 52, 64-66). It should be noted that even though the words 
heat shock proteins and stress proteins are used synonymously, the latter include in 
addition to Hsp; gp96, glucose-regulated proteins (GRP) and ubiquitin (67). Several 
classes of Hsp are present based on molecular weight of which the major six families are; 
Hsp11O, Hsp90, Hsp70, Hsp60, Hsp40 and small Hsps which includes Hsp27 and Hsp8.5 
(68). Hsps can also be grouped into two categories; constitutive and inducible. 
Constitutive Hsp are normally present in the cell and function as molecular chaperones 
by folding proteins into their proper configuration and help in transferring proteins across 
cell membranes. Inducible Hsps are produced under conditions of stress and serve to 
stabilize proteins, preventing their denaturation. Overall, the major functional properties 
of Hsp are; a) to maintain normal protein homeostasis by assisting in protein folding, b) 
facilitating assembly and disassembly of protein complexes, c) inhibition of improper 
protein aggregation (as occurs during thermallchemical denaturation), d) direction of 
newly formed proteins to target organelles for final packaging, degradation or repair (69-
60 
76). Induction of Hsps by mild stress conditions confers protection from subsequent 
lethal stress and this phenomenon is referred to as stress tolerance. Hence, it is thought 
that Hsps are an endogenous defense mechanism for cells to overcome deleterious effects 
of toxic agents. 
Hsp expression is transcriptionally regulated by heat shock factors (HSF). Four HSFs 
have been identified in vertebrates; HSF-l, 2 and 4 are present in mammals and HSF-3 is 
specifie to avians (58, 77-79). It is weIl established that HSF-l is the key transcription 
factor that is necessary for Hsp induction in all conditions in different cell types while 
HSF-2 is more a developmental regulator (80, 81). HSFI is constitutively present in cells 
but under this condition its transcription initiating activity is limited by binding with 
Hsp90 multichaperone complex (82). Under stress, several denatured proteins compete 
with the HSFI for Hsp90 multiehaperone complexes, resulting in unbinding of HSFI that 
facilitates formation of its homotrimers which acquire transcriptional activity following 
nuclear translocation. This is an oversimplification of HSF-l activation but it is suffice to 
mention that it is regulated at multiple levels; the oligomeric status, its DNA-binding 
ability, posttranslational modification, transcriptional competence, nuclear/ subnuclear 
localization, as weIl as its interactions with regulatory cofactors or other transcription 
factors (83). Nonetheless, transcription is initiated by the binding of HSF to the heat 
shock response element (HSE) in the promoters of Hsp genes. HSE are characterized by 
the presence of specific nucleotide motif which is an inverted repeats of nGAAn (81, 84). 
FunctionaIly, Hsp27 (murine Hsp25) and Hsp70 (murine Hsp72) have been extensively 
studied with regard to their abilities to suppress apoptosis induced by various factors. 
Both have been found to possess powerful anti apoptotic properties through different 
mechanisms such as chaperone activity, ability to inhibit several key components of 
apoptotic machinery and induction of proteasomal mediated degradation of apoptosis-
regulatory proteins. Overexpressed Hsp27 or Hsp70 prevented cell death induced by 
hyperthermia, oxidative stress, cytotoxie drugs, staurosporin and ligation of death 
receptors Fas/Apo-l/CD95 (85). However, Hsp70 might also enhance apoptosis in a cell 
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specific manner as overexpreSSlOn of Hsp70 was found to enhance TCRlCD3- and 
Fas/Apo-l/CD95-mediated apoptosis in Jurkat T cells (86). 
In vivo IECs express all Hsps though with varying degrees at different locations in the 
gut. Several factors such as inflammation, bacterialload, acidity, nutrients like glutamine 
and short chain fatty acids, immune cell mediators etc. regulate Hsp expression in IEC 
(87). While much information is available on Hsp induction by physical, chemical and 
nutritional stressors, microbial regulation of Hsp in IEC has not been well studied. High 
Hsp expression in IEC induced by the intestinal flora is thought to main tain the barrier 
function and protect the host from the damaging effects of toxic agents. Gut inflammation 
as a result of changes in the intestinal flora seen during antibiotic treatment and C. 
difficile colitis might result from reduced protective factors from commensal bacteria. It 
has been shown that metronidazole treatment decreases colonic mucosal Hsp25 and 
Hsp72 expression and decreases barrier function to C. difficile toxin A (51). Kojima et al. 
(88) showed that E. coli LPS induces Hsp25 but not Hsp72 in young adult mouse colon 
(YAMC) cells in a p38 and ERK MAP kinase dependent manner. This increased Hsp25 
protected the cells against actin depolymerization induced by the oxidant 
monochloramine. Bacterial superantigen was the only second purified microbial product 
that has been shown to induce a similar heat shock protein expression from IEC. 
Staphylococcal aureus enterotoxin B (SEB) induces Hsp25 and Hsp72 but not Hsc73 in 
mouse small intestinal epithelial cells (52). Inhibition of ERK1I2 but not p38 
significantly inhibited SEB induced Hsps. Probiotics have excellent beneficial effects in 
different intestinal inflammatory conditions such as inflammatory bowel disease (IBD), 
irritable bowel syndrome (lBS), pouchitis, and antibiotic associated diarrhea. However, 
the mechanism of this protection is poorly understood. Petrof et al. (66) demonstrated 
that treatment of mouse colonie epithelial cells with conditioned medium of probiotic 
bacterial mix VSL#3 induces the expression of Hsp25 and Hsp72. Again this is 
accompanied by protection against oxidative damage through stabilization of actin. 
Similar observations were also reported by Tao et al. (64) who found up-regulation of 
Hsp25 and Hsp72 by soluble factors of probiotic bacteria Lactobacillus GG from young 
adult mou se colon cells. An acid and heat stable low molecular weight peptide from the 
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conditioned medium of bacteria induced these Hsps in p38 and JNK MAP kinase 
dependent manner. Recently cytokines and immune ceIl secretions have been shown to 
induce Hsp expression in IEe. Musch et al. (52) showed that co-culture of mou se IEC 
with lamina propria lymphocytes also induced Hsp25 and Hsp72 and this induction is 
inhibited when neutralizating antibody against IL-2 are added during the co-culture. Role 
of lymphocytes in IEC Hsp expression was also confirmed in RAG-I-I- mice (51). RAG-
1-1- mice are devoid of Band T ceIls and colonic mucosa from these mice express greatly 
reduced levels of Hsp72 with not much change in Hsp25 and Hsc73. Sasaki et al. (89) 
reported that TGF-~ and IL-l~ activate HSF-l and indu ces Hsp47 expression in human 
fibroblasts. To summarize, microbes and immune mediators can induce heat shock 
protein expression in intestinal epithelial cells. 
References: 
1. Turner, J. R. (2003) Functional morphology of the intestinal mucosae: from crypts 
to tips. In: Microbial pathogenesis and the intestinal epithelial ceIl. (Ed.) Gail A. 
Hecht. ASM press. Washington, De. 1-22. 
2. OueIlette, A. J. (1997) Paneth ceIls and innate immunity In the crypt 
microenvironment. Gastroenterology 113: 1779-1784. 
3. Witthoft, T. L., Eckmann, L., and Kim, J. M. (1998) Enteroinvasine bacteria 
directly activate expression of iNOS and NO production in human colon epithelial 
cells. Am J Physiol275: G564-571. 
4. Mashimo, H., Wu, D-e., Podolsky, D. K., and Fishman, M. e. (1996) Impaired 
defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274: 
262-265. 
5. Mestecky, J., and Russel, M. W. (2003) Intestinal immunoglobulin A: role in host 
defense. In: In: Microbial pathogenesis and the intestinal epithelial cell. (Ed.) Gail 
A. Hecht. ASM Press. Washington, De. 95-112. 
6. Jung, H. e., Eckmann, L., Yang, S. K., Panja, A., Fierer, J., Morzycka-
Wroblewska, E., and Kagnoff, M. F. (1995) A distinct array of proinflammatory 
63 
cytokines is expressed in human colon epithelial cells in response to bacterial 
invasion. J Clin Invest 95: 55-65. 
7. Eckmann, L., Smith, J. R., Housley, M. P., Dwinell, M. B., and Kagnoff, M. F. 
(2000) Analysis by high density cDNA arrays of altered gene expression in 
human intestinal epithelial cells in response to infection with the invasive enteric 
bacteria Salmonella. J Biol Chem 275: 14084-94. 
8. Stadnyk A.W. (2002) Intestinal epithelial cells as a source of inflammatory 
cytokines and chemokines. Can J Gastroenterol16: 241-246. 
9. Okazawa, A., Kanai, T., Nakamaru, K., Sato, T., Inoue, N., Ogata, H., Iwao, Y., 
Ikeda, M., Kawamura, T., Makita, S., Uraushihara, K., Okamoto, R., Yamazaki, 
M., Kurimoto, M., Ishii, H., Watanabe, M., and Hibi, T. (2004) Human intestinal 
epithelial cell-derived interleukin (lL)-18, along with IL-2, IL-7 and IL-15, is a 
potent synergistic factor for the proliferation of intraepithelial lymphocytes. Clin 
Exp Immunol 136: 269-276. 
10. Ruiz, P. A., Hoffmann, M., Szcesny, S., Blaut, M., Haller, D. (2005) Innate 
mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host 
responses in intestinal epithelial cells after the colonization of germ-free rats. 
Immunology 115:4441. 
11. Lin, X. P., Almqvist, N., and Telemo, E. (2005) Human small intestinal epithelial 
cells constitutively express the key elements for antigen processing and the 
production of exosomes. Blood Cells Mol Dis 35: 122-128. 
12. Shao, L., Kamalu, O., and Mayer, L. (2005). Non-classical MHC class 1 
molecules on intestinal epithelial cells: mediators of mucosal crosstalk. Immunol 
Rev 206:160-176. 
13. Huang, G, T.-J., Eckmann, L., Savidge, c., and Kagnoff, M. F. (1996) Infection of 
human intestinal epithelial cells with invasive bacteria upregulates apical 
intercellular adhesion molecule-1 (ICAM -1) expression and neutrophil adhesion. 
J Clin Invest 98: 572-583. 
14. Jobin, c., Hellerbrand, c., Licato, L. L., Brenner, D. A., and Sartor, R. B. (1998) 
Mediation by NF-kappa B of cytokine induced expression of intercellular 
64 
adhesion molecule 1 (ICAM -1) in an intestinal epithelial ceIl line, a process 
blocked by proteasome inhibitors. Gut 42: 779-787. 
15. Yang, S. K., Eckmann, L., Panja, A., and Kagnoff, M. F. (1997) DifferentiaI and 
regulated expression of C-X-C, C-C, and C-chemokines by human colon 
epithelial cens. Gastroenterology 113: 1214-1223. 
16. Ohno, Y., J. Lee, R P. MacDermott, and 1. R Sanderson. (1997) Macrophage 
inflammatory protein-2: chromosomal regulation in rat small intestinal epithelial 
cens. Proc Natl Acad Sei USA 94: 10279-10284 
17. Jobin, c., and Sartor, R B. (2000) The lld3/NF-KB system: a key determinant of 
mucosal inflammation and protection. Am J Physiol Cell Physiol 278: C451-
C462. 
18. Pédron, T., Thibault, C., and Sansonetti, P. J. (2003) The Invasive phenotype of 
Shigella flexneri directs a distinct gene expression pattern in the human intestinal 
epithelial cellline Caco-2. J Biol Chem 278: 33878-33886. 
19. Stokes, N. R, Zhou, X., Meltzer, S. J., and Kaper, J. B. (2004) Transcriptional 
responses of intestinal epithelial cells to infection with Vibrio cholerae. Infect 
Immun 72: 4240-4248. 
20. Ukena, S. N., Westendorf, A. M., Hansen, W., Rohde, M., Geffers, R, Coldewey, 
S., Suerbaum, S., Buer, J., and Gunzer, F. (2005) The host response to the 
probiotic Escherichia coli strain Nissle 1917: specifie up-regulation of the 
proinflammatory chemokine MCP-l. BMC Med Genet 13:43-48. 
21. Roxstrom-Lindquist, K., Ringqvist, E., Palm, D., and Svard, S. (2005) Giardia 
lamblia-induced changes in gene expression in differentiated Caco-2 human 
intestinal epithelial cells. Infect Immun 73: 8204-8208. 
22. Eckmann, L., Reed, S. L., Smith, J. R, and Kagnoff, M. F. (1995) Entamoeba 
histolytica trophozoites induce an inflammatory cytokine response by cultured 
human cells through the paracrine action of cytolytically released interleukin-1 
alpha. J Clin Invest 96:1269-1279. 
23. Seydel, K. B., Li, E., Swanson, P. E., Stanley, S. L Jr. (1997) Human intestinal 
epithelial cens produce proinflammatory cytokines in response to infection in a 
65 
/-. 
SCID mouse-human intestinal xenograft model of amebiasis. Infect Immun 
65: 1631-1639. 
24. Yu, Y., and Chadee, K. (1997) Entamoeba histolytica stimulates interleukin 8 
from human colonic epithelial cens without parasite-enterocyte contact. 
Gastroenterology 112: 1536-1547. 
25. Zhang, Z., and Stanley, S. L. Jr (2004) Stereotypic and specific elements of the 
human colonic response to Entamoeba histolytica and Shigella flexneri. Cell 
Microbiol 6: 535-554. 
26. Kim, J. M., Lee, J. Y., Yoon, Y. M., Oh, Y.-K., Youn, J., Kim, Y.-J. (2006) NF-
KR activation pathway is essential for the chemokine expression in intestinal 
epithelial cens stimulated with Clostridium difficile toxin A. Scand J Immunol 
63:6453. 
27. Murphy, P.M. (1994) The molecular biology of leukocyte chemoattractant 
receptors. Annu Rev Immunol 12: 593-633. 
28. Baggiolini, M. (2001) Chemokines in pathology and medicine. J Intern Med 250: 
91-104. 
29. Kim, J. J., Nottingham, L. K., Sin, J. I., Tsai, A., Morrison, L., Oh, J., Dang, K., 
Hu, Y., Kazahaya, K., Bennett, M., Dentchev, T., Wilson, D. M., Chalian, A. A., 
Boyer, J. D., Agadjanyan, M. G., and Weiner, D. B. (1998) CD8 positive T cells 
influence antigen-specific immune responses through the expression of 
chemokines. J Clin Invest 102: 1112-1124. 
30. Yang, S. K., Eckmann, L., Panja, A., and Kagnoff, M. F. (1997) DifferentiaI and 
regulated expression of ç-X-C, C-C, and C-chemokines by human colon 
epithelial cens. Gastroenterology 113: 1214-1223. 
31. Sansonetti, P. J., Arondel, J., Huerre, M., Harada, A., and Matsushima, K. (1999) 
Interleukin-8 controls bacterial transepithelial destruction in experimental 
shigellosis. Infect Immun 67: 1471-1480. 
32. Melmed, G., Thomas, L. S., Lee, N., Tesfay, S. Y., Lukasek, K., Michelsen, K. 
S., Zhou, Y., Hu, B., Arditi, M., and Abreu, M. T. (2003) Human intestinal 
epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent 
66 
bacterial ligands: Implications for host-microbial interactions 10 the gut. J 
Immunol170: 1406 -1415. 
33. Abreu, M. T., Vora, P., Faure, E., Thomas, L. S., Arnold, E. T., and Arditi, M. 
(2001) Decreased expression of ToIl-like receptor-4 and MD-2 correlates with 
intestinal epithelial cell protection against dysregulated proinflammatory gene 
expression in response to bacteriallipopolysaccharide. J Immunol167: 1609-1616. 
34. S. Rakoff-Nahoum, J. P., Eslami-Varzaneh, F., Edberg, S., and Medzhitov, R. 
(2004) Recognition of commensal microflora by Toll-like receptors is required for 
intestinal homeostasis. Cell118: 229-241. 
35. Cario, E., and Podolsky, D. K (2000) DifferentiaI alteration in intestinal 
36. 
37. 
epithelial cell expression of ToIl-like receptor 3 (TLR3) and TLR4 in 
inflammatory bowel disease Infect Immun 68:7010-7017. 
Hausmann, M., Kiessling, S., Mestermann, S., Webb, G., Spottl, T., Andus, T., 
SchOlmerich, J., Herfarth, H., Ray, K, Falk, W., and Rogler, G. (2002) Toll-like 
receptors 2 and 4 are up-regulated during intestinal inflammation. 
Gastroenterology 122: 1987 -2000. 
Pierik, M., Joossens, S., Van Steen, K, Van Schuerbeek, N., Vlietinck, R., 
Rutgeerts, P., and Vermeire, S. (2006) Toll-like receptor-l, -2, and -6 
polymorphisms influence disease extension in inflammatory bowel diseases. 
Inflamm Bowel Dis 12: 1-8. 
38. Abreu, M. T., Arnold, E. T., Thomas, L. S., Gonsky, R., Zhou, Y., Hu, B., and 
Arditi, M. (2002) TLR4 and MD-2 expression is regulated by immune-mediated 
signaIs in human intestinal epithelial cells. J Biol Chem 277: 20431-20437. 
39. Mueller, T., Terada, T., Rosenberg, 1. M., Shibolet, O., and Podolsky, D. K 
(2006) Th2 cytokines down-regulate TLR expression and function in human 
intestinal epithelial cells. J Immunol 176:5805-5814. 
40. Colgan, S. P., Furuta, G. T., and Taylor, e. T. (2003) Cytokines and epithelial 
function. In: Microbial pathogenesis and the intestinal epithelial cell. (Ed.) Gail 
A. Hecht. ASM Press. Washington, De. 61-78. 
67 
41. Kagnoff, M. F. (2003) Upregulation of innate defense mechanisms by enteric 
infections. In: Microbial pathogenesis and the intestinal epithelial cell. (Ed.) Gail 
A. Hecht. ASM Press. Washington, De. 155-174. 
42. Panja, A., Goldberg, S., Eckmann, L., Krishen, P., and Mayer, L. (1998) The 
regulation and functional consequence of proinflammatory cytokine binding on 
human intestinal epithelial cells. J Immunol161: 3675-3684. 
43. Dotan, 1., and Mayer, L. (2003) Intestinal immunity. In: In: Microbial 
pathogenesis and the intestinal epithelial cell. (Ed.) Gail A. Hecht. ASM press. 
Washington, De. 43-59. 
44. Taylor, e. T., Dzus, A. L., and Colgan, S. P. (1998) Autocrine regulation of 
intestinal epithelial permeability induced by hypoxia: role for basolateral release 
of tumor necrosis factor (TNF)-a. Gastroenterology 114: 657-668. 
45. Cerf-Bensussan, N., Quaroni, A., Kumick, J. T., and Bahn, A. K. (1984) 
Intraepitheliallymphocytes modulate la expression by intestinal epithelial cells. J 
lmmunol 132: 2244-2252. 
46. Mayer, L., and Shlien, R. (1987) Evidence for function of la molecules on gut 
epithelial cells in man. J Exp Med 166: 1471-1483. 
47. Haller, D., Bode, e., Hammes, W. P., Pfeifer, A. M., Schiffrin, E. J., and Blum, S. 
(2000) Non-pathogenic bacteria elicit a differential cytokine response by 
intestinal epithelial cell/leucocyte co-cultures. Gut 47: 79-87. 
48. Haller, D., Russo, M. P., Sartor, R. B., and Jobin, e. (2002) IKK beta and 
phosphatidylinositol 3-kinase/ Akt participate in non-pathogenic Gram-negative 
enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both 
primary and intestinal epithelial celllines. J Biol Chem 277: 38168-38178. 
49. Haller, D., HoIt, L., Parlesak, A., Zanga, J., Bauerlein, A., Sartor, R. B., and 
Jobin, e. (2004) DifferentiaI effect of immune cells on non-pathogenic Gram-
negative bacteria-induced nuclear factor-KB activation and pro-inflammatory gene 
expression in intestinal epithelial cells. lmmunology 112: 310-320. 
50. Haller, D., Serrant, P., Peruisseau, G., Bode, e., Hammes, W. P., Schiffrin, E., 
Blum, S. (2002) IL-lO producing CD1410w monocytes inhibit lymphocyte-
68 
,.-, dependent activation of intestinal epithelial cells by commensal bacteria. 
Microbiol Immunol46: 195-205. 
51. Kojima, K., Musch, M. W., Ren, H., Boone, D. L., Hendrickson, B. A., Ma' A., 
and Chang, E. B. (2003) Enteric flora and lymphocyte-derived cytokines 
determine expression of heat shock proteins in mouse colonic epithelial cells. 
Gastroenterology 124:1395-407. 
52. Musch, M. W., Petrof, E. O., Kojima, K., Ren, H., McKay, D. M., and Chang, E. 
B. (2004) Bacterial superantigen-treated intestinal epithelial cells upregulate heat 
shock proteins 25 and 72 and are resistant to oxidant cytotoxicity. Infect Immun 
72:3187-3194. 
53. Kanzato, H., Manabe, M., and Shimizu, M. (2001) An in vitro approach to the 
evaluation of the cross talk between intestinal epithelium and macrophages. 
Biosei Biotechnol Biochem 65:449-451. 
54. Stockmann, M., Schmitz, H., Fromm, M., Schmidt, W., Pauli, G., Scholz, P., 
Riecken, E. O., and Schulzke, J. D. (2000) Mechanisms of epithelial barrier 
impairment in HIV infection. Ann N Y Acad Sei 915:293-303. 
55. Lugering, N., Kucharzik, T., Gockel, H., Sorg, c., StoIl, R., Domschke, W. 
(1998) Human intestinal epithelial cells down-regulate IL-8 expression in human 
intestinal microvascular endothelial cells; role of transforming growth factor-beta 
I(TGF-betal). Clin Exp Immunoll14: 377-84. 
56. Burdon, R. H. (1986) Heat shock and heat shock proteins. Biochem J 240: 313-24. 
57. Ostberg, J. R., Kaplan, K. c., and Repasky, E. A. (2002) Induction of stress 
proteins in a panel of mou se tissues by fever-range whole body hyperthermia. Int 
J Hyperthermia 18:552-562. 
58. Wu, C. (1995) Heat shock transcription factors: structure and regulation. Annu 
Rev Cell Dev Biol 11: 441-469. 
59. Plesset, J., Palm, c., and McLaughlin, C. S. (1982) Induction of heat shock 
proteins and thermotolerance by ethanol in Saccharomyces cerevisiae. Biochem 
Biophys Res Commun 108: 1340-1345. 
69 
60. Kukreja, R. c., Kontos, M. c., Loesser, K. E., Batra, S. K., and Qian, Y. Z. 
(1994) Oxidant stress increases heat shock prote in 70 rnRNA in isolated perfused 
rat heart. Am J Physiol Heart Circ Physiol267: H2213-2219. 
61. Diller, K. R. (2006) Stress Protein Expression Kinetics. Annu Rev Biomed Eng 
8:403-424. 
62. Richard, V., Kaeffer, N., and Thuillez, C. (1996) Delayed protection of the 
ischemic heart from pathophysiology to therapeutic applications. Fundam Clin 
PharmacoI1O:409-415. 
63. Patel, B. A., Khaliq, J., and Evans, J. (1995) Hypoxia induces Hsp70 gene 
expression in human hepatoma (HEP G2) cens. Biochem Mol Biol Int 36:907-
912. 
64. Tao, Y., Drabik, K. A., Waypa, T. S., Musch, M. W., Alverdy, 1. c., Schneewind, 
O., Chang, E. B., and Petrof, E. o. (2006) Soluble factors from Lactobacillus GG 
activate MAPKs and induce cytoprotective heat shock proteins in intestinal 
epithelial cens. Am J Physiol Cel! Physiol290:C1018-1030. 
65. Targosz, A., Pierzehalski, P., Krawiee, A., Szezyrk, U., Brzozowski, T., 
Konturek, S. J., and Pawlik, W. W. (2006) Helicobacter pylori inhibits expression 
of heat shock protein 70 (Hsp70) in human epithelial cellline. Importance of Cag 
A protein. J Physiol Pharmacol57: 265-278. 
66. Petrof, E. O., Kojima, K., Ropeleski, M. J., Musch, M. W., Tao, Y., De Simone, 
c., Chang, E. B. (2004) Probioties inhibit nuclear factor-kappaB and induce heat 
shock proteins in colonie epithelial cens through proteasome inhibition. 
Gastroenterology 127: 1474-1487. 
67. Moseley, P. (2000) Stress proteins and the immune response. Immunopharmacol 
48: 299-302. 
68. Feder, M. E., and Hofmann, G. E. (1999) Heat-shock proteins, molecular 
chaperones, and the stress response: evolutionary and ecological physiology. 
Annu Rev Physiol61: 243-282. 
69. Zimmerman, S. B., and Minton, A. P. (1993) Macromolecular crowding: 
biochemical, biophysical and physiological consequences. Annu Rev Biophys 
Biomol Struct 22: 27-65. 
70 
70. Lamand'e, S. R, and Bateman, J. F. (1999) Procollagen folding and assembly: the 
role of endoplasmic reticulum enzymes and molecular chaperones. Sernin Celi 
Dev Biol 10: 455-464. 
71. Saibil, H. (2000). Molecular chaperones: containers and surfaces for folding, 
stabilizing or unfolding proteins. Curr Opin Struct Biol 10: 251-258. 
72. Schr··oder, M., and Kaufman, R J. (2005) The mammalian unfolded protein 
response. Annu Rev Biochern 74: 739-789. 
73. Ellis, R J. (1997) Molecular chaperones: avoiding the crowd. Curr Biol7:R531-
533. 
74. Ohtsuka, K., and Hata, M. (2000) Molecular chaperone function of mammalian 
Hsp70 and Hsp40 - a review. Int J Hyperthermia 16: 231-245. 
75. Hass, 1. G. (1991) BiP - a heat shock protein involved in immunoglobulin chain 
assembly. Curr Top Microbiol Irnrnunol167: 71-82. 
76. Gottesman, S. (2003). Proteolysis in bacterial regulatory circuits. Annu Rev Celi 
Dev Biol 19: 565-587. 
77. Morimoto, R I. (1998) Regulation of the heat shock transcriptional response: 
cross talk between a family of heat shock factors, molecular chaperones, and 
negative regulators. Genes Dev. 12: 3788-3796. 
78. Squires, C. L., and Zaporajets, D. (2000) Proteins shared by the transcription and 
translation machines. Annu Rev Microbiol54: 775-798. 
79. Harding, H.P., Calfon, M., Urano, F., Novoa, 1., and Ron, D. (2002) 
Transcriptional and translational control in the mammalian unfolded protein 
response. Annu Rev Celi Dev Biol 18: 575-599. 
80. Christians, E. S., Yan, J. J., and Benjamin, 1. J. (2002) Heat shock factor 1 and 
heat shock proteins: Critical partners in protection against acute cell in jury. Crit 
Care Med 30: S43-50. 
81. Baler, R., Dahl, G., and Voellmy, R. (1993) Activation of human heat shock 
genes is accompanied by oligomerization, modification, and rapid translocation of 
heat shock transcription factor HSFI. Mol Celi Biol 13: 2486-2496. 
71 
82. Guo, Y., Guettouche, T., Fenna, M., Boellmann, F., and Pratt, W. B. (2001) 
Evidence for a mechanism of repression of heat shock factor 1 transcriptional 
activity by a multichaperone complex. J Biol Chem 276: 45791-45799. 
83. Voellmy, R (2004) On mechanisms that control heat shock transcription factor 
activity in metazoan cells. CeU Stress Chaperones 9: 122-133. 
84. Fernandes, M., O'Brien, T., and Lis, J. T. (1994) Structure and regulation of heat 
shock gene promoters. In: The biology of heat shock proteins and molecular 
chaperones. (Eds). Morimoto, R I., Tissieres, A., and Georgopolis, C. Cold 
Spring Harbor, NY. 375-393. 
85. Garrido, c., Schmitt, E., Cande, c., Vahsen, N., Parcellier, A., and Kroemer, G. 
(2003) Hsp27 and Hsp70 Potentially Oncogenic Apoptosis Inhibitors. Cel! Cycle 
2: 579-584. 
86. Liossis, S. N., Ding, X. Z., Kiang, J. G., and Tsokos, G. C. (1997) Overexpression 
of the heat shock prote in 70 enhances the TCR/CD3-and Fas/ Apo-l/CD95-
mediated apoptosis cell death in Jurkat T cells. J Immunoll58: 5668-5675. 
87. Petrof, E. O., Ciancio, M. J., and Chang, E. B. (2004) Role and regulation of 
intestinal epithelial heat shock proteins in health and disease. Chinese J Dig Dis 5: 
45-50. 
88. Kojima, K., Musch, M. W., Ropeleski, M. J., Boone, D. L., Ma, A., and Chang, E. 
B. (2004) Escherichia coli LPS induces heat shock protein 25 in intestinal 
epithelial cells through MAP kinase activation. Am J Physiol Gastrointest Liver 
Physiol 286: G645-652. 
89. Sasaki, H., Sato, T., Yamauchi, N., Okamoto, T., Kobayashi, D., Iyama, S., Kato, 
J., Matsunaga, T., Takimoto, R, Takayama, T., Kogawa, K., Watanabe, N., and 
Niitsu Y. (2002) Induction of heat shock prote in 47 synthesis by TGF-beta and 
IL-l beta via enhancement of the heat shock element binding activity of heat 
shock transcription factor 1. J Immunol168: 5178-5183. 
72 
CHAPTER 4: NF -KB SIGNALING 
4.1 Introduction 
Signaling is an essential event by which a living cell communicates with environmental 
cues by sensing and responding to them. Signaling pathways modulate plethora of cell 
functions under both physiological and pathological states such as growth, proliferation, 
apoptosis, defense against pathogens etc. While an appropriate regulation of cell 
signaling is beneficial to the host, the consequences of an aberrant activation/suppression 
cou Id be disastrous. Signaling cascades involve several components which are intricately 
connected via a myriad of networks and broadly consist of five steps; receptor-ligand 
interaction, intracellular signal transduction, nuclear events such as transcriptional/post-
transcriptional modulation, cellular responses and phenotypic responses. A thorough 
deciphering of signaling events contributes immensely to our understanding the 
pathogenesis of diseases and also to discovering drugs against myriad of health problems 
such as infectious diseases, diabetes and cancer. Sorne examples of weIl studied pathways 
include, G-protein coupled receptor, protease activated receptor, cytokine receptor 
signaling, NF-KB signaling, Toll receptor signaling, Wnt signaling, JAK/STAT signaling, 
MAP kinase, phosphoinositide 3 kinase signaling, calcium and calmodulin signaling (1). 
NF-KB (nuclear factor KB), the best-studied and characterized signaling mediator, was 
first identified as the transcription factor required for K chain in B cells. Today it is 
recognized as a ubiquitous molecule that is activated by plethora of stimuli inc1uding 
pathogens, cytokines, growth factors, stress etc. It regulates a number of genes involved 
in inflammation and immune response and thus assumes a central role in host defense (2). 
Its significance is evident from the fact that aIl most aIl effects of TLR signaling 
described in chapter 2, are mediated by this transcription factor. The diverse genes that 
are regulated by NF-KB inc1ude those encoding cytokines (IL-l, IL-2, IL-6, IL-8, IL-12, 
IL-18, TNF-a, IL-I~, LT-a, LT-~, GM-CSF), chemokines such as (IL-8, MIP-Ia, MCP, 
RANTES, eotoxin), adhesion molecules (ICAM-I, VCAM, E-selectin), acute phase 
proteins (SAA), inducible enzymes of inflammatory response (iNOS, COX-2), anti-
microbial peptides (defensins), molecules for adaptive immune signaling (MHC 1 and II, 
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B7.1, B7.2) and apoptosis regulators (c-IAP-I, cIAP-2, BCL, Fas ligand, c-myc, cyclin 
Dl). Given this long li st of genes, it is not surprising that NF-KB has bec orne the target 
molecule of choice to modulate various disease processes. This lead to an intense 
research aimed at understanding the various aspects of this transcription factor under 
different conditions. Its activation was found to be rapid and is regulated very tightly. It 
is a family of five transcription factors and exists as either homo or hetero dimers which 
differ in their ability to bind the promoter regions of target genes and induce the gene 
transcription (3). There are 5 genes of NF-KB family in mammalian cells: RelA, RelB, c-
Rel, NF-Ki3l and NF-KB2. These genes gives tise to 7 NF-KB proteins- Rel A (p65), Rel 
B, c-Rel, p50 and its precursor protein p105, and p52 and its precursor protein plOO. P50 
and p52 correspond to the amino terminal halves of the precursor proteins p105 and plOO 
respectively. AU 5 members share a 300 aminoacid Rel Homology Domain (RHD) at N-
terminal, which is essential for DNA binding, dimerization and binding to the IKB family 
ofNF-KB inhibitory proteins. However, the transactivation domains (TAD) are present in 
the c-termÏnal of only Rel A, Rel Band c-Rel (Fig. 4.l). TADs interact with the basal 
transcriptional activators such as TBP, TFIIB, CBP etc (4-6). The glycine rich regions 
(GRR) are important for co-translational processing of p105 to p50 and post-translational 
processing of plOO to p52. The prototypical NF-KB is composed of p50 and p65 which 
has the greatest transcriptional ability where as p50/p50 and p52/p52 homodimers repress 
the gene transcription owing to the absence of TADs (7). Various other combinations of 
dimers are known to exist and mice lacking individual subunits display distinct 
phenotypes, suggesting specific role of dimers in inducing distinct sets of NF-KB target 
genes (3). The di mers of NF-KB exist in a latent form in the cytoplasm, bound to the 
Inhibitory KB (IKB) proteins. The major members of the IKB family include IKB-a, IKB-
~, IKB-y, IKB-E, and BCL-3. The hallmark of IKB proteins is the presence of ankyrin-
repeating domain that mediates interaction with NF-KB proteins (Fig. 4.1). Aiso p105 and 
p100, the precursor proteins respectively of NF-KB p50 and p52, contain ankyrin 
repeating domains and act as inhibitors of NF-KB. BCL-3 is unique because it contains a 
TAD in addition to ankyrin repeats. Consequently p50 and p52 units of NF-KB when 
form a complex with BCL-3, acquire transcriptional activation properties. Various stimuli 
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that activate NF-KB cause degradation of inhibitory proteins and nuclear translocation of 
NF-KB subunits (8). Once in the nucleus, NF-KB transcription factors recognize a 
specifie consensus sequence in the promoter regions of target genes which contain one or 
more KB-enhancer consensus sequences 5' -GGGRNYYYCC-3', where R is a purine, Y 
is a pyrimidine and N is any nucleic acid. Binding of NF-KB together with recruitment of 
co-activators such as CBP, TBP and TFIIB then stimulates gene transcription. 
It should be mentioned that NF-K13-IK13 complexes can also shuttle between the 
cytoplasm and the nucleus in unstimulated cells, but the nuclear export is more efficient 
and, therefore constitutively, the NF-K13-IKB complexes remain mainly cytoplasmic. This 
is facilitated by the existence of nuclear export signaIs (NES) on IKB-a and also the 
incomplete masking of nuclear localization signaIs (NLS) on NF-KB subunits. Majority 
of the studies on NF-KB activation have focused on IKB-a but NF-KB is also sequestered 
by another isoform IKB-~. However, complexes of IKB-~ can not enter nucleus because 
of the absence of nuclear ex port signaIs (NES) on IKB-~ and also the complete masking 
of NLS on NF-KB molecules by this isoform (2). 
4.2. Activation of NF-KB 
Fundamentally, there are two mechanisms by which the transcription factor NF-KB is 
activated; one depends on the phosphorylation and degradation of inhibitory proteins 
with subsequent release of NF-KB dimers, while the second pathway depends on the post-
translational modifications of NF-KB molecules. These two pathways are complementary 
and are found to be required for optimal NF-K13 activation. Four pathways exist that 
involve degradation of IKBs: classical, alternative, atypical and pI05 pathways (Fig. 4.2) 
(9). 
Classical pathway: 
This is triggered by proinflammatory cytokines TNF-a, IL-l ~ and TLRs and involves a 
sequential recruitment of various adaptors to the cytoplasmic membrane and activation of 
kinases that converge at the lev el of Inhibitory Kappa B Kinase (IKK) complex. IKK 
75 
complex consists of regulatory unit, a scaffolding protein NF-1(B essential modulator 
(NEMO) or IKK-y and two catalytic subunits, IKK-a (or IKK-l) and IKK-~ (or IKK-2). 
IKK phosphorylates IKB-a at serine 32 and 36 positions which is then tagged by 
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Fig. 4.1: Structure of NF-KB and IKB molecules: AlI NF-KIl/Rel molecules have a common 
NHrterminal Rel Homology Domain (RHO). C-terminal TAO is present only in Rel A(p65), Rel 
Band c-Rel. LZ is essential for transcativation by Rel B. IKIl molecules (includes plO5 and plOO) 
possess ankyrin repeat regions which mediate interaction with NF-KIl proteins. GRR is essential 
for processing of plO5 and plOO into their respective NF-KIl molecules; BCL-3 is unique in that 
it possesses both ankyrin repeats and TAO. 
ubiquitin. Polyubiquitination of IKB-a lS mediated by ubiquitin ligase complex 
designated ~-TrCP-SCF (10, 11). Several other components make up this complex, 
including the ubiquitin-conjugating enzyme and a subunit, Cu11. Ubiquitinated IKB-a is 
recognized by 26S regulatory subunit of proteasome followed by proteolytic digestion of 
inhibitory protein. Following de gradation of the inhibitory IKB, the NF-KB subunits are 
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released with their Nuclear Localization SignaIs (NLS) exposed. Thus, they get 
translocated to the nucleus and induce transcription of a number of genes. A simplistic 
mechanism of this pathway is depicted in Fig. 4.2. In addition, diverse stimuli activate 
initiator caspases 1, 2, 8 and 10 that again converge on and activate IKK complex and 
thus, the classical p50/p65 nuclear translocation (12). 
Alternative pathway: 
A second pathway that depends on inhibitory protein degradation involves the activation 
of IKK-a homo di mer via NF-KB inducing kinase (NIK). The inhibitory protein plOO is 
the downstream target for IKK-a. Following phosphorylation on specific serines at both 
C- and N-terminals, plOO is cleaved by proteasome, generating p52 subunit of NF-KB. 
P52 then forms heterodimer with Rel B, moves to the nucleus and activate a set of target 
genes. This is found to be triggered by cytokine lymphotoxin B, B-cell activating factor 
(BAFF), CD40 ligand and by certain viruses like Epstein-Barr virus and human T cell 
leukemia virus (13-17). 
Atypical pathway: 
A third mechanism by which IKB is degraded and activates NF-KB is IKK-independent. 
DNA damaging agents such as UV and doxorubicin induces IKB-a degradation via p38 
MAP kinase activated casein kinase 2 (CK2) (18, 19). CK2 phosphorylates IKB-a on N-
terminal serine residues thereby induces proteasomal degradation of the inhibitory 
protein. Another pathway wherein tyrosine but not serine residues of IKB-a are 
phosphorylated is activated by oxidative stress. N-terminal Tyr42 play a role in this and 
Syk protein tyrosine kinase is required for hydrogen peroxide mediated NF-KB activation 
(20, 21). As evidenced above, all these mechanisms require phosphorylation of IKB and 
indeed, cells expressing phosphorylation deficient- IKBa mutant fail to activate NF-KB 
(22). In addition to IKB-a and plOO, IKB-B and IKB-E are also targeted for 
phosphorylation on serine 19 and 23 by IKK complex that triggers the inhibitor protein 
degradation and release of NF-KB dimers (23, 24). 
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Fig. 4.2: Pathways for NF -lCB activation. A) Classical activation involves phosphorylation of 
IKB-a by IKK complex, ubiquitination, degradation by proteasome and activates p50/p65 dimers. 
These dimers bind to KB enhancer elements in the promoters of target genes and induce 
transcription. This is the most common pathway initiated by majority of stimuli. B) Alternative 
pathway, activated by few stimuli involves phosphorylation of pIOO by IKK-a homo dimer, 
followed by cleavage of pIOO to p52 that moves into nucleus with Rel B. C) Atypical pathway is 
similar to classical pathway except that IKB-a is phosphorylated by CK2 or Syk and is IKK-
independent. D) pI05 pathway involves phosphorylation of pI05 by IKK complex, GSK3~ and 
Tp12, processing into p50 that forms dimer with p65 and translocate to nucleus. 
P105 pathway: 
Another ankyrin containing inhibitory molecule p105 is subjected to phosphorylation-
dependent degradation by several kinases. Similar to that observed with pl 00, 
degradation of p105 generates another NF-KR protein p50. IKK-mediated 
phosphorylation of p105 on ser927 and ser932 is induced by TNF-(X, (25) and glycogen 
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synthase kinase 3~ (GSK-3~) plays a dual role in p105 phosphorylation and degradation. 
Phosphorylation of ser903 and ser907 by GSK-3~ prevents the degradation and stabilizes 
the inhibitory protein. However, phosphorylation at these sites is essential for IKK 
mediated phosphorylation of ser927 and ser932 that induces degradation of p105 (26). 
Mitogen activated kinase kinase kinase (MAP3K), TpI2/Cot, is also found to regulate 
p105 phosphorylation and this phenomenon plays an important role in lipopolysaccharide 
(LPS)-activated extracellular signal-related (ERK) signaling (27-29). 
Two more inhibitory proteins, IKB-Ç (30) and BCL-3 (31) exist in nucleus. The potential 
kinases that phosphorylate the se inhibitors and how this modulates NF-KB activation are 
poorly understood. IKB-Ç is required for the expression of a set of genes such as IL-6 
during TLR and IL-l signaling (32). Recently GSK-3~ is shown to constitutively 
phosphorylate BCL-3 and target the latter for proteasomal degradation (33). To 
summarize, NF -KB activation in principle, requires the degradation of inhibitory 
proteins (IKBs) that bind the NF-KB molecules and this degradation requires 
phosphorylation by upstream kinases. There are stimulus-dependent signaling 
events, which in volve activation of specifie kinases that have substrate specificity to 
a particular inhibitory proteine 
4.3 Post-translational modifications of NF-KB 
In addition to the pathways described above that depend on degradation of inhibitory 
proteins, it was found that posttranslational modifications of NF-KB subunits themselves 
could increase the transactivating potential of this transcription factor. In fact, 
degradation of IKB and subsequent nuclear translocation of NF-KB are not sufficient to 
elicit maximal transcriptional response. A second phase of events which occurs primarily, 
but not exclusively, in nucleus in volve phosphorylation and acetylation of NF-KB or 
acetylation of histones that surround the promoter regions of NF-KB target genes (3, 9). 
These events define the strength and duration of NF-KB induced gene activation. 
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4.3.1 Phosphorylation of NF-lCB 
It has been observed that cells lacking kinases such as T2K, GSK3~, TRAF-associated 
NF-KR activator (TANK)-binding kinase 1 (TBK1 or NAK) or that have been treated 
with PI3K inhibitors, have defective NF-KB activation despite efficient IKR degradation 
in response (34-37). Several kinases that function both in the cytoplasm and nucleus were 
found to target the RelA or p65 subunit of NF-KR (Fig. 4.3). Serines (Ser) at four 
positions are phosphorylated by specific kinases; Ser276 and Ser311 in the RHD, and 
Ser529 and Ser536 in the TAD regions of p65 are phosphorylated in a stimulus-
dependent manner. Catalytic domain of Protein kinase A (PKAc) mediated Ser276 
phosphorylation 10 the cytoplasm, induced by LPS modulates DNA binding and 
oligomerization properties of NF-KR (38). PKAc phosphorylation of Ser276 also 
enhances the ability of p65 to recruit histone acetyltransferases su ch as CREB-binding 
protein (CBP) and p300 (39) and to displace p50-histone deacetylase (HDAC)-1 complex 
from DNA (40). With this dual effect, PKAc potentiates the NF-KR activity. On the other 
hand, TNF-a stimulates mitogen and stress activated kinase-1 (MSK1) which 
phosphorylates the same Ser276 in the nucleus resulting in an increased NF-KR 
transcription al activity (41). TNF-a also phosphorylates Ser311 through the action of 
another kinase, PKCÇ leading to a similar enhancement of transcriptional response (42). 
As with PKAc, PKCÇ phosphorylation of p65 enhances its interaction with CBP and RNA 
polymerase II on IL-6 promoter. Ser529 and Ser536 in the TAD of p65 are 
phosphorylated by casein kinase II (CKII) and IKK respectively. IL-1~ (43) and TNF-a 
(44) activate CKII and phosphorylation of p65 on Ser529 by this kinase requires prior 
IKBa degradation. Ser536 phosphorylation of p65 was extensively studied and found to 
occur by several kinases via various signaling pathways. IKKs are the major kinases 
involved in ser536 phosphorylation. Lymphotoxin B (45) and oncoprotein Tax (46) 
phosphorylate p65 on Ser536 via IKKa. In case of 
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Fig. 4.3: Post-translational modifications of p65. Sites for serine (S) phosphorylation (P) and 
the kinases involved are shown on the top. PI3K/ Akt phosphorylates S536 via IKK and also 
through unidentified kinases. Sites for lysine (K) acetylation (Ac) are depicted in the bottom. _ 
: DNA binding domain, _ Dimerizarion / IKB-binding domain, • : Nuclear localization signal, 
mD : Transactivation domain. 
lymphotoxin B, NIK is required for IKKa activation (45). Conversely, IKK~ mediated 
Ser536 phosphorylation was observed in LPS treated monocytes/macrophages (47) and 
CD40 triggered hepatic stellate cells (48). LPS induced S536 phosphorylation is also 
mediated by a novel kinase, Bruton's tyrosine kinase (Btk) (49). Recently, the novel 
IKK, IKK-i/IKK-E was found to play a role in the constitutive but not cytokine-induced 
phosphorylation of S536 of p65 (50). DNA damaging agents, similar to their ability to 
induce IKB degradation independent of IKKs, also induce S536 phosphorylation of p65, 
which does not involve IKKs. Drugs such as doxorubicin and etoposide have been found 
to activate NF-KB via p53 pathway that depends on ribosomal S6 kinase-l (RSKl) 
induced phosphorylation of Ser536 (51). Ser536 is phosphorylated by several other 
kinases such as GSK3~ (52), PB kinase/Akt (53, 54) and NF-KB activating kinase 
(NAK; also called TBKl) (55). While sorne kinases directly phosphorylate p65, others 
such as PB kinase and Akt act indirectly via other kinases. The downstream effectors that 
mediate PBK/Akt pathway have not been identified and remain a point of controversy. 
IKKa, IKK~ and p38 have been implicated in carrying out the Ser536 phosphorylation 
by PB kinase/Akt (53, 56). It seems there are still unidentified kinases such as the one 
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that phosphorylates Ser468 upon T cell co-stimulation (57). Majority of the se 
observations were made in ceIllines and the precise role of p65 phosphorylation in an in 
vivo situation remains to be clarified. Despite the presence of several phospho acceptor 
sites that are phosphorylated by specifie kinases in a stimulus-dependent fashion, it is not 
clear if it confers unique functional advantage in a given situation or is a redundant 
phenomenon. 
The other transactivating domain (TAD) containing NF-KB proteins, Rel Band c-Rel 
also undergo phosphorylation (58, 59). However several issues su ch as which genes are 
specifically targeted by Rel Band c-Rel proteins, the effect of these phosphorylations on 
p65 transactivating potential etc. merit further investigation. Not much is known about 
the phophorylation of other NF-KB proteins that do not have the TAD, p50 and p52. 
Though evidence exists that p50 is phosphorylated (60) upon stimulation, the significance 
is not clear. PKA, calmodulin Il, CKII and PKG are potential kinases that target Ser337 
on p50 (61). As these NF-KB proteins lack the transactivating region, phosphorylation 
might affect only the DNA binding ability and could indirectly influence the 
transcriptional responses induced by TAD containing NF-KB subunits. To summarize, 
NF-KB p65 is phosphorylated principally on four serines leading to reeruitment of 
transeriptional eo-aetivators or displaeement of repressors resulting in enhaneed 
transeriptional response. Various kinases are involved in phosphorylating p65 at 
specifie positions following activation by different stimuli. 
4.3.2 Acetylation of NF-KB 
Similar to phosphorylation, acetylation was also found to be an important regulator of 
NF-KB function. As opposed to phosphorylation, acetylation occurs exclusively in the 
nucleus where acetyltransferases are localized. Acetylation by histone acetyltransferases 
(HATs) regulate the subcellular localization, DNA binding, interaction with 
transcriptional cofactors and transactivating potential of various transcription factors (62, 
63). Lysine (Ly) 218, 221 and 310 are the three major acetylation sites on NF-KB p65 
molecule that modulate distinct biological responses (Fig. 4.3) (64). Acetylation at Ly221 
enhances DNA binding by p65 and reduces association with IKBu. On the other hand, 
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acetylation of Ly310 is required for full transcriptional activity of p65 and does not affect 
DNA binding or IKBa interaction. Acetylation at two other sites, Ly122 and Ly123 has a 
negative effect by reducing p65 binding to DNA and consequent reduction in the NF-KB 
transactivating potential (65). P50 subunit is acetylated at Ly431, 440 and 441 leading to 
increased transcriptional response by p50 heterodimers (66, 67). (p50 homodimers are 
repressive because of the absence of TAD). It is possible that phosphorylation is required 
for subsequent acetylation. In case of p65, phosphorylation at ser276 and 311 enhances 
association with p300/CBP and this leads to increased acetylation and transcriptional 
activation (40, 42). Several puzzles remain unanswered su ch as the stoichiometry of RelA 
acetylation, the relationship between signal intensity, acetylation and ensuing 
transcriptional response. It is suffice here to mention that in addition to the post-
translational modification of NF-KB proteins themselves, similar modifications of 
histones that surround the NF-KB target genes also equally regulate NF-KB 
transcriptional activity (3). 
4.4 Suppression of NF-lCB activation by pathogens 
AlI pathogens, viral, bacterial or eukaryotic, developed various strategies to exploit the 
hosts in order to continue their life cycle. On the other hand, hosts too evolved several 
defense mechanisms to ward-off the pathogens. A successful parasite must be able to 
overcome the se defense mechanisms. This constant interaction and evolution rnight 
eventually terminate in commensalism or symbiotic relationship. In the former, both ho st 
and pathogen remain harmless to each other while in the latter both get benefited by each 
other. Because of the importance of NF-KB as a regulator of apoptosis, inflammatory and 
immune responses, it became a potential target for pathogens to modulate host response 
for their replication and survival. Studying how pathogens modulate the NF-KB system 
thus provides an exciting paradigm for host-pathogen interactions. 
Invasion of the host by pathogen, in majority of cases, is associated with activation of 
NF-KB which regulates various immune/inflammatory processes that are required for 
host defense against the infection. It is increasingly being recognized that various steps 
of NF-KB activation are targets for microbes to interfere with immune and inflammatory 
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responses (Table 4.1). TLR signaling which primarily results in NF-KB activation is the 
target for vaccinia virus. This virus produces the protein A52R, a homologue of MyD88 
that is required for TLR and IL-1 signaling induced NF-KB activation. A52R acts as a 
dominant negative regulator of MyD88 and suppresses the NF-KB pathways requiring 
this scaffolding protein (68). IL-1 is required for host defense against this virus and by 
this mechanism the pathogen effectively overcomes the host responses, which are 
deleterious to the virus. 
A large number of bacteria target a further downstream molecule, IKB whose de gradation 
is essential for NF-KB activation. Different species of gram negative extracellular 
bacteria Yersinia secrete type III secretory molecule, Yersinia Outer proteins (Y op) that 
inhibit NF-KB by different mechanisms. YopJ of Y. enterocilitica associates with IKK-~, 
inhibits the kinase activity and consequently, the phosphorylation and degradation of 
IKB-(l (69). This would suppress the NF-KB nuclear translocation and inflammatory 
cytokine induction. While the precise mechanism of how YopJ blocks IKK activity is not 
understood, Mukherjee et al. (70) recently showed that YopJ acetylates the critical 
serine/threonine residues required for IKK-~ phosphorylation and thus competitively 
inhibits the phosphorylation. 
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Table 4.1: Mechanism ofNF-K'B inhibition by microbes 
Mechanism of NF -KB 
inhibition 
I. At the receptor level 
Mimics MyD88 and 
blocks initiation of 
signaling 
II. Blocks regulatory 
protein function upstream 
ofIKK 
Pathogen 
Vaccinia virus 
a. interfering with Y.pseudotuberculosis 
ubiquitination Y.pestis 
b. blocks tyrosine Y.pseudotuberculosis 
phosphorylation 
III. Direct inhibition of 
IKK activity 
(indirectly blocks lK:B Yersinia 
phosphorylation) 
IV. At IKB level 
a. blocks phosphorylation Pox viruses 
Measles virus 
b. blocks ubiquitination HIV 
A virulent Salmonella 
UPEC 
c. blocks degradation Probiotics 
d. mimics IKB (binds NF- African swine fever 
1(B) VIruS 
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Molecule 
responsible 
A46R 
A52R 
YopJ 
YopH 
YopJ 
Vpu protein 
Soluble 
factors 
Soluble 
factors 
A238L 
Comments 
Signaling pathways 
that require MyD88 
as adaptor (IL-l 
and TLR) are 
blocked 
Cleaves ubiquitin 
by cysteine 
protease activity 
Blocks T and B cell 
activation 
Acetylates IKK-~ 
and blocks its 
phosphorylation 
By 
dephosphorylation 
Blocks ~-TrCP 
Blocks ~-TrCP or 
deubiquination 
Blocks proteasome 
activity 
Epstein-Barr virus 
V. Pre vents nuclear 
transport of p65 subunit Bordetella 
bronchiseptica 
Toxoplasma gonodii 
VI. Prevents DNA Mycobacterium 
binding and ulcerans 
transcriptional activity of 
NF-KR Bacteroides vulgatus 
Schistosoma mansoni 
Salmonella enterica 
serovar typhimurium 
ZEBRA 
Soluble toxin 
Excretory-
secretory 
product 
SspHl 
Prevents p65 
phosphorylation 
Mediated by TGF-
~ via histone 
deacetylation 
Disrupts protein 
complex formation 
at KR site of E-
selectin 
Via interaction 
with PKNI In 
nucleus 
Several signaling intermediates require ubiquitin or ubiquitin-like molecules such as 
SUMO-l for activation. Such modifications are involved at several regulatory events in 
NF-KR pathway: a) TRAF6 ubiquitination mediated by Ubc13 and UevlA, b) 
ubiquitination of SCF complex mediated by unknown ligase and c) addition of ubiquitin 
onto phospho- IKR mediated by the ~-TrCP-SCF. YopJ of Y. pseudotuberculosis and Y. 
pestis acts as cysteine protease and targets these ubiquitins, preventing the functions of 
many regulatory proteins. This virulence factor was found to inhibit MAP3K via direct 
association or indirectly by inhibiting ubiquitin conjugation (71). These effects are 
primarily observed in macrophages but can also occur in epithelial cells, fibroblasts and 
lymphocytes. In both T and B cells, Y opH of Y. pseudotuberculosis acts as tyrosine 
phosphatase that prevents phosphorylation of sorne early proteins that are activated 
following antigen-specific receptor signaling (72). Though no specific inhibition of NF-
KR pathway was studied, decreased costimulatory molecule and cytokine expression was 
observed. As the phosphorylation of earliest signaling molecules su ch as PKC and CD3Ç 
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were suppressed, it is hypothesized that YopH cou Id also interfere with NF-KB 
activation. Apart from the inhibition of events proximal to IKB, measles virus was found 
to directly inhibit IKB phosphorylation in neuronal cells through an unknown mechanism 
(73). 
A further downstream mechanism is inhibition of degradation of IKB even after its 
phosphorylation. Many pox viruses including vaccinia virus inhibit IKB degradation by 
dephosphorylation of IKB-a or interfering with its degradation by an unknown 
phenomenon (74). Vpu protein of HIV-I interferes with ubiqutination of IKB in a unique 
way. It targets f3-TrCP, a component of ubiquitin ligase complex that is required for IKB 
ubiquitination and subsequent proteasomal degradation (75). The non-pathogenic species 
of intracellular bacteria, salmonella were also found to shut down NF-KB activation by a 
similar mechanism of interfering with IKB ubiquitination. This is thought to help 
colonization of the se species without inducing mucosal inflammation (76). 
Uropathogenic E. coli (UPEC) pre vents the degradation of IKB thereby stabilizes this 
inhibitory molecule and inhibits NF-KB activation. However, the precise mechanism is 
not known (77). Nonetheless, this results in a decrease of anti-apoptotic proteins and 
increases apoptosis of urothelial cells. UPEC also inhibits MAP kinase signaling in a 
contact dependent or independent mechanism. The latter is thought to be mediated by 
undefined soluble factors. Sorne pathogens like African swine fever virus possess a 
protein, A238L that mimics IKB and binds NF-KB dimers even after ho st IKB is degraded 
(78). Recently, commensal bacteria (a mix containing Streptococcus thermophilus and 
several species of Lactobacillus and Bifidobacteria) were shown to inhibit NF-KB 
activation by a novel mechanism of proteasome inhibition without affecting 
ubiquitination (79). Inhibition of proteasome activity also suppressed the cleavage of 
inhibitory pI05 protein. Together this blocked the release of NF-KB molecules from the 
inhibitory proteins. 
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Sorne pathogens inhibit the nuclear translocation of NF-KB molecules after they are 
released from IKB. A viral protein ZEBRA in Epstein-BarrVirus (EBV) binds p65 
molecule and prevents nuclear localization of NF-KB (80). A soluble toxin of 
Mycobacterium ulcerans blocks phosphorylation of p65 subunit and prevents its DNA 
binding activity leading to suppression of immune celI functions (81). Bordetella 
bronchiseptica also inhibits nuclear translocation of NF-KB p65 subunit in response to 
TNF-a in respiratory epithelial celIs through an unknown mechanism involving type III 
secretory system (82). 
Further downstream, pathogens modulate the nuc1ear events of NF-KB activation. SspHI, 
a Salmonella enterica serovar Typhimurium TTSS effector, localizes to the mammalian 
nucleus and down-modulates production of proinflammatory cytokines by inhibiting NF-
KB-dependent gene expression. Though the precise mechanism is not known, it could be 
mediated via the interaction with PKN 1, a serine/threonine protein kinase that is found to 
regulate the NF-KB induced gene expression (83). Haller et al. (84) proposed a novel 
mechanism of NF-KB inhibition that in volves histone acetylation. Non-pathogenic, 
enteric bacteria Bacteroides vulgatus induces an initial NF-KB and then a persistent TGF-
~1 signaling. It was found that TGF-~l inhibits B. vulgatus induced NF-KB activation by 
deacetylating the histones surrounding the NF-KB recruitment site in the promoter of IL-6 
gene and thus suppresses the latter' s expression. 
Evidence for parasite mediated NF-KB suppression came from studies in Toxoplasma 
gondii and Schistosoma mansoni. T. gondii blocks inflammatory stimuli-induced nuclear 
translocation of NF-KB and inhibits IL-12 and TNF-a production that are required for 
host resistance of this infection (85). Similarly, excretory-secretory products of S. 
mansoni inhibits a protein complex formation at KR binding sites in the promoter of E-
selectin, thereby reduces the expression of this adhesion molecule in lung endothelial 
cells. This prevents recruitment of inflammatory cells that could effectively eliminate the 
schistosomula (86). 
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It should be noted that pathogens also exploit NF-KB activation to promote inflammation 
and spread infection to other organs (87). From these observations it is apparent that 
microbes usurp or mimic a eukaryotic activity and refine this activity to produce an 
extremely efficient mechanism to combat NF-KB signaling. To summarize, various 
pathogens developed different means to suppress NF-lCB as a potential mechanism 
to circumvent host defense. 
4.5 Modulation of NF -lCB activation by stress response 
It has been found that activation of cellular stress response inhibits subsequent 
proinflammatory responses in various cell culture models. This has been unequivocally 
linked to the inhibitory effects of both heat shock proteins (Hsp) and heat shock 
transcription factor (HSF) on NF-KB activation. Similar effects are also observed in 
animal models of inflammation wherein inhibitory effects of stress response are 
associated with protection against organ in jury and death (88-92). 
In vitro, stress response was found to inhibit IL-l~ (93), TNF-a, IL-6 (94), iNOS (95, 
96), IL-8 (97), RANTES (98), complement components C3 & C5 (99), ICAM-l(100) and 
Cox-2 (101) expression in diverse cells types inc1uding monocytes, epithelial, endothelial 
and neuronal cells. While original observations reported inhibition of NF-KB mediated 
gene expression following heat shock protein induction by different stimuli, the exact 
mechanism and involvement of specific Hsps in this inhibition were not described. 
Recent studies looked into the identity of Hsps and mechanism of Hsp-mediated NF-KB 
inhibition, which has been shown to be operating by different mechanisms; inhibiting 
IKB degradation (by regulating IKK activity and increasing phosphatase activity), 
inducing IKB-a expression, preventing NF-KB nuc1ear translocation and finally by 
inhibiting gene transcription by repressing the promoter activity of inflammatory genes 
(Table 4.2). Hsps have been shown to associate with IKK complex and modify its ability 
to phosphorylate IKB-a. Hsp90 positively regulates IKK activity by its association with 
IKK complex and various stimuli that dissociate Hsp90 from IKK leads to suppressed 
NF-KB activation (102, 103). Heat shock or exposure to sodium arsenite dissociates 
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Hsp90 and insolubilizes IKK complex reducing the kinase activity in alveolar epithelial 
cell line A549 (104). Sustained PKC activation by PMA treatment in colonic epithelial 
cells also leads to dissociation of Hsp90 and makes the IKK complex vulnerable to 
proteasome degradation and consequently suppresses NF-KB activation by TNF-a (105). 
Interestingly, the gastric pathogen H. pylori induced IL-8 production is dependent on 
Hsp90. H. pylori phosphorylates Hsp90 and treatment with geldanamycin, an inhibitor of 
Hsp90 blocked H. pylori induced NF-KB activation and IL-8 production in gastric 
epithelial cells (106). 
Hsp70 has been shown to have contrasting effects on IKK activity. Ran et al. (107) 
reported a negative regulation of IKK activity by Hsp70. Hsp70 directly interacts with 
IKK-y and prevents the formation of functional IKK complex thereby inhibits IKK 
activity. Over expressing Hsp70 inhibited phosphorylation and degradation of IKB-a, 
induction of anti-apoptotic gene expression and increased apoptosis in response to TNF-
a. However, in a recent study, Lee et al. (108) reported a positive role for Hsp70 in 
restoring IKK activity following heat shock. It was shown that over expression of Hsp70 
did not inhibit TNF induced NF-KB activation but helped in the resolubilization of IKK 
complex following heat shock in BEAS-2B, a bronchial epithelial cell line. Thermal 
stress in cells with reduced Hsp70 expression resulted in delayed recovery of IKK 
Table 4.2: Modulation of NF -lCB activation by stress response 
Target event Molecules and mechanisms Positive/Negative 
Receptor activation Hsp60 via TLR-4 Positive 
Hsp70 blocks ubiquitination of Negative 
Modulation of regulatory TRAF-6 
protein function Sequestration of TRAF2 into stress Negative 
granules 
Hsp90 acts as chaperone for IKK Positive 
Hsp70 acts as chaperone for IKK Positive 
IKK activity Hsp70 interacts with IKK-y prevents Negative 
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IKK complex formation 
Hsp27 interacts with and blocks Negative 
IKK-u 
Hsp27 acts as ubiquitin binding Positive 
NF-KB/IKR protein and promotes IKR 
complex degradation 
Hsp70 binds to the complex and Negative 
stabilizes 
IKR synthesis HSF-I binds to HSE 10 IKR-u Negative 
promoter and induces transcription 
Phosphatase activity Decreases phosphorylation and Negative 
degradation of IKR 
Nuclear transport of NF- Hsp70 binds to p65, c-Rel and p50 Negative 
KB Hsp60 (?) Negative 
Transcriptional HSF-I binds to cytokine gene Negative 
repression promoters and represses transcription 
and/or interfere with NF-KR binding 
activity and cellular inflammatory response to TNF-u. Here Hsp70 played a chaperone 
function for IKK by renaturating and restoring the latter' s kinase activity in response to 
TNF-u. It is thought that the role of Hsp70 in NF-KR activation could be cell and stimuli 
specific. As mentioned earlier in this chapter, several regulatory proteins require 
ubiquitination for their activation and a recent report by Chen et al. (109) suggests that 
Hsp70 interacts with TRAF-6, a signal transducer in TLR signaling and pre vents its 
ubiquitination. This mechanism was found to inhibit LPS induced iNOS and COX-2 
expression in murine macrophage cell line RAW264.3. Though, no specifie Hsp was 
identified to be responsible, TRAF2 was found to sequester into stress granules following 
thermal shock and thus inhibit TNF induced NF-KR activation (110). Another Hsp that 
associates with and regulate IKK activity is Hsp27. Park et al. (111) for the first time 
showed that phosphorylated Hsp27 interacts with both IKK-u and IKK-~ but its 
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/-..,... association is increased only with IKK-a following TNF-a treatment in HeLa celIs, 
resulting in suppression of IKK activity. However, acting downstream of IKK, Hsp27 
enhances b:B-a ubiquitination and promotes proteasomal degradation of IKB-a leading 
to increased NF-KB activity (112). Though no specifie Hsps have so far been implicated, 
stress response in general is found to augment intracellular phosphatase activity and 
inhibition of phosphatases at least partially reversed the inhibitory effect of stress 
response on LPS-induced IKB-a degradation (113, 114) 
IKB-NF-KB complex exists Via an interaction between ankyrin repeats of IKB with 
nuclear localization sequences (NLS) in NF-KB. As mentioned earlier, phosphorylation 
of IKB is essential for the dissociation of this complex. Hsp70 has been shown to contain 
the NLS (115) and hence can directly interact with IKB-a ankyrin region and interferes 
with IKB-a phosphorylation, probably by steric hindrance. This hypothesis was recently 
confirmed in an in vivo study. Chen et al. (116) reported that heat shock treatment of rats 
suppresses subsequent sepsis induced NF-KB activation and found that Hsp70 forms a 
complex with NF-KB/IKB and prevents the degradation of IKB and decreased 
translocation of NF-KB. 
It is also evident that Hsps induce IKB expression. A 20 bp heat shock response element 
has been identified in the promoter region of IKB-a. Increased IKB-a expression 
following stress could stabilize the NF-KB-IKB complex and hinder NF-KB activation 
(117). In IEC, heat shock was associated with constant levels of IKB-a, that hampered 
LPS induced NF-KB DNA binding activity and increased IKB-a expression was found to 
be partially responsible for this effect (118). 
In contrast to the Hsp70- IKB-a interaction as reported above, association of Hsp70 with 
NF-KB subunits was proposed. Feinstien et al. (119) suggested that Hsp70 could interfere 
with p65 nuclear translocation in glial celIs, though no specific interaction was 
demonstrated. One of the mechanisms hypothesized was that because of the presence of 
NLS on Hsp70 molecule, it may compete with p65 for nuclear pore complexes and 
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decrease latter's accumulation in nucleus. The interaction between Hsp70 and NF-1d3 
molecules was demonstrated by Guzhova et al. (120) who reported that in human 
lymphoma cells Hsp70 is specifically associated with p65, c-Rel and p50 but not with 
IKB-a. By binding to NF-1d3 molecules and preventing their nuclear translocation, 
Hsp70 could suppress NF-1d3 activation by PMA and LPS. 
Hsp60 has both pro and anti-inflammatory properties. It was found to have opposite 
effects on innate and adaptive immune systems, probably via activating different Tolllike 
receptors. In innate cells such as dendritic cells, it induces maturation and a Th1 cytokine 
response which is TLR-4 dependent (121) while in T cells, signaling through TLR-2, it 
suppresses nuclear translocation of NF-1d3 and inflammatory cytokines and induced IL-
10 secretion (122). The exact mechanism of NF-1d3 inhibition is not known. In vivo, it 
was found to exert a protective effect against Th1 mediated inflammations such as 
experimental immune arthritis and type1 diabetes (123, 124). 
Several studies reported decreased inflammatory responses following HSF inhibition. 
However, it is not clear if this is mediated directly by HSF-1 or indirectly by reducing 
Hsp expression. Wirth et al. (125) observed increased I1d3 degradation in the absence of 
HSF-l. This has two opposing effects in a mou se model of toxin inhalation. HSF/- mice 
had greater activation of NF-1d3, particularly p50. The consequent increase in the activity 
of p50/p50 homo dimers suppressed TNF-a expression while increased p50/p65 hetero 
di mers increased GM-CSF expression. This could be the result of differential 
involvement of NF-1d3 complexes in the transcription of these two cytokine genes. 
Nonetheless, this study demonstrated that HSF-l mediated lung protection against 
cadmium instillation involves specific cytokine repression via inhibition of NF-1d3 
activation in vivo. Recently, Chen and Curie (126) reported exacerbated pro-
inflammatory activation of angiotensin I1-induced NF-KB and AP-1 in vascular smooth 
muscle cells following siRNA knockdown of HSF-1 expression. Accumulating evidence 
from recent studies shows that heat shock transcription factor (HSF)-1 by itself inhibits 
NF-1d3 activation, independent of Hsp expression. This occurs primarily at the level of 
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gene transcription but no direct interaction between HSF-l and NF-KB signaling 
molecules has been established. It seems that HSF-l acts, as a transcriptional repressor 
for NF-KB induced genes by poorly understood mechanism. Promoter region of TNF-a 
also has HSF-l binding site that represses transcription and lack of HSF-l thus leads to 
sustained TNF-a expression (127). A similar transcriptional inhibition occurs with regard 
to IL-l~ via binding of HSF-l with the transcription factor, NF-IL6 (C/EBPbeta) (128). 
To summarize, heat shock response antagonizes NF-KB mediated inflammatory 
cytokine response by various means such as inhibiting IKK activity, inducing IKB 
expression and by transcriptional repression of cytokine genes. 
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Abstract 
The Gai/GalNAc lectin (Gal-Iectin) of Entamoeba histolytica is a surface molecule 
involved in parasite adherence to host cells and is the most promising subunit vaccine 
candidate against amoebiasis. As macrophages are the major effector cens in host defense 
against amoebae, we studied the molecular mechanisms by which Gal-Iectin activates 
macrophages. Microarray analysis showed that Gal-Iectin up-regulated mRNAs of 
several cytokines and receptor genes involved in pro-inflammatory responses. The 
mechanism whereby the Gal-Iectin regulates Toll-like receptor 2 (TLR-2) expression in 
macrophages was studied. Native Gal-Iectin increased TLR-2 rnRNA expression in a 
dose- and time-dependent fashion; peak response occurred with 1.0 Ilg/ml after 2 h 
stimulation. By immunofluorescence, enhanced surface expression of TLR-2 was 
observed after 12 h. Using non-overlapping anti-Gal-Iectin monoclonal antibodies that 
map to the carbohydrate recognition domain, amino acid 596-1082 was identified as the 
TLR-2 stimulating region. The Gal-Iectin increased TLR-2 gene transcription and the 
half-life of the rnRNA transcripts was 1.4 h. Inhibition of NF-KB suppressed TLR-2 
rnRNA induction by the Gal-Iectin. Moreover, cells pre-treated with an inhibitor of p38 
kinase (SB 208530) inhibited Gal-Iectin-induced TLR-2 mRNA expression by 40%. We 
conclu de that the Gal-Iectin activates NF-KB and MAP kinase-signaling pathways in 
macrophages culminating in the induction of several genes including TLR-2 and 
hypothesize that this could have a significant impact on macrophage activation and 
contribute to amoebic pathogenesis. 
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Introduction 
Entamoeba histolytica, an intestinal protozoan parasite, is the causative agent of human 
amoebiasis. Invasive amoebiasis daims around 70,000 lives annually making it the 
fourth leading cause of death and the third cause of morbidity, due to a protozoan 
infection (1). The Gal-lectin of amoebae is the major surface glycoprotein involved in 
parasite adherence to colonic mucin and mucosal epithelial cells. This adherence is an 
absolute prerequisite for colonization and invasion. The Gal-lectin is shown to be highly 
immunogenic and is the most promising subunit vaccine candidate. It is a 260 kDa, 
heterodimeric protein consisting of 170 kDa and 35 kDa subunits, linked by disulphide 
bonds. The cysteine rich region (CRR) of the heavy subunit encompasses the 
carbohydrate recognition domain (2). A protective efficacy ranging from 67% to 83% 
was reported using recombinant CRR of the heavy subunit (3). Thl-type of immune 
response characterized by cell-mediated immunity (CMI) has been shown to confer 
resistance against amoebiasis. We have previously shown that the Gal-Iectin induces the 
expression of several pro-inflammatory molecules including nitric oxide, TNF-a and IL-
12 from macrophages (4-6). However, the signal transduction pathways initiated by the 
Gal-Iectin leading to priming or activation of macrophages is not known. 
Toll-like receptors (TLRs) are a recently discovered Pattern Recognition Receptors 
(PRRs) that recognize conserved molecular patterns on pathogens. Activation of TLRs on 
the surface of antigen presenting cells (APCs) induces the expression of co-stimulatory 
molecules and secretion of pro-inflammatory cytokines via activation of the transcription 
factor NF-KR (7). TLRs thus play a crucial role in skewing the immune response to Th1 
type and are aptly called adjuvant receptors. Recently, a number of reports have 
suggested a potential role for TLRs in intestinal inflammation (8-10). 
With the notable exception of LPS, very few studies have examined the intracellular 
mechanisms initiated by pathogens or their products that activate host immune cells. Of 
the multitude of signaling cascades, NF-KR and MAP kinase pathways play a central role 
in cellular response to diverse stimuli. The transcription factor NF-KR regulates several 
III 
pro-inflammatory molecules such as IL-12 and TNF-a, (11). Recently it has also been 
shown to regulate TLR-2 gene expression (12). MAP kinases play a critical role in 
regulating the expression of several cytokines through activation of transcription factors 
(13-15). Extending our molecular characterization studies to decipher the mechanisms of 
macrophage activation by the Gal-lectin, we studied the regulation of TLRs by the Gal-
lectin. Using specific inhibitors, we determined the role of downstream signaling 
mediator, NF-KR and upstream signaling intermediates such as MAP kinases in Gal-
lectin induced TLR-2 mRNA expression. 
Herein, we report that TLR-2 expression in response to the Gal-lectin is dependent on 
NF-KB and p38 MAP kinase in murine macrophages. By monoclonal antibody inhibition 
studies, we identified that the region between aa 596-1082 of the CRR mediates this 
response. This is the first report of a parasite molecule up-regulating Toll expression and 
also implicating MAP kinase in TLR-2 gene regulation. We hypothesize that enhanced 
expression of TLR-2 could have a profound impact on macrophage activation, skewing 
the immune response to protective Thl type. Our study supports the CUITent contention 
that in the design of an ideal subunit Gal-lectin based-vaccine, the CRD regions should 
be included to optimize Thl responses. Furthermore, Gal-lectin induced up-regulation of 
TLR expression in macrophages or other immune celIs could play a role in amoebic 
pathogenesis. 
Materials and Methods 
Cultivation of E. histolytica and preparation of secretory components, soluble 
amebic proteins and purified Gal-lectin 
E. histolytica (strain HMl-IMSS) was cultivated in our laboratory as previously 
described (16). E. histolytica secretory components (EhSc) were prepared by collecting 
secretory/excretory components of live amoebae incubated in Hanks' balanced salt 
solution (2 x 107/ml) in the absence of serum at 37°C for 2 h. Viability of amoebae after 
2 h was 95% as determined by trypan blue exclusion assay. Soluble amoebic proteins 
(SAP) were prepared from trophozoites in mid log growth phase (3 days) by freeze-thaw 
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lysis. Lysed trophozoites were centrifuged at 15,OOOx g at 4°C for 10 mm and 
supernatants collected. Protein concentration in the EhSc and SAP was quantified by the 
method of Bradford (17) using bovine serum albumin as standard. The Gal-Iectin was 
purified by mAb affinity chomatography as described (18). Endotoxin contamination was 
undetectable by the E-Toxate assay (sensitive to 0.05-0.5 endotoxin unit/ml: Sigma) in 
EhSc at 10 Jlg/ml, SAP at 50 Jlg/ml and Gal-Iectin at 1 Jlg/ml. 
Preparation of polyclonal Ab and MAb against the Gal-Iectin 
Pre-immune serum and rabbit polyclonal anti Gal-Iectin serum was prepared as described 
[3]. The production of murine anti-Gal-lectin MAbs has been previously described (19). 
The epitopes recognized by MAb IG7 (IgG2b), 7F4 (lgG2b), H85 (lgG2b), 3F4 (lgGl) 
and 8C12 (lgGl) were mapped to the CRR of the Gal-Iectin (Fig. 5.6) using a series of 
successive deletion peptides of the 170kDa Gal-Iectin subunit (20). Monoclonal 
antibodies 3F4 and 7F4 act as internaI isotype-matched controis. 
Cell culture and reagents 
The murine macrophage cellline RAW 264.7 was obtained from American Type Culture 
Collection (Rockville, MD) and maintained in RPMI (Life Technologies Inc., ON, 
Canada) medium with 10% FCS. The cells were grown in tissue culture flasks at 37°C in 
5% COz and passaged regularly to maintain logarithmic growth. PD98059, a specific 
inhibitor of ERK kinase and SB208530, a specific inhibitor of p38 kinase were purchased 
from Calbiochem (San Diego, CA). LPS from Escherichia coli serotype 0111:B4, 
cycloheximide, PDTC, and anti Goat IgG FITC conjugate (F7367) are from Sigma (St. 
Louis, MO). Wortmannin and Herbimycin-A are from Alexis Biochemicals (Qbiogene, 
Carlsbad, CA). AlI other antibodies, NF-KB consensus and mutant oligonucleotides are 
from Santa Cruz Biotechnology (Santa Cruz, CA). NE-PER nuclear and cytoplasmic 
extraction kit was from Pierce (Rockford, IL). Poly (dl-de) was from Amesham 
Pharmacia biotech. AlI primers and Actinomycin-D are from Invitrogen. 
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Northern blot analysis 
Total cellular RNAs were extracted usmg TRIZOL reagent (Life Technologies, 
Rockville, MD) according to manufacturer's instructions. Aliquots (10 Jlg) of the total 
RNAs were fractionated in a 1 % agarose gel containing lOmM sodium phosphate buffer 
and transferred to a nylon membrane. After UV cross-linking, the membranes were 
prehybridized for 3h at 42°C in hybridization solution (5X SSPE, 50X Denhardt's 
solution, 50% formamide, 0.25mg/ml of salmon sperm DNA and 0.1 % SDS) followed by 
incubation with 32p labeled-probe in the same solution for 14 h. The membranes were 
washed in 2X SSC for 15 min twice at room temperature and in 0.1 %SSC +0.1 % SDS 
for 15 min twice at 50°C (0.5% SSC+0.1 % SDS at 60°C twice for actin) and were 
exposed to Kodak XAR-5 film with intensifying screen for 12-18 h at -70°C. Blots were 
scanned and densitometric results analyzed with the UN-SCAN IT Gel program. The 
mTLR-2 DNA probe was prepared by amplifying 2300 bp coding region by RT-PCR and 
cloning into TA vector. Actin probe consisted of a 1.25 kb Pstl fragment of pBA-1. 
Western blot analysis 
Nuclear or cytoplasmic extracts were collected from 2 X 107 cells using the Pierce NE-
PER kit as per manufacturer' s instructions. Protein concentrations were estimated by 
micro BCA method (Pierce). Equal amounts of the samples were then separated in 12% 
SDS-Polyacrylamide gels and transferred onto nitrocellulose membrane (Bio-Rad, CA). 
The membranes were blocked in 3.5% skim milk-TBS-T (20nm Tris-HCl (pH 7.5), 
500mM NaCI. 0.1 % Tween-20) at 4°C ovemight, incubated with primary antibodies in 
skim milk-TBS-T at 4°C ovemight, washed three times with TBS-T and incubated with 
HP-conjugated anti mou se or goat Ig in skim milk-TBST ovemight at 4°C. After three 
washes each in TBS-T and TBS-3T, the blot was developed with the enhanced 
chemiluminescence system (Amersham Pharmacia Biotech, Piscataway, NJ)) according 
to the manufacturer's instructions. 
Nuclear run-on assay 
TLR-2 gene transcription was detected in a PCR-based nuclear ron-on assay (5). 
Following 2h stimulation, macrophages (2 x 107/sample) were washed in PBS and 
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resuspended in lysis buffer (320 mM sucrose, 5mM MgCh, lOmM Tris-HCl, 1 % Triton 
X-100, pH 7.5), incubated on ice for 10 min, and centrifuged at 1300 x g for 15 min at 
4°e. The nuclear pellets were washed once in lysis buffer and the nuclei divided into two 
aliquots, each resuspended in 100 !lI of storage buffer (50mM Tris-HCI, pH8.0, 40% 
glycerol, O.lmM EDTA, 5mM MgCh, and 1mM DTT) and frozen in liquid nitrogen until 
use. Elongation of the nascent RNA in vitro was done by adding 100 !lI of transcription 
buffer (20mM Tris-HCl, pH 8.0, 300 mM KCI, lOmM MgCh, 200mM sucrose, 48!lM 
EDTA and 1mM DTT) with or without ribonucleotide phosphates (lmM each of rATP, 
rCTP, rGTP and rUTP) to 100 !lI of nuclei and incubating at 30°C for 30 min. The 
reactions were stopped by adding 1ml Trizol and RNA extracted for RT -PCR analysis. A 
difference between samples incubated with and without rNTP is indicative of active 
transcription. 
Electrophoretic mobility shift assay 
AlI buffers, including those in the NE-PER kit were added with a mixture of protease 
inhibitors (1.0 !lg/ml each of aprotinin, leupeptin, pepstatin, 0.5 mM PMSF, and 1 mM 
EDTA). Double stranded NF-KB consensus oligonucleotide was labeled with [y'2P]_ATP, 
using T4 polynucleotide kinase. Unlabeled nucleotides were removed using Sephadex G-
25 columns. The binding reaction consists of 20 !lI total volume of 0.5 ng of DNA probe, 
5 !lg of nuclear extract, 1 !lg of pol y (dI-dC) in the binding buffer (12 mM HEPES, 60 
mM KCl, 4 mM MgCh, 1 mM EDTA, 1 mM of DTT and 12% glycerol) (pH 8.0), and 
incubation for 30 min at room temperature. For competition assay, nuclear extracts were 
incubated with 50-100-fold excess of unlabeled probe before the addition of labeled 
probe. For supershift assay, 2 !lI of anti p65 NF-KB was incubated with nuclear extract 
for 2 h before binding reaction. DNA-protein complexes were resolved by 
electrophoresis on 6% poly-acrylamide gels at 4°C in TBE buffer (90 mM Tris-borate, 
2mM EDTA). Gels were subsequently dried and autoradiographed with intensifying 
screens at -70°e. 
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Immunofluorescent assay 
Macrophages were grown on coyer slips and stimulated with Gal-Iectin or LPS for 12 h. 
Cells were washed with lx PBS, fixed in 4% paraformaldehyde at room temperature for 
1 h, washed again and permeabilized with cold absolute methanol for 20 min at -20°C. 
The cells were incubated with primary antibody or control goat IgG (in PBS) for 1 h at 
room temperature, washed and FITC-conjugated secondary antibody (in PBS-Evans's 
blue) was added and incubated at room temperature for 1 h in dark. Finally the cover 
slips were mounted onto microscopic slides using Vectashield as a quenching solution 
and examined under fluorescent microscope. 
Microarray study 
GE Array Q series Mouse NF-KB signaling pathway specific-gene array membrane 
(MM-016; SuperArray Biosciences Corporation, Frederick, MD) was used to study the 
differential expression of genes involved in NF-KB mediated signal transduction. RNA 
was extracted using TriZol reagent (lnvitrogen) from RAW 264.7 cens stimulated with 
lectin or with medium alone. Probe labeling and hybridization to the membranes were 
done as per the manufacturer's protocol. Membranes were exposed to X-ray film and data 
acquisition do ne using the ScanAlyze software. The numerical data generated by 
ScanAlyze was analyzed using another software, GEArray Analyzer. Both these 
softwares are free and can be downloaded from the website, www.superarray.com. 
Initially, an raw signal intensities were corrected for background by subtracting the signal 
intensity of negative control, PUC18. This was followed by normalization of all signal 
intensities to that of the housekeeping gene GAPDH. These corrected, normalized signaIs 
were then used to estimate the relative abundance of particular transcripts. 
Results 
Gal-Iectin induces pro-inflammatory response from macrophages 
From our previous observations on Gal-lectin induction of TNF-a and IL-12 from 
macrophages, we hypothesized that this molecule might be stimulating an NF-KB-
mediated pro-inflammatory pathway. Accordingly, microarray studies were done using 
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NF-KB specific gene array with control and Gal-Iectin-stimulated macrophages (Fig. 5.1). 
As shown in Table 5.1, the Gal-lectin up-regulated several cytokines and molecules 
involved in inflammation and down-regulated others. Of particular interest to the present 
objective, is the up-regulation of TLR-2. Thus, we further probed the mechanism of 
regulation of TLR-2 by Gal-Iectin with a view to decipher the signaling pathways 
activated by the Gal-Iectin. 
A B 
Fig. 5.1: Gal-Iectin induces pro-inflammatory response from macrophages. Macrophages 
were treated with either medium alone or with 500 ng/ml of Gal-lectin for 2 h, RNA extracted 
and microarray experiment was done as described in experimental procedures. One up-regulated 
(IL-l/3) (0) and one down-regulated (TLR-4) (0) gene is shown. 
117 
Table 5.1: Differentiai gene expression induced by E. histolytica Gal-Iectin in macrophages 
Functional Gene Grouping Up-regulated Down-regulated 
Adhesion molecules Intercellular Adhesion 
Molecule-l 
Cytokines Interleukin -1 a 
Interleukin -1 ~ 
Tumor necrosis factor-a 
Transmembrane receptors Toll-Like Receptor (TLR)-2 TLR-4 
Cell death protein 
Adaptor proteins TNF-receptor associated factor 1 
Signal transduction kinases NF-KB-Inducing Kinase 
P38MAPK 
Transcription factors Nuclear Factor-KB-l 
Nuclear Factor-KB-2 
Interferon Regulatory Factor 
Acute phase proteins Serum Amyloid A 1 
Serum Response Factor 
Table 5.1: Macrophages were treated with either medium alone or 500 ng/ml of Gal-lectin for 2 h and 
differential gene expression was studied as described. The experiment was done twice and genes increased, 
at least by 3-fold (up-regulated) or decreased by less than half (down-regulated) in Gal-Iectin treated cells 
compared to that of control cells in both the experiments are represented. 
118 
Gal-Iectin stimulates TLR-2 mRNA and protein expression in macrophages 
To determine if TLR-2 rnRNA expression is altered in response to amoebic components 
in general, cells were stimulated with E. histolytica secretory components (EhSC), 
soluble amoebic proteins (SAP) and purified Gal-Iectin for 2 h and relative rnRNA levels 
were detected by Northern blot analysis. As shown in Fig. 5.2, EhSC and SAP which 
contain Gal-Iectin and other proteins stimulated TLR-2 mRNA expression moderately 
while purified Gal-Iectin induced significant expression (3-4 fold) of TLR-2 mRNA 
indicating the relative potential of this molecule. Based on this and microarray data, 
subsequent studies were do ne on TLR-2 regulation by the purified Gal-Iectin. As shown 
in Fig. 5.3A, Gal-Iectin stimulated TLR-2 mRNA expression in a dose-dependent 
fashion. Significant expression was induced with as little as 250 ng/ml of Gal-Iectin and 
peak response observed with 1.0 /lg/ml. In a detailed time course experiment with a sub-
optimum dose of 500 ng/ml of Gal-Iectin, TLR-2 mRNA expression was induced by 1h, 
peaked at 2h, and returned to basallevels by 12 h (Fig. 5.3B). The surface expression of 
TLR-2 protein was significantly increased when stimulated with 1.0 /lg/ml of lectin for 
12 h (Fig. 5.4) and was comparable to that stimulated with LPS (data not shown), 
demonstrating the potency of the Gal-Iectin in stimulating TLR-2 rnRNA as well as 
protein expression in macrophages. 
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Fig. 5.2: Regulation of TLR-2 rnRNA by E. histolytica cornponents. Macrophages were 
stimulated with soluble amoebic proteins (SAP), secretory components from amoebae (EhSc), 
Gal-Iectin (Lec) or LPS for 2 h and analyzed by Northem blot using TLR-2 probe. The membrane 
was stripped and re-probed with actin for standardization. Quantity of TLR-2 rnRNA was 
normalized to actin levels and expressed as densitometric units (TLR-2/ Actin) in the histogram 
with identical lane designations for Northem blot and histogram. Blot is representative of three 
experiments. 
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Fig. 5.3: Dose- and tirne-dependent expression of TLR-2 rnRNA by the Gal-Iectin. A). 
Macrophages were stimulated with increasing amounts of Gal-Iectin for 2 h prior to extraction of 
total RNA and Northem analysis. B) Macrophages were stimulated with 500nglrnl of Gal-Iectin 
and RNA collected at different time points for Northem analysis. TLR-2 rnRNA levels were 
normalized to actin and histograms are representative of three separate stimulations. 
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Fig. 5.4: Increased surface expression of TLR-2 protein by the Gal-lectin. Macrophages were 
stimulated with medium or 1.0 Jlglml of Gal-Iectin for 12 h and protein expression assessed by 
immunofluorescent as say using FITC-tagged secondary antibody as described in experimental 
procedures. A) Control cells were unstimulated and probed with anti TLR-2 antibody; B) isotype 
controls were stimulated with Gal-Iectin and probed with normal goat IgG: C) Gal-Iectin 
stimulated cells probed with anti TLR-2 antibody. 
Polyclonal antiserurn and MAbs against the CRR of the Gal-lectin inhibit TLR-2 
rnRNA expression 
To address the specificity for the Gal-lectin, polyclonal rabbit immune serum (1: 1000) 
raised against the native Gal-Iectin was used to inhibit TLR-2 induction. As shown in Fig. 
5.5, anti Gal-Iectin serum inhibited Gal-Iectin-induced TLR-2 expression by 90% while 
LPS-mediated response remains unaffected. Pre-immune serum at 1: 1000 did not affect 
TLR-2 expression. To identify the specific region of the Gal-Iectin that stimulates TLR-2 
rnRNA expression, we examined the inhibitory effects of a panel of monoclonal 
antibodies which map to non-overlapping epitopes on the CRR of the Gal-lectin (Fig. 
5.6). Three MAbs, 1G7 (aa 596-818), 8C12 (aa 895-998) and H85 (aa 1033-1082) 
markedly inhibited TLR-2 rnRNA expression in response to Gal-Iectin, whereas, MAb 
3F4 (aa 895-998) and 7F4 (aa 1082-1138) did not (Fig. 5.7). The latter MAbs also acted 
as internaI isotype controls. Thus, aa 596-1082 of the CRR is responsible for stimulating 
TLR-2 rnRNA expression in macrophages. 
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Fig. 5.5: PolycIonal anti-Gal-Iectin serum specifically inhibits Gal-Iectin-induced TLR-2 
mRNA expression. Purified Gal-lectin (500 nglml) or LPS (100nglml) were treated with either 
medium, pre-immune rabbit serum (1:1000) or polydonal anti-lectin serum (1:1000) for 2 h at 4° 
C prior to incubation with macrophages for 2 h at 37° C. Results of scanning densitometric 
analysis of Northem blot are presented as histogram with identical lanes for Northem blot and 
histograms. Value in parenthesis shows percentage inhibition relative to homologous controls. 
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Fig. 5.6: Epitope mapping of the binding sites by monoclonal antibodies to the Gal-Iectin. 
The location of the epitopes recognized by mAbs as determined by reactivity with deletion 
constructs of thel70-kDa subunit (19) is shown. C-W R= Cysteine-Tryptophan Rich, C-poor= 
Cysteine poor, CRR= Cysteine Rich Region, TM= Transmembrane domain, CT= Cytoplasmic 
Tail 
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Fig. 5.7: Monoclonal antibody inhibition study to identify the region of the Gal-Iectin 
responsible for TLR-2 rnRNA induction. The Gal-lectin was treated with 1.0 J..lg/ml each of 
affinity purified mAbs against the Gal-Iectin at 4°C prior to stimulating the cells for 2 h. Results 
of scanning densitometric analysis of Northem blots are presented as histogram and are expressed 
as densitometric units with identical lane designations for blots and histograms. Values in 
parenthesis show percentage inhibition of the response relative to that induced in the presence of 
7F4 or 3F4 (isotype matched controIs). Similar results were obtained from three independent 
experiments. 
Regulation of TLR-2 rnRNA expression in response to Gal-Iectin 
Previous studies have shown that the pro-inflammatory cytokines, TNF-a and IL-l ~ can 
up-regulate TLR-2 rnRNA expression in murine macrophages (21). As Gal-Iectin can 
also stimulate pro-inflammatory cytokines from macrophages, we determined if TLR-2 
induction by Gal-Iectin occurs directly or via autocrine stimulation with these cytokines. 
As shown in Fig. 5.8, no change in TLR-2 mRNA expression was observed when 
macrophages are stimulated with Gal-Iectin in the presence of neutralizing antibodies 
against TNF-a and IL-l~, confirming that TLR-2 rnRNA expression is independent of 
these cytokines. Moreover, TNF-a and IL-l~ stimulated TLR-2 rnRNA expression 
similar to the Gal-Iectin and this induction was completely inhibited by their respective 
neutralizing antibodies. To determine if de nova prote in synthesis is required for TLR-2 
rnRNA expression, cells were pre-treated with different concentrations of cyc10heximide 
for 30 min and then stimulated with Gal-Iectin for 2h. Cyc10heximide treatment markedly 
increased TLR-2 rnRNA expression in both control and stimulated cells (Fig. 5.9) 
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indicating that newly synthesized proteins negatively regulate TLR-2 rnRNA expression. 
Actinomycin-D treatment followed by RNA chase ex periment was do ne to examine the 
stability of the TLR-2 rnRNA transcript induced by Gal-Iectin in comparison to that of 
LPS. TlI2 for TLR-2 mRNA transcripts induced by the Gal-Iectin was calculated to be 1.4 
h while that induced by LPS was 2.5 h (Fig. 5.10). These results show that TLR-2 mRNA 
induced by lectin is stable and undergoes slow post-transcriptional degradation similar to 
that of LPS. The molecular regulation of TLR-2 gene expression was determined by a 
PCR based nucIear mn-on assay. As shown in Fig. 5.11, a three fold-increase of TLR-2 
gene transcription was observed in cells stimulated with Gal-Iectin, similar to that of the 
positive control LPS. 
Lectin + + + 
TNF-a + + 
IL-1 f} + + 
Anti-TNF + + 
Anti IL-1f} + + 
TLR-2 
Actin 
Fig. 5.8: Gal-Iectin induced TLR-2 rnRNA is independent of TNF-a. and IL-IJ3. 
Macrophages were stimulated with Gal-Iectin (500 ng/ml) or medium only in the presence or 
absence of neutralizing antibodies against mouse TNP-a (2 /lg/ml) or IL-IJ3 (10 /lg/ml) for 2 h 
and total RNA collected for subsequent Northern blot analysis. Under the same conditions 
recombinant mouse TNF-a (10 ng/ml) and IL-IJ3 (10 ng/ml) were used as specifie controls. 
Results are from three separate experiments. 
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Fig. 5.9: Effect of cycloheximide treatment on TLR-2 mRNA induction by the Gal-Iectin. 
CeIls were treated with the protein synthesis inhibitor cyc10heximide or medium for 30 min 
before stimulation with medium or Gal-Iectin for 2 h. Results of scanning densitometric analysis 
of Northem blots are presented as histogram and are expressed as densitometric units with 
identical lane designations for blots and histograms. Results are from three independent 
stimulations. 
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Fig. 5.10: Stability of TLR-2 mRNA in response to Gal-Iectin and LPS. Cells were stimulated 
for 2 h with 500 ng/ml of Gal-Iectin or 100 ng/ml of LPS. The transcriptional inhibitor 
actinomycin-D (2.0 ~g/ml) was added and total RNA collected at 0.5, 1,2,3,4,5,6,8, 10 and 12 
h for Northem blot analysis. TLR-2 rnRNA levels are expressed as percentage of rnRNA 
remaining where 100% represents rnRNA expression (normalized to actin) at the time of 
actinomycin treatment (0 h). The t 1/2 (50% stability) of TLR-2 rnRNA transcripts as calculated 
from the graph are 1.4 h (r=0.974) and 2.5 h (r=0.9677) for Gal-Iectin and LPS, respectively. 
Results are from two experiments. 
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Fig. 5.11: Gal-Iectin stimulates TLR-2 mRNA gene transcription in murine macrophages. 
Cells were stimulated for 2 h with medium alone, Gal-Iectin (500 ng/ml) or LPS (lOOng/ml). 
Nuc1ei were isolated and in vitro transcription done as described. After densitometric scanning, 
TLR-2 rnRNA 1evels were normalized to those of actin. Basal rate of transcription (in control 
ceIls) was assigned an arbitrary value of 1 and fold-increase of transcription expressed as Relative 
Transcription Units. Similar results were obtained from two independent experiments. 
NF -KR is involved in Gal-Iectin-induced TLR-2 rnRNA expression 
NF-KB has been shown to regulate TLR-2 gene transcription in murine macrophages 
(12). Rence its role in Gal-Iectin-induced TLR-2 gene transcription was determined 
using two NF-KB inhibitors pyrollidine dithiocarbamate (PDTC) and SN50 peptide. As 
shown in Fig. 5.I2A, PDTC inhibited Gal-Iectin-induced TLR-2 expression by 64% at 10 
/-lM concentration and completely suppressed TLR-2 expression at 25 /-lM, Moreover, the 
specific NF-KB inhibitor SN50 inhibited TLR-2 mRNA induction by 80% (Fig. 5.12B) 
confirming a role for this transcription factor in Gal-Iectin signaling. In support of this, 
we observed nuclear translocation of the two subunits of NF-KB, p65 and p50 as early as 
30 min following Gal-Iectin stimulation (Fig. 5.I2C). Furthermore, EMSA was do ne to 
check the DNA binding activity of NF-KB that was activated by the Gal-Iectin. As 
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shown in Fig. 5.12D, Gal-Iectin treatment significantly increased the DNA binding 
activity of NF-KB. Specificity was determined by pretreatment of the nuclear extracts 
with 50 and loo-fold concentration of cold probe and by mutant NF-KB consensus 
sequence. As expected, pretreatment of nuclear extracts with cold probe inhibited DNA 
binding by the labeled probe in a dose-dependent fashion while pretreatment with mutant 
probe did not inhibit subsequent binding by labeled probe. The P65 subunit of NF-KB has 
been implicated in the transcativating function of this transcription factor (11). Thus, to 
determine if this subunit is activated by the Gal-Iectin, supershift assay was done using 
anti p65 antibody. Fig. 5.12E shows a clear supershifted band, validating its role in Gal-
lectin signaling. 
Role of MAP kinases in Gal-lectin induced TLR-2 rnRNA expression 
MAP kinases play a key role in cellular responses to diverse stimuli by acting as 
signaling intermediates in the expression of cytokines (13-15). Accordingly, we tested if 
the Gal-Iectin can activate the MAP kinase pathways. By Western blot studies 
employing antibodies against phosphorylated forms of the three important MAP kinases; 
ERK, JNK and p38, we observed that the Gal-Iectin activates p38 kinase (Fig. 5.13A) but 
not ERK or JNK (data not shown). Specific inhibitors of the MAP kinase pathways were 
then used to check their role in Gal-Iectin-induced TLR-2 rnRNA expression. As shown 
in Fig. 5.l3B, pretreatment of cells with SB203580, a specifie inhibitor of the p38 kinase 
pathway, significantly inhibited (by 40%) TLR-2 rnRNA induction by Gal-Iectin while 
the ERK inhibitor had no effect. In order to understand further the upstream signaling 
events in Gal-Iectin signaling, we studied the effects of two inhibitors Wortmannin, a PI3 
kinase inhibitor and Herbimycin-A, a specific tyrosine kinase inhibitor on Gal-Iectin-
induced TLR-2 rnRNA expression. Neither of these inhibitors had any significant effect 
on TLR-2 mRNA expression (Fig. 5.14), suggesting that PI3 kinase and tyrosine kinases 
do not play a role in Gal-lectin mediated TLR-2 expression. 
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Fig. 5.12: NF-lCB is involved in Gal-Iectin signaling. A). Cells were pretreated with NF-KR 
inhibitor pyrollidine dithio carbomate (POTC) at different concentrations or medium alone for 30 
min before stimulating with lectin (500 ng/ml) for 2 h and Northern analysis.Values in 
parenthesis indicate percentage of inhibition relative to that observed with lectin. B) Cells were 
pretreated with 100 ~g/ml of either control peptide (CP) or SN50 peptide (SN50) for lh before 
stimulation with 500ng/ml of Gal-Iectin for 2 h. Figure in parenthesis show percentage of 
inhibition relative to that observed with control peptide. C) Western blots showing the nuc1ear 
translocation of NF-KR subunits by the Gal-lectin. Cells were stimulated with 500 ng/ml each of 
lectin or LPS for 30 min and 2 h and nuclear extracts collected as described. 30 ~g of protein was 
fractionated by SOS-PAGE and probed with antibodies against the two NF-KR subunits p65 and 
p50. 0) NF-KR activation by the Gal-Iectin. Macrophages were stimulated with Gal-Iectin (500 
ng/ml) for 30 min. Nuclear extracts from stimulated and unstimulated cells were prepared as 
described in experimental procedures and then assayed for ONA-binding activity by EMSA. 
Arrows indicate positions of ONA complexes. E) Supershift with anti p65 antibody. To check 
the specificity and identify the subunits induced by Gal-Iectin, the nuc1ear extracts were pre-
incubated anti p65 antibody for 2 h before EMSA. Supershifted band (arrow) with p65 is shown. 
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Fig. 5.13: P38 MAP kinase is activated by the Gal-Iectin. A) Gal-Iectin indu ces the 
phosphorylation of p38 kinase. Cells were stimulated with Gal-Iectin (1.0 flg/ml) or LPS (1.0 
flglml) for 30 min, cytoplasmic extracts prepared using NE-PER kit and 100 flg of protein per 
lane were fractionated by SDS-PAGE. The membranes were probed with antibodies that 
specifically recognize the phosphorylated form of P38. To check equalloading, membranes were 
subsequently stripped and re-probed with antibody that recognizes total p38. B) P38 kinase is 
involved in Gal-Iectin-induced TLR-2 rnRNA expression. Cells were treated with indicated 
concentrations of specific MAP kinase inhibitors for 30 min before stimulating with Gal-Iectin 
for 2 h. Values in parenthesis show percentage of inhibition relative to that induced by the Gal-
lectin. Results are representative of three separate experiments. 
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Fig. 5.14: Gal-Iectin-induced TLR-2 rnRNA expression is independent of tyrosine kinases 
and PI3 kinase. Cells were pretreated with herbimycin-A (tyrosine kinase inhibitor) and 
wortmannin (PI3 kinase inhibitor) at indicated concentrations for 30 min prior to stimulation with 
Gal-Iectin for 2 h. Total RNA was extracted and Northem blot analysis done as described. TLR-2 
rnRNA Ieveis were normalized to those of actin and expressed as densitometric units with 
identicai Iane designations for blots and histograms. Results are representative of two 
independent treatments. 
Discussion 
DNA rnicroarray technology is increasingly becoming a powerful tool which aIlows a 
global view of gene profiling in a rapid and efficient fashion (22) and several researchers 
are reporting microarray analysis of rnRNA levels from macrophages in response to 
variety of pathogens (23, 24). Hence we initiaIly exploited this technique to have 
simultaneous analysis of 96 genes involved in NF-KB signaling pathway. The observed 
gene profile, over aIl, supports our previous observations of pro-inflammatory cytokine 
induction and suggests the involvement of the important transcription factor NF-KB in 
Gal-lectin signaling. As we are interested in the regulation of ToIl receptors and 
deciphering the signaling events involved in this activation, we focused our study on 
regulation of TLR-2 induction by the Gal-lectin. Of the 10 TLRs identified to date in 
mammals, TLR-2 appears to be the most promiscuous one that can be activated by a 
variety of stimuli. In this study, we show that the Gal-Iectin induces robust TLR-2 
130 
expression in murine macrophages. To our knowledge, this is the first purified molecule 
isolated from a parasite that induces Toll receptor expression in macrophages. The others 
include LPS from Gram-negative bacteria (21), H. influenzae (25), and M. avium (26). In 
addition, seve raI parasitic components have been shown to signal via TLR-2 and activate 
the Toll pathway. These include GPI anchors and protein Tc52 from T. cruzi (27, 28) 
and schistosomal lyso-phosphatidyl serine (29). Although our study shows that Gal-
lectin can stimulate TLR-2 expression, it is premature to hypothesize that it is a ligand for 
TLR-2. 
Using a panel of monoclonal antibodies, we identified the reglOn of Gal-Iectin that 
stimulates TLR-2 mRNA expression and protein production. This is of paramount 
importance in the design of a subunit vaccine. The same region of the Gal-Iectin 
stimulates TNF-a and IL-12 production by macrophages. It is interesting to note that 
IFN-y priming was not necessary for the Gal-Iectin-induced TLR-2 rnRNA or protein 
expression by murine macrophages. Thus, even unprimed antigen presenting cells 
(APCs) exposed to Gal-Iectin can express high levels of this ToU receptor, which can 
potentially contribute to skewing the immune response to protective Th1 type. In 
addition, other workers have shown that aU the functional properties of Gal-Iectin such as 
parasite adherence, cytotoxicity and complement resistance are mediated by the CRR, a 
part of the large extracellular domain (2, 30). In this context, it would be of interest to 
explore the structural properties that confer su ch a diverse functionalities to this 
molecule, and to the CRR in particular. 
NF-KB encompasses a very important family of transcription factors and is critical for the 
inducible expression of several genes involved diverse cellular responses (11). The 
promoter region of murine TLR-2 contains the foUowing consensus binding sequences: 
two NF-KB, two CCAAT/enhancer binding protein, one cAMP response element-
binding prote in and one STAT (12). Hence, it is not surprising that NF-KB plays a 
central role in TLR-2 gene expression. In fact, LPS and M. avium have been shown to 
regulate TLR-2 rnRNA via NF-KB (12,26). We also observed that NF-KB plays a critical 
role in Gal-Iectin-induced TLR-2 expression. This is consistent with the observation that 
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no new protein synthesis is required for TLR-2 induction by the Gal-Iectin as initial NF-
KB activation does not require de novo protein synthesis (31). Although both Gal-Iectin 
and LPS regulate TLR-2 in an NF-KB-dependent manner, there are c1ear differences in 
the mechanisms used by these diverse molecules. While MAP kinases do not play a role 
in LPS-mediated TLR-2 regulation, p38 kinase was a significant intermediate in Gal-
lectin mediated TLR-2 induction. AIso, LPS induced a much robust DNA-binding by 
NF-KB than Gal-Iectin at 30 min (data not shown). These observations together with a 
c1ear difference in the stability of TLR-2 rnRNA, suggest that LPS induces a sustained 
expression of TLR-2 probably though activation of other transcription factors in addition 
to NF-KB, while Gal-Iectin induces a less stable expression of TLR-2 which appears to be 
dependent mainly on NF-KB. This is supported by the fact that NF-leB was not 
absolutely necessary for LPS-induced TLR-2 gene expression (12) while inhibition of 
this single transcription factor by SN50 peptide resulted in 80% inhibition of TLR-2 
rnRNA expression induced by the Gal-Iectin. However, promoter analysis studies are 
warranted to assess the full spectrum of transcription factors involved in Gal-Iectin 
induced TLR-2 gene expression and to identify the putative responsive elements in the 
gene promoter region. These differences are also reflected in the kinetics of protein 
expression where a significant expression with Gal-Iectin was observed only at 12 h 
while LPS stimulation resulted in a relatively rapid induction by 6 h (data not shown). 
Although we showed that both Gal-Iectin and LPS induces TLR-2 gene transcription, 
differential post-transcriptional regulation of TLR-2 rnRNA might be responsible for 
these quantitative and kinetic differences. 
The family of MAP kinases inc1udes the extracellular signal-regulated kinase (ERK), c-
Jun N-terminal kinase (JNK) and p38 kinase. P38 MAP kinase is an important mediator 
of stress-induced gene expression (32) and it appears to differentially regulate TLR-2 
rnRNA expression in different cell types in response to different stimuli. P38 kinase and 
ERK pathways have been shown to positively regulate TLR-2 rnRNA expression in 
response to PMA in T-Iymphocytes (33) while nontypeable Hemophilus influenzae and 
glucocorticoids were reported to enhance TLR-2 expression in human epithelial cells via 
a negative cross-talk with p38 kinase (25). We showed that the p38 kinase pathway is a 
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significant mediator of TLR-2 induction by the Gal-Iectin. Severallines of experimental 
evidence support this contention. First, Gal-Iectin induced a marked phophorylation of 
p38 kinase as early as 30 min. Second, pretreatment of cells with SB203580, specific 
inhibitor of p38 kinase blocked Gal-Iectin-induced TLR-2 rnRNA expression by 40%. In 
contrast, inhibiting the ERK pathway resulted in slight increase in TLR-2 rnRNA 
expression, confirming an earlier report of negative regulation by ERK (21) in response 
to LPS stimulation. However, the clear discrepancy in signal transduction pathways 
activated by Gal-Iectin and LPS is that Gal-lectin does not activate ERK or JNK while 
LPS potently induces both. As weIl, LPS mediated-TLR-2 rnRNA induction was not 
signifieantly inhibited even at 50 !lM concentration of SB208530 (21). Although the 
exact mechanism for this differential activation is not known, modulation of different 
membrane receptors may be involved. 
MAP kinases are one of the downstream targets for protein tyrosine kinases (PTKs) and 
inhibition of PTK and PI3 kinase activities has been shown to modulate transcription 
factor activation and gene induction (11, 34-36). Both have been implicated in induction 
of proinflammatory molecules such as iNOS and TNF-a in response to LPS and IFN-y 
(37, 38). However, specifie inhibitors at a concentrations shown to inhibit respective 
target kinases, fail to influence the TLR-2 rnRNA expression by Gal-lectin. PKC is one 
of the prominent downstream target of PI3-kinase (39) and we previously observed that 
E. histolytica activated and translocated PKC to the membrane fraction in murine 
macrophages (40). Also, previous reports have shown that these kinases are involved in 
transcription factor activation and gene induction (40, 41). However, we fail to associate 
these kinases with TLR-2 expression indicating that Gal-lectin induced NF-KB and p38 
are independent of PB kinase and tyrsosine kinases. 
While this study clearly helps in developing an ideal subunit vaccine against this 
important pathogen, its contribution to furthering our understanding of amoebie 
pathogenesis, and intestinal inflammation in general, cannot be ignored. Our observation 
of up-regulation of TLR-2, via NF-KB, by Gal-lectin is of paramount importance in this 
context. The contribution of NF-KB, partieularly the p65 subunit, to intestinal 
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inflammation has been weIl documented (42-44). Up-regulation of TLR-2 could 
definitely be one of the diverse consequences of NF-KR activation. lndeed, several 
reports are revealing an increased expression of TLRs in both epithelial cells and lamina 
propria macrophages during inflammatory conditions (8-10, 45). Recently, TLR-2 was 
shown to contribute to liver injury by Salmonella infection via Fas ligand expression on 
NKT cells in mice (46). Based on this work and other studies, a working model for the 
role of TLR-2 in amebic pathogenesis can be hypothesized (Fig. 5.15) wherein E. 
histolytica through Gal-Iectin enhances the surface expression of TLR-2 in lamina 
propria mononuclear cell (LPMNCs) which renders these cells more responsive to 
diverse ligands of gut pathogens or even commensals which gain access to these 
underlying cells though the leaky gut. During the course of E. histolytica infection, there 
is ample opportunity for epithelial cells and LPMNCs to be exposed to Gal-Iectin either 
through direct contact with the trophozoites or through exposure to the secreted products 
and/or lysates of dead amebae. The consequent activation of TLRs in intestinal 
epithelium results in further influx of inflammatory cells and development of colitis, thus 
perpetuating an uncontrollable intestinal inflammation. Thus, this study further supports 
the CUITent contention of regulating the TLR function as an attractive therapeutic target 
for controlling intestinal inflammation during infections with gut pathogens. It should be 
emphasized that this model proposes a role for TLR-2 in the exacerbation of the mucosal 
inflammation rather than in initiating the pathogenesis. Future proteomic studies might 
identify novel parasitic molecules such as lipoproteins or lipophosphoglycans as potential 
ligands for Toll receptors, which might directly implicate the innate pattern recognition 
receptors in amebic colitis . 
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Fig. 5.15: Hypothetical model for the role of TLR-2 in amebic pathogenesis. Enhanced TLR-
2 expression in lamina propria mononuclear ceUs (LPMNC) by Gal-lectin of E,histolytica via 
NF-KB and p38 pathways will amplify the ToU signaling activated by diverse ligands in gut. The 
resulting amplified proinflammatory cytokine response from leukocytes in turn can up-regulate 
Toll receptor expression in epithelial cells (47). Consequently, epithelial cells that are hitherto 
unresponsive/hyporesponsive to gut antigens begin responding to diverse ToU ligands. The 
resulting production of chemokines and cytokines while helping signaling the adaptive response, 
also contributes to inflammatory reaction by recruiting phagocytes to the site of tissue damage. 
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Connecting Statement 1 
In the first manuscript we showed that the Gal-Iectin induces ToU like receptor-2 
expression in macrophages and hypothesized that amplified immune cell responses would 
contribute to pathogenesis of amebiasis. However, it is not clear how immune cens home 
into the lamina propria du ring amebic colitis. As intestinal epithelial cens sense the 
invading pathogens and signal the immune system and it has been previously shown that 
amebic components indu ce IL-8 secretion from IEC, we determined the mechanism of 
amebic induction of macrophage chemokine, MCP-l from IEC. It should be mentioned 
that while Gal-Iectin is a potent activator of immune cens, we failed to see any responses 
in IEC to this molecule in our studies and hence employed a more realistic substance, 
soluble amebic components. 
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Abstract 
The role intestinal epithelial cells play in the pathogenesis of amebic colitis is poody 
understood. Herein, we demonstrate that soluble Entamoeba histolytica proteins (SAP) 
induce the chemoattractant, Monocyte Chemotactic Protein (MCP)-l mRNA and protein 
expression in colonie epithelial cells. SAP failed to activate any of the MAP kinase 
pathways and IKK activity. Inhibiting the classical pathway of NF-KB activation did not 
affect SAP induced MCP-l expression. Instead we find that it is dependent on post-
translational modification of NF-KB p65 subunit. SAP induced phosphorylation of p65 
and enhanced NF-KB transcriptional activity, which are PI3 kinase dependent. Treatment 
with PI3 kinase inhibitor L Y290004 significantly abrogated the activation of Akt, p65 
and MCP-l rnRNA induction. We conclude that colonie epithelial cells play a role in the 
initiation of inflammation by secreting chemokines in response to soluble amebic 
components. 
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,------- Introduction 
Entamoeba histolytica is an enteric protozoan parasite that is responsible for the disease 
amebiasis in humans. The disease affects 50 million people globally and is the fourth 
leading parasitic cause of death (1). Host inflammatory responses are thought to play an 
important role in the pathogenesis of intestinal amebiasis. However, the role of intestinal 
epithelial cells and mediators of colonic inflammation have not been fully elucidated. 
Invasive amebiasis is characterized by infiltration of immune cells such as leukocytes and 
lymphocytes (2). It has not been well established if this cellular infiltration is a cause or 
consequence of inflammation. The parasite has been previously shown to elicit IL-8 
production from colonic epithelial cells (3,4). IL-8 is a potent chemoattractant primarily 
for neutrophils and its secretion alone does not explain the homing of other immune cells 
such as monocytes and lymphocytes seen in the amebic lesions (2). Monocyte 
chemotactic protein, MCP-1 belongs to a group of C-C or ~-chemokines and is produced 
by a variety of cells, including intestinal epithelial cells (5). MCP-l is potently 
chemotactic for monocytes, lymphocytes and basophils (6). MCP-1 levels are increased 
during various inflammatory conditions that are characterized by cellular infiltration (7-
9). Recently, amebic infection in a human intestinal xenograft model has been shown to 
increase a number of genes in the epithelial cells inc1uding MCP-1 (10). However, the 
mechanism of induction is not known and also it is not c1ear if ameba components 
themselves can induce this chemokine. 
The transcription factor NF-1d3 regulates a number of genes involved in immune 
response and inflammation (11). It is composed of two subunits most commonly of P65 
and P50. Only P65 has the transactivating domains and hence is critical for NF-1d3 
activity. Various pathogens and pathogen molecules activate NF-1d3 and there by induce 
an inflammatory response. NF-1d3 is activated by different pathways inc1uding c1assical, 
altemate, atypical and p105 pathways (12). All these pathways involve phosphorylation 
and subsequent degradation of I1d3, increased nuc1ear translocation of NF-1d3 subunits, 
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increased binding to DNA in the promoter regions of target genes and increased gene 
transcription. However, it is increasingly being recognized that post-translational 
modifications of NF-KB p65 subunit is equally important in the transactivating function 
of the transcription factor (13). The two important post-translation al events that 
determine the strength, duration and efficacy of NF-KB function are phosphorylation and 
acetylation. Indeed, phosphorylation appeared to be a requirement for subsequent 
acetylation. Importantly, this p65 phosphorylation can lead to transcription of a set of 
NF-KB target genes independent of IKB degradation (14, 15). IKK, Akt, NIK, Casein 
kinase II have been implicated in the phosphorylation of cysteine residues at different 
positions of P65 subunit (12). In this study we show that soluble amebic proteins can 
induce MCP-l from IEC by a unique pathway involving PB kinase and NF-KB p65. 
Materials and Methods 
Ce Ils, reagents and amebic components 
Human adenocarcinomal cell li ne Caco-2 ceIls from A TCC were grown to confluent 
monolayers in minimum essential medium with 5% serum and penicillin and 
streptomycin for 5-7 days. Antibodies against MCP-l, total p65, phospho-p65 are from 
Santa Cruz Biotech. Anti IKB, phospho-IKB, total and phospho Akt antibodies and LY 
290004 are from CeIl signaling. PD98059 and SB203580 are from Calbiochem. AIl other 
reagents are from Sigma. Soluble Amebic Proteins (SAP) were prepared by three cycles 
of freeze-thaw lysis of log phase E. histolytica virulent strain HMl: IMSS and quantified 
by the BCA assay (Pierce) as described previously (16). For transwell studies, amebic 
trophozoites were added to the Coming's transweIl inserts with pore diameter 0.6 J..LM 
with Caco-2 ceIls in the bottom weIl. 
Real-time PCR 
Total RNA was extracted with TriZoI reagent (Invitrogen), quantified and 5 Jlg of RNA 
was reverse transcribed using M-MLV reverse transcriptase (Invitrogen) and oligo d(T) 
as per manufacturer's instructions. 2 JlI of cDNA was used for real-time PCR. Real-time 
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,--- primers used are forward: GATCTCAGTGCAGAGGCTCG, reverse: 
TGCTTGTCCAGGTGGTCCAT for MCP-l, forward: 
GAAGA TGGTGA TGGGATTTC, reverse: GAAGGTGAAGGTCGGAGT for GAPDH. 
Amplifications were carried out with Qiagen's Quantitect SYBR Green PCR kit at the 
following cycling conditions: 94° C hold for 10 min, followed by 40 cycles of 
denaturation at 94 ° C for 20 s, annealing at 60 ° C for 30 s and extension at 72 ° C for 60 
s. Specificity of amplification was checked by melt curve analysis, MCP-l expression 
was normalized to that of GAPDH and fold change over control was determined 
according to Ct method as described (17). 
Western blot 
Cytoplasmic or nuclear extracts were collected using the NE-PER (Pierce) kit as per the 
instructions of the manufacturer. Protein concentrations were estimated by micro BCA 
method (Pierce). Equal amounts of the samples were then separated in 12% SDS-
polyacrylamide gels and transferred onto nitrocellulose membrane (Bio-Rad). The 
membranes were blocked in 3.5% skim milk-TBS-T (20 nm Tris-HCI, pH 7.5, 500 mM 
NaCI, 0.1% Tween-20) at 4°C overnight, incubated with primary antibodies in skim 
milk-TBS-T at 4°C overnight, washed three times with TBS-T, and incubated with HRP-
conjugated secondary antibody in skim milk- TBST overnight at 4°C. After three washes 
each in TBS-3T and TBS-T, the blot was developed with the enhanced 
chemiluminescence system (Amersham Pharmacia Biotech, Piscataway, NJ) according to 
the instructions of the manufacturer. Actin and histone are used as loading controls for 
cytoplasmic and nuclear extracts respectively. 
In vitro kinase assay 
Cells were incubated with celllysis buffer (20mM Tris, pH 7.5, l50mM NaCl, 25mM ~­
glycerophosphate, 2mM EDTA, 2mM pyrophosphate, ImM orthovanadate, and 1 % 
Triton X-100, lmM DTT, lmM NaF with protease inhibitors) followed by addition of 
anti IKK-a antibody. Following overnight end-to-end rotation of tubes at 4°C, 
immunoprecipitates were washed 3 times with lysis buffer and once with kinase buffer 
(20mM Tris, pH 7.5, lmM MnCh, lOmM MgCh, 20mM ~-Glycerophosphate, O.lmM 
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sodium orthovanadate, 2mM NaF and 1mM DTT). Immunoprecipitates were finally 
resuspended in 20.0 J!l of kinase buffer containing 5J!Ci of [r 32p] ATP and incubated at 
30 0 C for 30 min. 1 J!g of GST-IKBa (Santa Cruz Biotech) was used as substrate. The 
reaction was terminated by boiling with SDS sample buffer for 5 min. FinaIly, the protein 
was resolved on 10% SDS-PAGE, the gel was dried, and the radioactive bands were 
visualized by autoradiography. Cell lysates were also checked for IKK-a expression for 
normalization. 
Luciferase reporter assay 
NF-KB transactivation was studied using luciferase reporter plasmids from Stratagene 
according to manufacturer's instructions. Briefly, vector DNA (pNF-KB-Luc with or 
without p FC-MEKK positive control plasmid) was allowed to form complexes with 
Fugene 6 (Roche), which was used at 0.003% v/v (final concentration). Cells were 
washed once in serum-free medium and the DNA-fugene mixture containing the pNF-KB-
luc plasmid was added to 40-50% confluent Caco-2 cells. The transfection continued at 
37°C for 6 h, after which the medium was changed to normal growth medium and the 
cells were allowed to grow for another 48 h. Tansfected cells were treated with soluble 
amebic proteins for 6 h and luciferase was extracted with Luciferase assay systems 
(Promega) and the emitted light measured with luminometer. 
Statistical analysis 
Statistical analysis to check significance was done with Student' s t test using Prism 
software. Graphs plotted were from two to three independent experiments and error bars 
in aIl graphs represent mean± SD. 
Results 
Soluble arnebic proteins induce MCP-l rnRNA and protein production 
Human colonic epithelial cells were treated with 100 J!g/ml of soluble amebic protein for 
different time points and checked for MCP-1 rnRNA expression by real-time PCR and 
protein production by Western blot. As shown in Fig. 6.1A, SAP induced significant 
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expression of MCP-l rnRNA as early as 2 h reaching a peak after 8 h. Little protein 
expression was observed after 6 h but increased steadily thereafter with significant 
expression seen after 24 h (Fig. 6.1B). 
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Fig. 6.1: Amebic components induce MCP-l mRNA and protein production from intestinal 
epithelial cells. A) Confluent Caco-2 cells were treated with 100 IlVmg of soluble amebic 
proteins for different time periods, RNA extracted with TriZol reagent and real-time PCR was 
done as described in methods. B) Caco-2 cells treated as above for different time periods and 
whole cell lysates were subjected to SDS-PAGE and western blot analysis with anti MCP-! 
antibody and actin antibodies. 
Ameha induced MCP-l rnRNA induction is independent of IKK activity and IKB-a 
degradation 
As MCP-l expression is regulated by the transcription factor NF-KB (18), we checked its 
role in ameba induced MCP-l. induction. Surprisingly, pre-treating cells with the 
proteasome inhibitor MG 132, failed to suppress SAP induced MCP-l production, while 
significantly reducing the basal MCP-l rnRNA expression (Fig. 6.2A). SAP treatment 
also failed to induce IKK activity (Fig. 6.2B) and to phosphorylate IKB (Fig. 6.2C). 
Amehic components indu ce NF -KB transcriptional activity and p65 phosphorylation 
Despite the lack of IKB degradation, amebic protein treatment was found to result in 
around 6-fold increase of the NF-KB transcriptional activity (Fig. 6.3A). To decipher the 
mechanism underlying the apparently contradicting observations of lack of IKK 
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activation but increased NF-1d3 transactivation, we focused on the dynamics of p65 
subunit. First we checked its nuc1ear translocation but did not observe significant 
accumulation until after 2 h (Fig. 6.3B). To check if amebic components activate NF-1d3 
by post-translational modification, we checked the phosphorylation status of p65 subunit. 
Indeed, SAP was found to increase the levels of phosphorylated p65 following 30 min 
treatment (Fig. 6.3C). 
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Fig. 6.2: Amebic components do not activate IKK activity. A) Cells were treated or not with 
MG-132 for 2 h followed by SAP for 2 h. RNA extracted and real time PCR was done as 
described. B) IEC treated with different concentrations of SAP for 30 min, cell lysates were 
immunoprecipitated using IKK-a antibody and in vitro kinase as say was done using GST-IKB-a 
as substrate. Equal quantities (20 Jlg) of cellular proteins were subjected to western blot to check 
the IKK-a levels. KA: kinase assay; IB: immunoblot. C) Cells treated with 100 Jlg/ml of SAP for 
different time points and cell lysates subjected to SDS-PAGE and western blot with 
phosphorylated IKB and actin. 
E. histolytica activates Akt 
As Akt is one of the proposed upstream kinases implicated in p65 phosphorylation (19), 
its activation was checked with antibody that specifically recognizes phosphorylated Akt. 
As shown in Fig. 6.4A, SAP treatment rapidly increased P-Akt levels as early as 15 min 
and this activation was continued for 2 h. Moreover, secreted products from live E. 
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histolytica trophozoites separated by a se mi-permeable membrane also activated Akt after 
2 h treatment of epithelial cells (Fig. 6.4B). 
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Fig. 6.3: SAP induces NF -lCB transactivation and p65 phosphorylation. A) Caco-2 cells were 
transfected with p-NF-KB-Iuc plasrnid with or without the positive control (p-MEKK) and treated 
with different concentrations of SAP for 6 h and assayed for luciferase activity as described. 
RLU- relative luciferase units over the untreated cells. B) Cells were treated with 100 Jlglrnl of 
SAP for different time periods and nuc1ear extracts prepared as described, 10 Jlglrnl of protein 
separated by SOS-PAGE and checked for p65 nuc1ear translocation. The blot was stripped and 
reprobed with anti histone antibody for normalization. C) Whole celllysates from cells treated as 
above were subjected to western blot and probed with antibody specific to phosphorylated p65 
and then with antibody against total p65. Representative blots from 3 experiments were shown. 
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Fig. 6.4: E. histolytica activates Akt. A) Caco-2 cells were treated with 100 J..lg/ml of SAP for 
different time points and cell lysates were checked for phosphorylation of Akt by western blot. 
Blots were reprobed with total p65 antibody for normalization. B) 106 E. histolytica trophozoites 
were added to the transwell culture with confluent Caco-2 cells at the bottom as described in 
methods, cell lysates extracted at different time periods and checked for phosphorylated Akt as 
above. Actin expression was analyzed to check equalloading. 
SAP induced P65 activation is PI3 kinase but not MAP kinase dependent 
As Akt is a substrate for PB kinase, we checked the role of this kinase in SAP induced 
Akt and P65 phosphorylation. As expected, inhibition of PB kinase with L Y294002 
inhibited SAP induced Akt phosphorylation (Fig. 6.5A) but interestingly also abrogated 
ameba induced P65 phosphorylation (Fig. 6.5B). To study the role of MAP kinases that 
are purported to function downstream of PB kinase/Akt, we checked their activation by 
ameba components (Fig. 6.5C) but failed to see activation of ERK, JNK or p38 MAP 
kinases. Consistently, treatment of colonie cells with inhibitors of ERK and p38 MAP 
kinases failed to suppress SAP induced p65 phosphorylation (Fig. 6.5D). 
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Fig. 6.5: SAP induced P65 phosphorylation is dependent on PB kinase but is independent of 
MAP kinases. A) Caco-2 cells were pretreated with PB kinase inhibitor LY294002 for 1 h prior 
to SAP or trophozoite (in transwells) exposure for 2 h and whole cell lysates checked for 
phosphorylated Akt levels in relation to total Akt expression. B) Lyates from cells pretreated or 
not with L Y294002 followed by SAP for 30 min were subjected to SDS-PAGE and western blot 
using anti phospho- and anti total p65 antibodies. C) Caco-2 cells were exposed to SAP for 
different time periods and cell lysates checked for activation of MAP kinases using phospho-
specifie antibodies against JNK, ERK and p38 MAP kinases. Actin expression was checked for 
normalization. D) Cells were pretreated with 50 !lM of PD98059 (ERK inhibitor) or SB203580 
(p38 inhibitor) for 2 h before incubating with SAP for 30 min and who le celllysates checked for 
phosphorylation of p65. Blot was stripped and reprobed with total p65 antibody. Representative 
blots from at least two different experiments were shown. 
PB kinase inhibition suppresses SAP induced MCP-l rnRNA expression 
Finally we checked if PB kinase inhibition can suppress MCP-l rnRNA induction by 
amebic components. As shown (Fig. 6.6) L Y294002 significantly inhibited SAP induced 
MCP-l rnRNA even at the low concentration of 10 JlM and completely abrogated at a 
high concentration of 50 JlM. 
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Fig. 6.6: SAP induced MCP-l induction is PB kinase-dependent. Caco-2 cells were pretreated 
or not with different concentrations of L Y294002 for 1 h followed by Sap treatment for 2 h. RNA 
was extracted and real time PCR done as described. The experiment was repeated three times and 
fold-increase of MCP-I over untreated cells was depicted in the graph. (**; p= 0.0088). 
Discussion 
Herein, we report that soluble amebic components can induce the chemoattractant MCP-l 
via a unique mechanism involving PB kinase and NF-KR p65 pathway. IEC have been 
shown to secrete a number of macrophage-specifie chemokines like MCP-l and MIP-l~ 
during several infections that signal macrophages to the site of infection and haIt them 
once they have arrived via macrophage inhibition factor (9). In addition to 
chemoattraction function, colonie epithelial cells secrete cytokines such as GM-CSF, IL-
6, and TNF-a: that stimulate macrophage activation, proliferation, and additional cytokine 
secretion, which further perpetuate the inflammatory response. Macrophages are potent 
phagocytes and limit the infection at an early stage and in addition to engulfing and 
destroying pathogens, are also a source of cytokines such as IL-l a/~ and TNF. 
During the pathogenesis of amebic colitis, early invasive lesions are characterized by 
infiltration of neutrophils as a result of contact (3) or non-contact (5) dependent secretion 
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of IL-8 by colonic epithelial cells. However, the role of these cells in ameba killing is 
doubtful as observed in vitro, wherein highly virulent strains of ameba could resist 
neutrophils at a high ratio of 3000 neutrophils per ameba (20). More so, the neutrophils 
may contribute to host tissue damage. As invasion progresses, the ulcers extend deep into 
the submucosa and during this late invasive stage, macrophages and lymphocytes are 
seen (2). Despite their presence in the lesions, the efficacy of monocytes and 
macrophages in killing trophozoites is not very clear but probably related to their state of 
activation (2). Moreover, ameba has been shown to secrete a monocyte locomotion 
inhibition factor, which has been implicated in the absence of macrophages in severe 
amebic lesions (21). Apparently, whether macrophages home in and kill trophozoites 
depends on several factors such as the balance between epithelial MCP-1 production, 
parasite release of inhibitory factors and the release of other activating factors like TNF-a, 
and IFN-y. Nonetheless, monocytes and macrophages are present in amebic lesions and 
might play a role both in the destruction of ho st tissue and also in killing the trophozoites. 
As MCP-l is also able to activate cytotoxic T cells (22) and these cells have been found 
to kill ameba trophozoites (23), this observation is of great importance to pathogenesis. 
NF-KB is an important transcription factor that is usually activated by a classical pathway 
involving IKB degradation and increased NF-KB nuclear translocation or non-canonical 
pathway involving P65 phosphorylation. While IKK has been shown to be involved in 
both the pathways, it is mandatory for the former but dispensable for the latter. P65 
su bu nit is phosphorylated at 4 serine residues by several kinases and this post-
translational modification is either supplementary to classical IKK-dependent NF-KB 
activation or is required for the transcription of certain NF-KB dependent genes (12). 
Sorne reports suggest phosphorylation of p65 enhances nuclear transport through an 
unknown mechanism but most probably via decreased affinity to IKB-a, (24) and this 
could be the reason for the delayed increase of nuclear expression of p65 in response to 
ameba components and the delayed peak induction of MCP-l rnRNA at 8 h. Nonetheless, 
rapid induction at 2 h without apparent increase of p65 is most probably related to the 
phosphorylated p65-mediated gene transcription seen in the luciferase reporter studies. 
MCP-1 is constitutively regulated by the classical NF-KB pathway as observed by its 
inhibition by the proteasome inhibitor, MG-132 in cells not treated with SAP. It could be 
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reasonably argued that NF-1d3 dependent genes are under the regulation of redundant 
pathways and could be activated in a stimulus-dependent manner. Interestingly, it has 
been shown before that ameba proteins induce IL-8 production via a post-transcriptional 
regulation, which is inhibited by dexamethasone (4). This suggests that the host has 
developed multitude of mechanisms to sense the pathogen and signal the immune system. 
We previously observed that prolonged treatment with ameba proteins inhibit NF-1d3 
activation via a negative regulation of IKK activity by stress proteins (25). 
The pathway involving PB kinase and p65 phosphorylation could be an alternative 
mechanism by which colonie epithelial cells activate the important transcription factor 
NF-1d3 to sense the pathogen and signal the immune system. Indeed the DNA damaging 
agents such as doxorubicin and etoposide induce I1cB degradation independent of IKK 
and also phosphorylate p65 via ribosomal S6 kinase 1 (24). We failed to identify if PB 
kinase or Akt directly phophorylates p65 subunit in IEC in response to ameba 
components. While previous reports implicate different kinases such as IKK-a, IKK-~, 
p38 MAP kinases as mediators of PB kinase induced p65 phosphorylation (26, 27), we 
did not find activation of IKK-a in a kinase assay and also failed to see p38 activation by 
ameba components. Recently, several novel kinases such as Bruton's tyrosine kinase 
(Btk) and IKK-i/IKK-E are being found to phosphorylate S536 of p65 subunit (28, 29) 
and the relation between these kinases and PB kinase remains to be explored. It should 
also be noted that this study does not rule out phosphorylation of other serines and their 
possible role in regulating SAP induced NF-1d3 activation. In summary, we demonstrate a 
novel signaling pathway in colonIc epithelial cells for activation of MCP-I by the gut 
pathogen, E. histolytica and hypothesize that this could have an impact on the outcome of 
infection (Fig. 6.7). 
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Fig. 6.7: Model for the consequences of MCP-l production in amebiasis. Intestinal epithelial 
ceIls sense ameba and secrete the chemokine MCP-l via p65 pathway. The resulting homing of 
macrophages causes release of cytolytic agents such as reactive oxygen species which act both on 
amebic trophozoites and epithelial cells. Different outcomes are possible; trophozoites are killed 
and infection eliminated with varying degrees of inflammation; macrophages fail to kill ameba 
but cause apoptosis of IEC and enhances invasion. 
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Connecting Statement II 
Despite the homing and activation of immune cells by amebic components that has been 
reported so far, surprisingly, only a minority of individuals develop symptoms of colonic 
inflammation. As NF-KB is the principal inflammatory mediator and it has previously 
been shown that inhibiting this transcription factor reduces amebic colitis, we 
hypothesized that epithelial cells in the majority of infected hosts respond in a beneficial 
fashion that can potentially suppresses NF-leB induction. Looking at the other 
perspective, inhibiting NF-KB is also advantageous for parasite survival. Encouragingly, 
in our previous work (manuscript II) we observed that amebic components did not 
activate the classical NF-KB pathway. Rence, we sought to study its suppression by 
amebic components in IEe. As the stress response is a potent suppressor of NF-KB and 
its induction during amebic infection has not been studied so far, we studied the stress 
response and its inhibition of NF-KB by the parasite components. 
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Chapter 7: Manuscript III 
Suppression of NF -lCB activation by Entamoeba histolytica in intestinal epithelial 
cells is mediated by heat shock protein 27 
Srinivas J Kammanadiminti and Kris Chadee 
Manuscript published in the Journal of Biological Chemistry 
On 13 July, 2006, DOl: 10.1074/jbc; Manuscript # M601988200 
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Abstract 
Little is known about the pathogenesis of Entamoeba histolytica and how epithelial cells 
respond to the parasite. Herein, we characterized the interactions between E. histolytica 
and colonic epithelial cells and the role macrophages play in modulating epithelial cell 
responses. Human colonic epithelial cell lines, Caco-2 and T84 were grown either as 
monoculture or co-cultured in transwell plates with differentiated human THP-I 
macrophages for 24 h before stimulation with soluble arnebic proteins (SAP). In naive 
epithelial ceIls, prolonged stimulation with SAP reduced the levels of heat shock protein 
(Hsp) 27 and 72. However in THP-l conditioned intestinal epithelial cells SAP enhanced 
Hsp27 and Hsp72, which was dependent on the activation of ERK MAP kinase. Hsp 
synthesis induced by SAP confered protection against oxidative and apoptotic injuries. 
Treatment with SAP inhibited NF-KB activation induced by IL-l p; specificaIly, the NF-
KB-DNA binding, nuclear translocation of p65 subunit and phosphorylation of IKR-a 
were reduced. Gene silencing by siRNA confirrned the role of Hsp27 in suppressing NF-
KB activation at IKK level. By co-immunoprecipitation studies, we found that Hsp27 
interacts with IKK-a and IKK-p and this association was increased in SAP treated 
conditioned epithelial cells. Over expression of wild type Hsp27 amplified the effects of 
SAP while phosphorylation-deficient mutant of Hsp27 abrogated SAP induced NF-KR 
inhibition. In conditioned epithelial cells, Hsp27 was phosphorylated at serine 15 after 
prolonged exposure to SAP. This mechanism may explain the absence of colonic 
inflammation seen in the majority of individu ais infected with E. histolytica. 
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Introduction 
The intestinal protozoan parasite E. histolytica affects 50 million people worldwide, 
causing 100,000 deaths per year (1). Intestinal amebiasis is characterized by colitis and 
severe dysentery. Despite our knowledge of the role of several pathogen and host factors 
in causing colonic inflammation, the cell specific response to amebic infection is poody 
understood. Moreover, the majority of research do ne to unravel the mechanism of amebic 
colitis has been focused on proinflammatory responses (2, 3) by epithelial cells and a role 
of NF-KB (4) and chemokines such as IL-8 (5) as triggering events for inflammation. 
However, it is noteworthy that only 10% of E. histolytica infected individuals show 
symptoms of intestinal inflammation (6) and none of the studies addressed the question 
of why only a minority of infected individuals develops amebic colitis. 
Epithelial cells are the first layer of ho st defense and have been shown to be the effector 
cells capable of secreting several mediators in response to pathogens (7, 8). Epithelial 
cells in vivo do not respond in isolation but act in concert with several immune and non-
immune cells present in the lamina propria. To simulate this, several in vitro studies were 
carried out to assess the epithelial ceIl responses in the presence of immune ceIls su ch as 
leucocytes and lymphocytes. Under the se conditions, a differential response was 
observed in epithelial cell lines exposed to various pathogenic and non-pathogenic 
bacteria (9, 10). However, the effect of co-culturing with macrophages on epithelial cell 
responses has not been well characterized. 
The universal response to stress has been the induction of a group of highly conserved 
family of proteins called heat shock proteins (Hsps) and is commonly referred to as heat 
shock response or stress response. Several pathogens and their products have been shown 
to induce various hsps in different ceIl types including intestinal epithelial cells (11- 13). 
Hsps serve to protect the cells against several insults such as thermal, toxic or apoptotic 
stimuli (12, 14-16). Epithelial cell induction of Hsps in response to various pathogens 
such as E. coli, and toxins su ch as LPS and superantigen has been reported (10, 12, 14). 
It has also been shown that epithelial Hsp expression is regulated by cytokines and 
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immune cells such as lymphocytes (13). One emerging concept is that the stress response 
counters the inflammatory response mediated by NF-KB helping to reduce inflammation 
and promote healing of damaged tissues (12, 17-20). As proinflammatory cytokines 
secreted by immune cells have been shown to influence epithelial cell responses (16, 21) 
and macrophages are a major source of these cytokines, we studied the effect of 
macrophages on epithelial cell response towards E. histolytica. We hypothesized that 
amebae might be eliciting a protective response whereby inflammation is suppressed in 
the majority of infected individuals. Thus, we sought to study the stress response induced 
by ameba components in naïve and macrophage-conditioned colonic epithelial cells and 
made several interesting and novel observations. For the first time, we showed that 
macrophage conditioning primes epithelial cells for an augmented Hsp expression in 
response to amebic components. We identified Hsp27 as the key mediator suppressing 
NF-KB activation by virtue of its association with IKK complex in intestinal epithelial 
cells (IEC). We conclude that this could be one of the mechanisms by which colonie 
inflammation is suppressed in the majority of E. histolytica infected individuals, and that 
lack of such protective responses in susceptible individu al could lead to the symptoms 
associated with amebic colitis. 
Materials and Methods 
Celllines, amebic components and reagents 
Human colonic adenocarcinomal celllines T84 and Caco-2 from ATCC (Rockville, MD) 
were used and maintained in DMEM-FI2 and MEM media respectively, supplemented 
with 10% fetal bovine serum, 100 U / ml penicillin, 1 00 ~g / ml streptomycin sulfate, and 
20 mM HEPES (Sigma). Human THP-l macrophages were maintained at 37 oC and 5 % 
COz in complete RPMI 1640 (GIBCO) supplemented with 10 % heat-inactivated FCS 
(Hyclone Laboratories). To obtain adherent macrophages, 2 x 106 cells / well in 6-well 
culture plates were allowed to differentiate in the presence of 10 nM PMA (Sigma) for 3 
days. Macrophages were washed and made quiescent by incubation in complete RPMI 
1640 medium for 24 h prior to co-culturing. Soluble Amebic Proteins (SAP) were 
prepared by three cycles of freeze-thaw lysis of log phase E. histolytica virulent strain 
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HMl:IMSS and quantified by the BCA assay (Pierce). E. histolytica secretory 
components (SC) were prepared as described previously (5). Fas Ligand and Caspase 3 
antibody are from Oncogene. Antibody against NF-B p65 & MAP kinases, double 
stranded NF-KB oligonucleotide (sc-2505) and aIl siRNA reagents are from Santa Cruz 
Bio Tech, CA. Anti IKK antibodies are from Cell Signaling Technology. Antibodies 
against human Hsp27, Hsp72, Hsp60, Hsp90, HSF-l phospho Hsp27 (SI5), phospho 
Hsp27 (ser 72) and hamster Hsp27 (Hsp25) are from Stressgen, Victoria, Canada. For 
immunoprecipitation, agarose conjugated Goat antibodies from Santa Cruz Botech. Inc 
were employed; Hsp27 (sc-1048), Hsp60 (sc-1722), Hsp72 (sc-1060) and Hsp90 (sc-
1055). For overexpression studies, hamster Hsp25 was used. PD98059 was obtained from 
Calbiochem. AlI other chemicals are from Sigma, St. Louis, MO. The inhibitors 
galactose, E-64, and cycloheximide were used at slightly higher concentrations than those 
have been previously demonstrated to have their intended effects (22-24). 
Co-culturing of epithelial cells with macrophages 
T84 or Caco-2 cells between 10-30 passages grown in either regular or transwell plates 
for 7-10 days to achieve confluency were used. For siRNA experiments, sub confluent 
(40-50%) Caco-2 cells, grown for 2-3 days were used. Human monocyte-like ceIl line 
THP-l was differentiated with PMA for 3 days and quiescence for 24 h before use. 
Transwells with epithelial ceIls were kept in culture plates containing 2x 106 macrophages 
for 24 h (30h for siRNA studies), removed from co-culture and immediately used for 
experiments. Epithelial ceIls were kept under low serum condition (5% fetal bovine 
serum) during co-culturing and subsequent treatments, and without antibiotics for siRNA 
studies. 
Western blot 
Cellular extracts from amebic protein treated epithelial cells were prepared by scraping 
into the sample buffer containing SDS and mercaptoethanol (ME) and boiled for 10 min, 
equal volumes were separated in 12% SDS-Polyacrylamide gels and transferred onto 
nitrocellulose membrane (Bio-Rad, CA). For non-reducing gel run, sample buffer 
without ME was used. The membranes were blocked in 3.5% skim milk-TBS-T (20mM 
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Tris-HCl (pH 7.5), 500mM NaCl. 0.1% Tween-20) at 4°C overnight, incubated with 
primary antibodies in 1 % skim milk-TBS-T at 4°C overnight, washed three times with 
TBS-T and incubated with HRP-conjugated secondary antibody in skim milk-TBST 
overnight at 4°C. After three washes each in TBS-T and TBS-3T, the blot was developed 
with the enhanced chemiluminescence system (Amersham Pharmacia Biotech, 
Piscataway, NJ) according to the manufacturer's instructions. 
Electrophoretic mobility shift assay 
Nuclear extracts were collected using the NE-PER kit (Pierce) and protein quantified by 
BCA assay. Annealed double stranded HSE oligonucleotide -107 to -83 of the human 
Hsp70 gene (S'-GAT CTC GGC TGG AAT ATT CCC GAC CTG GCA GCC GA-3') 
(Sigma Genosys, ON) or NF-KB consensus oligonucleotide (Santa Cruz Biotech) was 
labeled with e2p]-ATP, using T4 polynucleotide kinase (Invitrogen). Unlabeled 
nucleotides were removed using Sephadex G-25 columns. The binding reaction consists 
of 20 1 total volume of 0.5 ng of DNA probe, 5 g of nuclear extract, 1 g of poly dI-dC in 
the binding buffer (12 mM HEPES, 60 mM KCI, 4 mM MgCh, 1 mM EDTA, 1 mM of 
DTT and 12% glycerol) (pH 8.0), and incubation for 30 min at room temperature. DNA-
protein complexes were resolved by electrophoresis on 6% poly-acrylamide gels at 4°C in 
TBE buffer (90 mM Tris-borate, 2mM EDT A). Gels were subsequently dried and 
autoradiographed with intensifying screens at -70°C. 
Neutral red as say 
Neutral red (Sigma) was reconstituted in serum free medium and added to cells at 
1.14mM concentration. After 2 h of incubation, the medium was removed and the cells 
washed twice with PBS; finaIly, the incorporated neutral red was released from the cells 
by incubation for 15 min at room temperature in the presence of 2 ml of the extraction 
buffer containing acetic acid (l %, v/v) and ethanol (50%, v/v). To measure the dye taken 
up, the cell lysis products were centrifuged and supernatants spectrophotometrically 
measured at 540 nm. 
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Co-Immunoprecipitation 
Cells were lysed in 1 % CHAPS buffer (lOmM Tris-HCl, pH 7.4, 150mM NaCI with 1 % 
CHAPS) with protease inhibitor cocktail (Roche). 500 Ilg of cell extracts were incubated 
overnight with 5 Ilg of agarose conjugated anti HSP antibodies (Santa Cruz Biotech). 
Precipitate was washed thrice with lysis buffer, dissolved in 2x Lammeli buffer, boiled 
and separated by SDS-PAGE, transferred to nitrocellulose membrane and detected by 
western blot analysis using ECL (Amersham Biosciences). 
RNA interference 
Caco-2 cells were transfected with small interfering RNA (siRNA) against HSF-l (sc-
35611), Hsp27 (sc-29350), Hsp70 (sc-29352), or control siRNA (sc-37007) from Santa 
Cruz Biotech as per the manufacturer's protocol. Briefly, sub-confluent (40-50%) Caco-2 
cells were transfected using siRNA transfection reagent for 30 h during the co-culture at a 
siRNA concentration of 40nM. Cells were immediately used for SAP and subsequent 
treatments. 
Over expression of wild type and phosphorylation deficient-mutant Hsp27 in M-
IEC 
Plasmids (pcDNA3.1) encoding wild type hamster Hsp25 (WT) and phosphorylation 
deficient-mutant Hsp25 (AA) in which ser 15 and ser 90 are replaced by alanine were 
kindly provided by Dr. T. Tomako, McGill University, Montreal. Caco-2 cells were 
transfected with empty plasmid (vector), WT and AA by Fugene reagent (Promega) 
overnight according to the manufacturer' s instructions. A transfection efficiency of 50-
60% was observed using a GFP control. Cells were recovered for 24 h while 
simultaneously co-cultured with differentiated THP-l and then at the end of 24 h, 
conditioned IEC was treated with SAP and IL-l ~ as described before. 
In vitro kinase assay 
Cells were incubated with celllysis buffer (20mM Tris, pH 7.5, 150mM NaCI, 25mM p-
glycerophosphate, 2mM EDT A, 2mM pyrophosphate, ImM orthovanadate, and 1 % 
Triton X-IOO, ImM DTT, ImM NaF with protease inhibitors) followed by addition of 
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anti IKK-a antibody. Following ovemight end-to-end rotation of tubes at 4°C, 
immunoprecipitates were washed 3x with lysis buffer and once with kinase buffer 
(20mM Tris, pH 7.5, ImM MnCh, lOmM MgC}z, 20mM ~-Glycerophosphate, O.lmM 
sodium orthovanadate, 2mM NaF and ImM DTT). Immunoprecipitates were finally 
resuspended in 20.0 III of kinase buffer containing 51lCi of [y 32p] ATP and incubated at 
30 ° C for 30 min. 1 Ilg of GST-IKBa (Santa Cruz Biotech) was used as substrate. The 
reaction was terminated by boiling with SDS sample buffer for 5 min. Finally, the protein 
was resolved on 10% SDS-PAGE, the gel was dried, and the radioactive bands were 
visualized by autoradiography. Cell lysates were also checked for IKK-a expression for 
normalization. 
TNF -0; ELISA 
Culture supematants collected from cells treated or not with SAP (for 12 h) and IL-l ~ 
(for 8 h) and quantified for TNF-a protein. DuoSet ELISA development system from 
R&D systems was used to check the TNF-a secretion from IEC according to 
manufacturer's protocol. Briefly, ELISA plates were coated with capture antibody 
ovemight, washed with PBS-T, incubated with 100 ~l of supematnant from the culture 
medium for 2h at room temperature followed by wash and further incubation with 
detection antibody for another 2 h at room temperature. Streptavidin-HRP was then 
added to wells for 20 min followed by substrate solution (1: 1 mixture of H20 2 and 
tetramethylbenzidine). Stop solution (2N H2S04) was added and optical density measured 
immediately at 450nm and 540nm. Readings at 540nm were suubstracted from those at 
450nm. Protein estimation in sainples was done from the standard curve as per the 
protocol. 
Statistical analysis 
Blots were scanned and densitometric values obtained by usmg Image J program. 
Statistical analysis to check significance was done with Student's t test using Prism 
software. Graphs plotted were from two to three independent experiments and error bars 
in aIl graphs represent mean ± SD. 
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Results 
Differentiai induction of Hsp27 and Hsp72 in naive and macrophage conditioned 
epithelial cells 
As the induction of Hsps is a universal stress response against various insults and has 
been widely shown to have an anti-inflammatory effect, we checked the expression of 
Hsps representing four families. While soluble amebic protein (SAP) treatment 
suppressed Hsp27 and Hsp72 in naïve IEC (Fig. 7.1A), the same two Hsps were 
significantly over expressed in macrophage-conditioned Caco-2 and T84 colonic 
epithelial cens (Fig. 7.1B). Expression levels of Hsp60 and 90 remained unaltered in both 
naïve and conditioned IEC (not shown). Surprisingly, even though both secretory 
components (SC) and SAP elicited this stress response, SAP was consistently found to be 
twice as potent as SC (Fig. 7.1 C) and was therefore used for an further studies. It should 
be noted that co-culturing alone did not affect the basal HSP expression significantly 
(Fig. 7.IB). AIso, treatment of IEC with 24 h THP medium was sufficient to prime 
epithelial cens for ameba induced Hsp72 induction (Fig. 7.2) without the need for co-
culturing. This confirms that macrophage secretions can alter epithelial cen responses to 
pathogen. 
Ameba induced Hsp72 expression is ERK MAP kinase dependent 
Mitogen activated protein kinases (MAPK) play important roles in regulating both 
inflammatory and stress responses (12) and HSPs have been shown to be regulated by 
different MAPK in intestinal epithelial cens (16, 25). Hence, we checked if ameba 
induced expression of Hsp27 and 72 are regulated by MAPK. As shown in Fig. 7.3A, 
when the conditioned epithelial cens was pre-treated with PD98059, an ERK MAPK 
inhibitor, SAP-induced Hsp expression was significantly inhibited. Correspondingly we 
observed the activation ofERK MAPK by amebic proteins as early as 30 min (Fig. 7.3B). 
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Fig. 7.1: Differentiai regulation of Hsps in naive and macrophage conditioned epithelial 
ceUs. A) Expression of Hsps in response to amebic lysate in naive epithelial cens. lOO Jlg/ml of 
soluble amebic proteins (SAP) were added to naive Caco-2 cens and cell lysate conected at 
different time points and checked for the Hsp expression by Western blot as described in 
methods. B) Caco-2 cens were co-cultured with differentiated THP-l cens for 24 h and 
immediately stimulated with lOO Jlg/ml of SAP for different time periods and equal volumes of 
cell extracts in Laemelli sample buffer were subjected to SDS-PAGE and Western blot. A 
representative blot from 3 independent experiments is shown. (*** P<O.OOI; ** P<O.OI). 
Bottom panel shows representative blots from T84 cens. C) Caco-2 cens were co-cultured with 
THP-l as described and stimulated with 100 Jlg/ml of SAP or ameba secretory components for 12 
h and checked for Hsp27 expression. (** P<O.OI; * P<0.05) 
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Fig. 7.2: Macrophage secretions prime IEC for Hsp induction. Caco-2 cells were treated with 
24 h macrophage culture medium for 12 h before stimulating with SAP for different time points 
and checked for Hsp72 expression by Western blot. Representative blots from two experiments 
are shawn. (**, P<O.OI; * P<O.05) 
E. histolytica induction of Hsp72 is independent of Gal-lectin and cysteine 
proteinase 
The three weIl recognized virulent factors in E. histolytica are the surface adhesin 
Gal!GalNac lectin, cysteine proteinases and amebapore. The pathogenic effects of the 
Gal-Iectin and cysteine proteinases have been extensively documented (26) and it was of 
interest to determine if the up-regulation of Hsp72 is mediated by these virulent factors. 
As shown in Fig. 7.4, pretreatment of SAP with either galactose or E-64 failed to inhibit 
Hsp72 expression indicating that Hsp induction by SAP is independent of Gal-Iectin and 
cysteine proteinases. In contrast, significant abrogation of Hsp72 induction was noted by 
boiled SAP, suggesting a yet to be characterized protein moiety might be responsible for 
this effect. 
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Fig. 7.3: Ameba induced Hsp expression in macrophage-primed IEC is dependent on ERK 
MAP kinase. A) Macrophage conditioned IEC (M-IEC) were pretreated with ERK MAP kinase 
inhibitor PD98059 at different concentrations for 2 h and then stimulated with SAP (100 Ilg/rnl) 
for 12 h. (*** P< 0.001). B) M-IEC treated with SAP for different time points and cell 
extracts probed with antibody against ERK MAP kinase. The blot shown is representative of 
three independent experiments. 
Amebic components induce Hsp72 via heat shock factor (HSF)-l 
We then studied the mechanism of up-regulation of Hsp72 by amebic components. 
Quercetin is a flavanoid compound and a known inhibitor of Hsp synthesis by inhibiting 
HSF-1 (27, 28) and it was of interest to determine if it could inhibit SAP-mediated Hsp72 
induction. As shown in Fig. 7.5A, quercetin (25 f.lM) significantly inhibited Hsp72 
expression. Quercetins at high concentrations are known to inhibit protein synthesis. 
Thus, to confirm that quercetin inhibits SAP induced Hsp72 expression by inhibiting 
HSF-1 and not by inhibiting Hsp protein synthesis, we treated the cells with an equi-
molar concentration of cycloheximide, an inhibitor of protein synthesis. Under these 
conditions cycloheximide treatment failed to inhibit SAP induced Hsp72 expression, 
confirming that amebic components, indeed, induce Hsp synthesis by activating HSF-l. 
To conclusively prove the role of HSF-1 in ameba induced Hsp synthesis, we silenced the 
HSF-1 gene by si RNA (Fig. 7.5B) and observed inhibition of Hsp72 expression by SAP 
in macrophage treated epithelial cells (Fig. 7.5C). Consistent with its role in regulating 
Hsp72 expression, HSF-1 was activated by amebic proteins as shown by Western blot 
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analysis (Fig. 7.5D). We found that arnebic components were able to induce trimerization 
of HSF-l in macrophage conditioned IEC (M-IEC) at a time point of 3 h. There was a 
corresponding increase in the DNA binding activity of HSF-l, which was inhibited by 
pre-treatment with quercetin (Fig. 7.5E). These studies confirm that amebic components 
activate HSF-l which in turn is inducing Hsp gene expression. 
c SAP 
Boiled Gal E64 
Hsp72 
Fig. 7.4: SAP induced Hsp72 induction is independent of GaI-lectin and cysteine protease. 
SAP was treated with 150mM of D-Galactose or l00J1M of E-64 for 1 h or boiled at 100° C for 5 
min before adding to the M-IEC for 12 h. Western blot was done as described in experimental 
procedures. NS= Not significant. (** P<O.OI) 
Heat shock response by amebic components inhibits NF -lCB activation and TNF-a 
secretion induced by IL-IP 
As NF-KB was shown to be the key mediator of colonic inflammation in amebic infection 
(4) and stress response is increasingly being shown to inhibit this molecule (12, 17- 20), 
we studied the activation of NF-KB following amebic protein treatment. For this we 
treated M-IEC with SAP for 12 h and then stimulated with IL-lp, a prototypical NF-KB 
activator. As shown, pre-treatment with arnebic proteins inhibited NF-KB-DNA binding 
activity (Fig. 7.6A), nuclear translocation of NF-KB p65 subunit (Fig. 7.6B) and IKB-a 
phosphorylation (Fig. 7.6C) induced by IL-lp in macrophage conditioned colonic 
epithelial cells. We also checked the effect of SAP treatment on TNF-(X. secretion. As 
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shown (Fig. 7.6D), pretreatment of M-IEC with SAP significantly inhibited IL-l~ 
induced TNF-a secretion. 
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SAP(3h} 
C QC 
Fig. 7.5: Amebic protein induced Hsp72 expression is mediated by HSF-l. A) M-IEC were 
treated with 25!1M of Quercetin (QC) or cyclohexirnide (chx) for 2 h before stimulating with SAP 
for 12 h. (** P<O.01). B) M-IEC transfected with different concentrations of siRNA against 
HSF-l for 30 h as described in Methods. CeIllysates subjected to SDS-PAGE and Western blot 
was done with HSF-l antibody. C) M-IEC cells were transfected or not with 40 nM HSF-l 
siRNA for 30 h before treating with SAP for 12 h and checked for Hsp72 expression by Western 
blot as described. D) M-IEC was treated with SAP for different time points and cell extract 
collected and ran in a non-reducing gel and Western blot done with HSF-l antibody as described. 
Arrows indicate activated dimeric and trimeric forms of HSF-l. E) M-IEC was incubated or not 
with quercetin (25!1M) for 2 h prior to treatment with SAP (lOOllg/rnl) for 3 h. 1O.01lg of nuclear 
extracts subjected to EMSA as described. Blots shown are one of two to three replicates. 
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Fig. 7.6: Amebic proteins inhibit IL-lI} induced NF-KR activation and TNF-a. secretion. A) 
M-IEC were treated with SAP (lOO,...g/ml) or medium for 12 h before stimulating with 5.0ng/ml 
of IL-lp for 30 min. 1O.0,...g of nuclear extract was subjected to EMSA using NF-KB consensus 
oligonucleotide as described in the experimental procedures. Arrows indicate NF-KB-DNA 
complexes. B) Cells were treated with IL-lp with or without prior treatment with SAP and 
nuclear extract collected at different time points and Western blot done to check the NF-KB p65 
subunit. Top panel shows p65 nuclear translocation with IL-lp alone. Bottom panel was from 
cells pretreated with SAP. Membranes were stripped and re-probed with anti-histone antibody for 
normalization (not shown). C) Western blots of whole cell extracts showing the phosphorylation 
status of IKB with IL-lp alone (top panel) or following SAP treatment and IL-lp stimulation 
(bottom panel). D) Culture supernatants tested for TNF-a. by ELISA as described in methods. 
*** (p<0.005). E) M-IEC transfected or not with HSF-l siRNA was treated with SAP or 
medium al one for 12 h before stimulating with IL-lj3 for 30 min. In vitro kinase as say was done 
following immunoprecipitation with IKK-a. as described in methods. Top panel shows kinase 
assay using GST-IKB as substrate. Bottom panel is Western blot of celllysate to confirm equal 
quantities of IKK-a.. AlI blots shown are one of two to three experiments. 
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Ameba induced stress response inhibits IKK activity via Hsp27 
As IKB is phosphorylated by IKB kinase (IKK), we checked IKK activity in an in vitro 
kinase assay. As shown in Fig. 7.6E, amebic pretreatment suppressed IL-l~ induced IKK 
activity. Moreover, when HSF-1 gene was silenced by siRNA, this suppression was 
abrogated suggesting that stress response is involved in this suppression. Thus, to 
precisely identify which HSP mediates this effect we silenced Hsp27 and 72 and checked 
the IKK activity. As shown in Fig. 7.7A, silencing Hsp27 significantly restored IKK 
activity while Hsp72 did not have a significant effect on this suppression. We observed a 
significant suppression in the expression of both Hsp27 (not shown) and Hsp72 (Fig. 
7.7B) by siRNA. 
A B 
SAP + + + + 
IL-lp + + + + + 
Si RNA Ctl 27 72 C siRNA Ctl 20nM 40nM 
IKA:IKB·a Hsp72 
ffi:IKK-a -. ....... ~ ........ ~ Actin 
Fig. 7.7: Hsp27 mediates amebic protein induced inhibition of IKK activity. A) M-IEC 
transfected with control, Hsp27 or Hsp72 siRNA were treated with SAP for 12 h followed by 30 
min stimulation with IL-l~. Kinase assay was done using IKB as substrate (top panel) and IKK-a 
level checked for normalization (bottom panel). B) M-IEC were transfected with either control or 
Hsp72 si RNA for 30 h as described and cell extracts probed with Hsp72 antibodies. 
Heat shock proteins associate with IKK complex in IEC and amebic components 
enhance this interaction 
Hsps are known to associate with IKK complex and modulate its activity in other cell 
lines (20, 29). Hence, for the first time we checked the interaction between Hsps and IKK 
in intestinal epithelial cells and found that Hsp27, 60 and 90 associate with IKK-a (Fig. 
7.8A) and treatment with SAP increased the association of Hsp27 with IKK-a by twofold 
(Fig. 7.8B). As expected, siRNA of Hsp27 reduced this association. Results from Figs. 
7.7A and 7.8B together confirm that Hsp27 negatively regulates IKK activity. AlI the 
Hsps tested, Hsp27, 60, 72 and 90 interacted with IKK-~ in Caco-2 IEC (Fig. 7.8A) and 
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agalO Hsp27 interaction with IKK-~ was also enhanced by SAP treatment (data not 
shown). 
A 
IP with anti Hsp 
27 60 72 90 Ctl Ig 
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IKK·a 
(Celllysate) 
Hsp27 
Fig. 7.8: Hsps associate with IKK complex in intestinal epithelial cells. A) Co-
immunoprecipitation of IKKs with Hsp antibodies. Macrophage conditioned Caco-2 celllysates 
were immunoprecipitated with antibodies against different Hsps ran on a reducing gel and probed 
with anti IKK-a or IKK-p antibody. Who le celIlysates checked for IKK-a and IKK-p expression 
(bottom 2 panels). B) Amebic proteins enhance the interaction between Hsp27 and IKK-a. M-
IEC transfected or not with Hsp27 siRNA were treated with SAP (100Jlglrnl) for 12 h, lysates 
coimmunoprecipitated with Hsp27 and checked for IKK-a by SDS-PAGE and Western blot. 
Relative densitometric values of the bands are shown. Equal quantity of celIlysates was probed 
with Hsp27 and IKK-a (bottom panels). AlI experiments were repeated two to three times and 
representative Western blots for each are shown. 
Phosphorylation of Hsp27 is required for interaction with and inhibition of IKK 
In order to confirm that Hsp27 mediated IKK inhibition in IEC and to fully understand 
the mechanism involved, we overexpressed wild type (WT) and phosphorylation 
deficient mutant of hamster Hsp25 (AA) in conditioned epithelial cells (Fig. 7.9A). 
Transfected M-IEC was treated with SAP and checked for interaction between Hsp25 and 
IKK-u. As shown in Fig. 7.9B, while over expression of Hsp25WT enhanced SAP 
induced association with IKK-a, Hsp25AA significantly inhibited this interaction. 
Consistent with the negative regulation of IKK by Hsp27, this decreased interaction 
between IKK-u and Hsp27 abrogated the inhibitory effect of SAP on IKK activity, seen 
as restored I1d3 phosphorylation and NF-KB p65 nuclear translocation (Fig. 7.9C). 
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Consistently, we observed that SAP induced a delayed but significant phosphorylation of 
ser 15 Hsp27 in M-IEC (Fig. 7.9D). 
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Fig. 7.9: NF-lCB inhibition by SAP requires phosphorylation of Hsp27. A) Conditioned IEC 
were transfected with vector, wild type or mutant Hsp25 plasmids during co-culture as described 
and whole cell lysates were subjected to SDS-PAGE and probed with antibodies against hamster 
Hsp25 and actin. B) M-IEC over expressing hamster Hsp25 plasmids were treated with SAP for 
12 h and lysates subjected to immunoprecipitation using anti hamster Hsp25 or control rabbit IgG 
antibody followed by Western blot using IKK-u antibody. Cell lysates from same cells were 
probed with IKK-u. C) Conditioned IEC transfected with vector, wild type or mutant Hsp25 
plasmids were pre- treated or not with SAP and IL-l~ and whole celllysates checked for phospho 
IKB-a, by Western blot as described. Bottom panel: 10 J..lg of nuclear extracts from cells treated 
similarly were probed with anti p65 antibody. D) M-IEC treated with SAP for different time 
periods and celllysates probed with phospho ser 15-Hsp27 and actin. Representative blots from 
at least two different experiments were shown. 
Ameba induced stress response in conditioned epitbelial cells bas cytoprotective 
function 
As Hsps also have cytoproteetive abilities in different cells, we eheeked if amebic 
proteins ean proteet IEC against injuries eaused by diverse agents. As shown in Fig. 
7.lOA, pretreatment with SAP signifieantly inereased ceIl viability foIlowing oxidative 
injury by hydrogen peroxide and reduced easpase-3 cleavage induced by the apoptotie 
agent, Fas L (Fig. 7. lOB). 
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Fig. 7.10: Amebic proteins confer protection against oxidative and apoptotic injuries. A) M-
IEC were treated with SAP (lOOllglml) for 12 h and then incubated with lOrnM of hydrogen 
peroxide for further 12 h and cell viability was checked by neutral red assay as described. 
** P<O.OI compared to control; * P<0.05 compared to H20 2 alone. NS= Not significant. B) M-
IEC (T84 cells) were exposed to SAP (lOOllglml) for 12 h before treating with 1.0 Ilglml of Fas L 
for 12 h. Cleavage of Pro caspase-3 was exarnined by Western blot. The experiment was repeated 
three times and one representative blot is shown. 
Discussion 
In this study we show that SAP have protective effects mediated by Hsps on intestinal 
epithelial cells. Interestingly, the Hsps were induced only in epithelial cells that have 
been exposed to macrophage secretions for 24 h but not in the naive IEC. We made 2 
novel observations: one, this is the first report on the protective effect of amebic proteins, 
and secondly, that macrophage secretions can prime epithelial cells to elicit stress 
responses. 
Co-culture systems have been popular owing to their better simulation of in vivo situation 
wherein epithelial and immune cells exist in close proximity and respond to each other 
components. Several studies reported a differential epithelial response, mostly with 
respect to cytokines, following exposure to immune cells. Two recent studies reported 
the induction of Hsp25 and Hsp72 in mouse intestinal epithelial cells co-cultured with 
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lymphocytes and IL-2 was found to be the mediator (13, 16). We made the novel 
observation that intestinal epithelial cells express Hsps in response to amebic proteins 
following exposure to macrophage secretions. 
Notably, basal Hsp expression remams unchanged in macrophage conditioned IEC 
suggesting that epithelial cells are only primed rather than activated by macrophage 
secretions. The cross talk between macrophages and IEC could be bi-direction al in the 
sense that macrophages also respond to epithelial secretions such as MCP-l and TGF-p 
(30). However, amebic proteins could induce Hsp72 in epithelial cells that have been 
incubated with macrophage secretions without co-culturing; suggesting that epithelial cell 
modification of macrophages is not required to elicit a differential epithelial response. As 
differentiated THP-l cells are shown to constitutively produce a variety of cytokines su ch 
as TNF-a, IL-l p, IL-6, IL-8 etc. (31) and IL-l p induce Hsp expression (32), we checked 
the role of these cytokines in priming the IEC. Adding neutralizing antibodies against 
TNF-a and IL-lp in the macrophage medium did not significantly inhibited ameba 
induced Hsp expression (data not shown). Previous studies (33) have shown that co-
culture with activated PBMC altered T84 epithelial cell physiology and that exogenously 
added TNF-a or IFN-y did not mimic the changes induced by immune cells. This 
suggests that mediators in immune cell secretions have an effect (both adverse and 
beneficial) on epithelial responses but their identities are not known. 
IEC are known to express Hsps in response to diverse insults such as pathogens, 
pathogen specific molecules and chemicals and immune cells can alter this response. 
Accordingly, we checked the expression of four Hsps belonging to different families and 
found specific up-regulation of Hsp27 and 72 but not Hsp60 and 90 (data not shown) by 
SAP. Our observation of involvement of ERK MAP kinase in ameba induced Hsp 
expression is consistent with previous reports (16, 34, 35) and extends the CUITent 
thinking that MAP kinases play an important role in regulating both inflammatory and 
stress pathways. After establishing that amebic proteins induce Hsps in macrophage 
primed epithelial cells by activating heat shock transcription factor (HSF)-l, we 
proceeded to check the functional significance of this phenomenon. As our objective was 
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to understand how colonic inflammation was absent in the majority of infected 
individuals and given the evidence that Hsps suppress NF-KB activation, we critically 
analyzed if and how Hsps induced by amebic proteins inhibits IL-1~ mediated NF-KB 
activation. We chose IL-1~ for two reasons; one is it is a prototypical NF-KB inducer and 
secondly, it was shown to play a role in ameba induced colitis (2, 36). Moreover, 
inhibiting NF-KB significantly reduces amebic colitis in a mouse model of intestinal 
amebiasis (4). NF-KB is a ubiquitous transcription factor that regulates a number of genes 
involved in inflammation and immune response (37). Activation of this transcription 
factor is critically regulated at multiple steps. Recently, the inhibitory effects of Hsps on 
NF-KB activation are increasingly being demonstrated in different cell systems. Hsp72 
has been found to associate with P65 subunit of NF-KB and inhibits the latter's nuclear 
transport in T -cells (38) and Hsp27 has been shown to be a ubiquitin binding protein 
regulating the degradation of IKB expression thereby indirectly influencing NF-KB 
activation (39). Recent studies show that IKK complex is the potential target for Hsp 
inhibition of NF-KB pathway (17, 18,40). In particular, one study showed that Hsp27 
interacts with IKK complex and negatively regulates its activation by TNF-a (20) in 
HeLa cells. As SAP increased Hsp72 expression and inhibited IL-1~ induced NF-KB p65 
nuclear translocation, we checked for their interaction in IEe but failed to see any 
association (data not shown). We found that IKB phosphorylation was also inhibited 
which was a direct result of reduced IKK activity by SAP treatment. SiRNA technology 
has rapidly become a revolutionary tool for efficient silencing of gene expression in a 
variety of experimental settings (41). We exploited this powerful system to silence Hsp 
genes to understand their role in ameba mediated suppression of IKK activation and 
found that silencing HSF-1 or Hsp27 but not 72 resulted in significant abrogation of this 
inhibition. As different Hsps interact with and regulate IKK complex, we checked if 
amebae-induced Hsps interacted with the IKK subunits in intestinal epithelial cells. For 
the first time, we reported an association between IKK and Hsps in IEe. Hsp27, 60 and 
90 constitutively interact with IKK-a and the interaction of Hsp27 with IKK-a was 
strongly enhanced following SAP treatment. While Hsp27 and Hsp90 have been 
previously shown to associate with the IKK complex, this is the first report of the 
184 
interaction between Hsp60 and IKK. Our observation that an Hsps tested interacted with 
IKK-p is surprising but could be attributed to the use of mild detergent (CHAPS) in the 
celllysis buffer for co-immunoprecipitation. We found that Hsp27 association with IKK-
p was also increased by amebic protein treatment (not shown). Previous report (20) 
showed that Hsp27 association with IKK-p but not with IKK-a increased in response to 
TNF-a. The reason(s) for this selective interaction is unc1ear. 
As posttranslational modifications of Hsp27 are known to regulate its biological activity 
(20), we tested the role of phosphorylation of Hsp27 in its ability to inhibit NF-KB 
activation. Overexpression of phosphorylation deficient mutant of hamster Hsp25 (at 
serine 15 and 90) in IEC resulted in significant reversaI of NF-KB inhibition by amebic 
proteins. There are two sites phosphorylated in hamster Hsp27 (SerI5, Ser90) and three 
in human (15, 78, 82). Ser78-Ser82 of human Hsp27 probably works in tandem as the 
equivalent of the unique Ser90 in hamster Hsp25. We also observed that SAP induces 
significant phosphorylation of serine 15 (Fig.7.9D) but not ser72 (data not shown) after 
prolonged treatment in M-IEC. As Hsp27 phosphorylation depends on p38 MAP kinase 
(20), this could have resulted from a delayed activation of p38 MAP kinase as we did not 
find either p38 (data not shown) or Hsp27 phosphorylation in the early time periods of 1 
h. Nonetheless it is c1ear that overexpression of Hsp27 amplified the SAP effects while 
blocking the Hsp27 phosphorylation significantly abrogated the amebic inhibitory effect 
on NF-KB activation. These studies confirm and further strengthen the concept that post-
translational modifications, particularly, the phosphorylation of Hsp27 plays an important 
role in NF-KB regulation via inhibiting IKK activity. Extending our observations on the 
protective effects of ameba induced stress responses we also showed that prior treatment 
with amebic proteins protected the epithelial cells against hydrogen peroxide and Fas L 
treatment. This is not surprising in view of the potent apoptotic inhibitory effects of 
Hsp72 (42-43). In fact, both Hsp27 and 72 are powerful chaperones and inhibit key 
effectors of the apoptotic machinery inc1uding apoptosome, caspase activation complex 
and apoptosis inducing factor (44). While this observation supports the anticipated 
protective effects of stress response, its functional significance with respect to ameba 
pathogenesis is difficult to surmise. Contact dependent apoptosis induction by E. 
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histolytica was reported in immune cells such as neutrophils, T -cells and erythrocytes 
(23, 45, 46). It was aiso shown that E. histolytica preferentially ingests apoptotic Jurkat 
T - cells. But hitherto no data is present on epitheliai cell apoptosis by the parasite. 
Assuming a similar phenomenon for epitheliai cells, it is reasonable to argue that stress 
response by the host is an efficient way to circumvent parasite induced cell death. At 
present, it is not known what soluble amebic molecule(s) is responsible for the induction 
of Hsp. In summary, we have shown that amebic proteins can inhibit NF-KB activation 
and promote cell survival via stress protein expression in macrophage primed intestinal 
epithelial cells (Fig. 7.11). These studies for the first time, demonstrate a potential 
mechanism by which intestinal inflammation induced by E. histolytica might be inhibited 
in majority of infected individuals and suggests that amebic colitis could result from the 
lack of such protective responses to suppress pro-inflammatory cytokine induction in a 
minority of susceptible individuals. 
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Fig. 7.11: Schematic mode) for suppression of amebic colitis. Soluble amebic proteins activate 
the heat shock transcription factor-l to form trimers from its inactive monomers. Activated HSF-
1 induces the expression of Hsp27 and Hsp72, which perform different functions. Phospho-Hsp27 
associates with IKK and inhibits its activity thereby suppressing NF-KB activation induced by the 
proinflammatory cytokines released in response to amebic infection. Suppression of NF-KB 
favors increased apoptosis. However, Hsp72, which apparently does not play a role in NF-KB 
signaling in IEC, rnight function to promote cell survival through its potent anti apoptotic activity. 
Together the stress response induced by amebic proteins functions to inhibit intestinal 
inflammation and promote cell survival. 
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SECTION III: GENERAL DISCUSSION 
In this work, 1 addressed sorne of the unsolved puzzles in the early interactions between 
the enteric protozoan parasite E. histolytica and host cells. The parasite virulence factor 
Gal-Iectin plays a key role in the colonization of the pathogen and host cell killing. In this 
regard, its properties as surface adhesin and as a receptor to initiate intracellular signaling 
within the parasite have been weIl documented. However, its immunological properties 
are increasingly being appreciated. It is highly antigenic and able to activate host immune 
system. For these reasons, its potential as a vaccine candidate is studied extensively and 
indeed a majority of researchers reported successful protection against amebic infection 
in various models of amebic liver abscess. One recent report showed a protection in a 
burgeoning mouse model of intestinal amebiasis (1). While Gal-Iectin induces good 
antibody response, this alone fails to exp Iain its efficiency as vaccine, as humoral 
immunity was not found to be sufficient for protection against the disease. In our 
laboratory attempts were made to study the ability of the Gal-Iectin to activate cell 
mediate immunity. Indeed we found that purified native Gal-Iectin is able to induce 
inflammatory cytokines such as TNF-(l and IL-12 from macrophages. As these cytokines 
can activate immune cells to kill ameba, their induction by Gal-Iectin is an important 
means of conferring resistance to host. 
Discovery of Toll like receptors (TLR) is a major breakthrough in our understanding of 
innate immune system. Multiple signaling cascades are activated by TLRs that in 
majority of cases result in the activation of NF-KB. NF-KB is a ubiquitous transcription 
factor which regulates the expression of a number of genes involved in inflammation, 
immune response and apoptosis. Its activation could be a double edged knife. A mild 
inflammation mediated by NF-KB could eliminate the pathogens and signal the adaptive 
immune system. However an uncontrolled severe inflammation leads to indiscriminate 
host tissue damage. Interestingly, expression of sorne TLRs is also regulated by this 
transcription factor. Its elevated expression during inflammatory bowel disease suggests 
it plays a dominant role in gut inflammation (2). 
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Our observation that the Gal-Iectin could up-regulate TLR-2 expression in macrophages 
has dual significance. Increased TLR-2 makes the immune ceIls more responsive to a 
number of opportunistic pathogens in gut. This results in amplifying the ToIl signaling, 
NF-KB activation and inflammatory cytokine production by lamina propria immune ceIls, 
thus initiates or aggravates the inflammation. The cytokines secreted by lamina propria 
immune cells could also alter epithelial response to intestinal pathogens or commensals 
(3). Gal-Iectin cou Id come in contact with underlying immune ceIls by two means; either 
by translocation of Gal-Iectin from lumen to lamina propria through epithelial ceIls (4) or 
following the breach of epitheliallayer by the amebic trophozoites. Recent report showed 
that another amebic molecule lipophosphoglycan (LPPG) activates both TLR-2 and TLR-
4 to induce TNF-a, IL-l2 and IL-8 in monocytes (5). Thus, increased TLR-2 expression 
by Gal-Iectin could act synergisticaIly with LPPG and amplify the ameba induced colonic 
inflammation. Destruction of mucosal barrier by trophozoites exposes immune ceIls to 
amebic Gal-Iectin or LPPG and other microbial TLR-2 ligands which aggravates the 
existing inflammation. Rence, we propose that this occurs in 1 % of individuals who show 
the severe symptoms of dysentery or extra-intestinal amebiasis, which are associated with 
extensive colonic tissue destruction. Another aspect of Gal-Iectin induced up-regulation 
of TLR-2 is with regard to the use of the lectin as a vaccine to induce protective Thl 
responses. Activation of immune ceIls via TLRs has been shown to skew the immune 
response towards Thl type and hence it is logical to think that increased Toll signaling 
would confer better protection against amebiasis. In this context, a combined Gal-Iectin 
and LPPG vaccine would work better than either of them alone. Even in the absence of 
LPPG, increased TLR-2 expression by the Gal-Iectin could enhance TLR activation by 
ligands present widely in gut commensals. Despite aIl the observations about the Gal-
lectin ability to activate immune cells, its receptor remained elusive. Indeed, efforts are 
now on in our laboratory to check if TLR-2 is a potential receptor for the Gal-Iectin. In 
short, our work unraveled a new facet of TLR involvement in the pathogenesis of 
amebiasis. 
Our observation of monocyte chemotactic protein (MCP)-l induction by amebic 
components is not surprising. MCP-l is chemoattractant for monocytes/ macrophages 
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and T-cells. While infiltration of neutrophils early in the amebic lesion is explained by 
induction of IL-8, the mechanism for subsequent horning of monocytes, lymphocytes or 
eosinophils remains unanswered. We showed for the first time that amebic soluble factors 
can induce MCP-1 production in IEC, resulting in the recruitment and activation of 
macrophages. While this alone is exciting, the mechanism of MCP-1 induction is quite 
novel. Amebic activation of PI3 kinase phosphorylates Akt and p65 subunit of NF-KB, 
thus inducing MCP-1 gene expression. However, it is not c1ear from our studies whether 
PI3 kinase or Akt directly phosphorylates p65 su bu nit or do so via other kinases. Further 
studies are required to completely understand the signaling events activated by the 
parasite in intestinal epithelial cells. Previously it has been shown that ameba induces IL-
8 via post-transcriptional regulation. Together, these studies suggest that the ho st 
developed diverse means to sense the presence of the parasite and to signal the immune 
system. The secretion of chemokines by IEC is beneficial during the non-invasive phase 
of infection, as the recruited immune cells wou Id rapidly kill any pathogen that tries to 
breach the barrier. This could also result in host tissue damage and form the foci of 
infection for the trophozoites. Indeed, depletion of neutrophils has been shown to make 
the mice more susceptible to intestinal amebiasis (6) and the in vivo significance of our 
observation needs a similar investigation. Nonetheless, it is c1ear that macrophages do 
home to lesion and could possibly play a role in pathology. We propose this could be 
occurring in the 10% of the individuals that show the symptoms of colitis and diarrhea. 
Most of the pro-inflammatory molecules su ch as TNF-a, iNOS, COX-2 etc. are regulated 
by the classical NF-KB activation involving IKK activation. Our failure to see any IKK or 
MAP kinase in the previous study leads us to study if amebic components could suppress 
NF-KB, the key inflammatory mediator. As 90% of infected hosts remain asymptomatic, 
we hypothesize that anti-inflammatory responses operate in majority of cases. Even in 
biopsy samples of late invasive lesions from amebiasis patients, trophozoites are found in 
the muscular layer in the absence of any tissue damage and inflammatory infiltrate (7). 
Keeping these observations in view, our primary objective was to begin exploring the 
protective host responses that cou Id inhibit inflammation. We focused on stress response 
as a potential means to suppress NF-KB for many reasons; it is a universal response to 
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diverse stimuli inc1uding pathogens, there are confirmed reports on the ability of heat 
shock proteins to inhibit NF-1d3 in different cell types inc1uding IEe. When we failed to 
see the induction of Hsp expression in naive epithelial cells, we undertook the transwell 
system in order to mimic the in vivo situation where the baso-Iateral surface of IEe is 
exposed to the secretions of immune cells. While previous studies utilized peripheral 
blood mononuc1ear cells, we employed differentiated THP-l cells which more c10sely 
mimic the tissue macrophages. AIso, using specific cell type would give better 
mechanistic details on cellular interaction. For the first time we reported that 
macrophages can prime IEe for stress response during infections. This is also the first 
observation that ameba can elicit a protective host responses. So far studies have been 
attempting to understand how the disease occurs (which is only in 10% cases) rather than 
why there is no disease (90% of cases) and focused on pro-inflammatory responses from 
host cells. Our observation that heat shock protein induction in response to amebic 
components inhibiting NF-KB and apoptosis in IEe is significant both for the amebic 
pathogenesis and epithelial biology. This is the first report demonstrating the anti-
inflammatory function of Hsp27 in intestinal epithelial cells. The precise mechanism of 
Hsp27 mediated suppression of IKK activity needs extensive biochemical 
characterization. The most plausible explanation seems to be a steric hindrance of 
catalytic domain but inhibition of IKK-a or IKK-~ in different cell types suggests 
additional factors might play a role. While in Hela cells, phosphorylated Hsp27 associates 
with IKK-~ following TNF-a treatment, in IEe we observed an increased association 
with both IKK-a and IKK-~ in response to amebic components. Subtle differences in the 
physical assembly of IKK complex in different cell types might also account for these 
differences. Suppression of TNF-a by amebic components is a novel finding that could 
potentially explain the absence of inflammation. This cytokine has been implicated in gut 
inflammation during various conditions such as IBD and also amebiasis. Importantly, this 
cytokine is primarily regulated by the c1assical NF-1d3 activation that requires IKK 
activation, I1d3 degradation and nuc1ear translocation of p65/p50 dimer. By suppressing 
IKK activity while maintaining the post-translational activation of p65, intestinal 
epithelial cells appear to maintain a tight regulation of NF-1d3 and consequently the set of 
genes that can be activated in response to a specific stimulus; as demonstrated in our 
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work wherein IEC produce MCP-l but not TNF-a in response to ameba. Other NF-KB 
regulated genes such as iNOS that require IKK activation might also be suppressed in 
IEC and we propose this could be occuring in 90% of amebic infections. It should be 
mentioned that from a recent in vivo mouse chimera studies, Hamano et al. (8) 
demonstrated that hemopoeitic cell derived IL-lO is required for non-hemopoeitic cell 
mediated protection against intestinal amebiasis. This work confirms the concept that 
immune cells alter epithelial cell responses to the parasite and futher justifies the in vivo 
validity of our observations. To thoroughly decipher the mechanism underlying the 
observations of Hamano's work, an in vitro approach as done in our work, should be 
undertaken by employing transwell cultures of hemopoeitic/non-hemopoeitic cells from 
different KO mice. 
One critical issue to be resolved is to identify the specifie factor(s) that are responsible 
for induction of chemokines and stress proteins from IEC. The principle immune cell 
activator Gal-Iectin was not able to induce any response from IEC. This is not surprising 
given the normal hyporesponsive status of IEC. It is not clear if a single or multiple 
moieties in amebic components induce IEC responses similar to those reported using 
soluble mediators from probiotic bacteria (9). Clearly, proteomic studies should be 
undertaken to identify and characterize the factors responsible for these beneficial effects. 
Putting these three observations together, we envisage a model (see Fig. III) whereby 
epithelial cells sense the ameba and respond by producing chemokines with the resultant 
homing of immune cells to mucosal tissue. Immune cells cou Id be successful in clearing 
the infection or fail to kill the trophozoites with varying degrees of tissue destruction; 
depending on severa! factors such as activation state of immune cells or virulence of the 
invading ameba. A leaky epithelium might result in immune cell activation by Eh Gal-
lectin and other opportunistic microbes via TLRs, aggravating the inflammation. Immune 
cell secretion of lytic agents such as NO and H20 2 can cause apoptosis of IEC and form 
foci of infections. Such a situation might result in systemic invasion of pathogens. 
However, the ho st has developed several mechanisms su ch as stress response to avoid 
such unwarranted inflammatory response and apoptosis. A disturbance and imbalance in 
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any of these events will give rise to different scenarios of asymptomatic, intestinal and 
systemic disease states in individuals infected with amebic trophozoites . 
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Fig. III: Model for dynamic host-parasite interactions and the outcomes during amebiasis: 
Parasite activating a non-classical pathway of NF-KB via Akt induces chemokine, MCP-l 
secretion from IEC. Homing of macrophages and T cells to the site exposes them to Gal-lectin 
and other microbes, results in enhanced TLR-2 signaling via secretion of pro-inflammatory 
cytokines IL-l~ and also cytolytic agents such as HzOz. Cytokines induce pro-inflammatory 
molecules such as TNF-a from IEC via the classical NF-KB pathway and the ROS induce 
apoptosis in IEe. However, ameba induced heat shock proteins suppress IKK activity and 
suppress inflammatory response of IEe. Hsp also rescue IEC from apoptotic effects of ROS. 
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Appendix 
Thesis guidelines state that "Theses involving human participants, animal subjects, 
microorganisms, living celIs, other biohazards, and/or radioactive materials, shall 
include the appropriate compliance certification." 
The required documents are appended in the following pages. 
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